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Abstract
Healthcare is evolving. Reimbursement is transitioning to a model based on quality and
patient outcomes. To remain relevant and survive this transition, providers of care must adapt
and implement new models of care delivery that account for these changes. This toolkit was
created as a deliverable of a Doctor of Nursing Practice dissertation that explored a successful
primary care delivery model of a Patient-Centered Medical Home that utilized an
interdisciplinary team approach that included nurses. Through this model high quality care was
delivered to achieve desired outcomes, specifically, successful attestation for Stage 2 of the
Meaningful Use Incentive Program during the first quarter of 2014. This toolkit was created as a
result of the exploration of this model in order to inform others regarding structures and
processes that can be integrated to meet the requirements of Stage 2 Meaningful Use. To do so,
this toolkit describes the structure utilized by practice of interest, including the roles of vital staff
members. Processes that result in meeting Meaningful Use objectives are also described, many in
the form of decision trees. The toolkit also includes an example of what an investment in this
model would entail along with guidelines for model replication. This toolkit provides a
framework for success in meeting Meaningful Use Stage 2 requirements.
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Introduction
The United States healthcare system is currently in a state of reform. Reimbursement is
advancing from a fee-for-service model to one based on value and quality outcomes. To remain
relevant and capitalize on new reimbursement opportunities, the way care is delivered must also
evolve.
To spur advancement in healthcare delivery, the federal government has created various
incentive programs. Two such programs are the Medicare and Medicaid Electronic Health
Record (EHR) Incentive Programs, collectively known as Meaningful Use. The Meaningful Use
Programs challenge eligible professionals (EPs) to integrate health information technology (HIT)
in a manner that will improve care delivery and, therefore, patient outcomes. Meaningful Use is
comprised of three stages, each building upon the previous. The first stage, Stage 1, has the set
goal of improving data capture and sharing (HealthIT.gov, 2015). Stage 2 requires the attainment
of all Stage 1 objectives with some additional requirements, setting the goal to advance clinical
processes. The final stage, Stage 3, aims to improve patient health outcomes. EPs are able to
participate in one Meaningful Use program (Medicaid or Medicare) per payment year (CMS,
2012a). EPs who participate benefit from, not only enhancing the quality of care delivered, but
also from the reimbursement offered through the program when the criteria associated with the
stage pursued is successfully met.
Despite the benefits of participating in Meaningful Use, many EPs are struggling to meet
the demands presented by the multiple objectives required for meeting each stage of the
program, particularly those associated with Stage 2. Therefore, a toolkit has been created by
Centers for Medicare & Medicaid Services (CMS) to provide information and resources for
eligible professionals, eligible hospitals, and critical access hospitals to use as they strive to

effectively utilize HIT and create reports reflective of its use in preparation for Stage 2
Meaningful Use attestation (Appendix).
This toolkit, however, does not provide suggestions regarding structures or processes that
can aid in meeting the objectives. Therefore, this process improvement toolkit which delineates
the structures and processes developed by the exemplar clinic, a privately owned private practice
that successfully attested for Stage 2 Meaningful Use during the first year of attestation, was
created. The exemplar provided by the clinic demonstrates how an interdisciplinary team and
associated processes are utilized to improve patient care delivery. Through proper documentation
and the creation of reports through the EHR, this practice demonstrated how Stage 2 Meaningful
Use can be attained.
A collection of processes that have been effective at the exemplar practice in meeting
Stage 2 Meaningful Use core objectives as they relate to diabetes control, in particular, is
provided in this toolkit. For this example, hemoglobin A1c levels, which are elevated in
uncontrolled diabetes, were chosen as the outcome measure of interest. Processes utilized by the
exemplar practice to meet Stage 2 objectives are described as they attempt to address elevated
A1c levels and illustrate how each member of the interdisciplinary team is utilized to the fullest
scope of their training and education. This measure was chosen as diabetes is on the rise
(Casagrande, Fradkin, Saydah, Rust, & Cowie, 2013) and A1c is a difficult measure for primary
care practices to address. Users of this toolkit are able to design additional workflow processes,
utilizing the structures described, to address additional outcome measures.
Materials derived from the exemplar practice that are found in this toolkit, include:


role descriptions for the innovative team member roles,



step-by-step instructions regarding how to create and run a population report (for A1c
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levels, as an example) in the Allscripts electronic health record (EHR) which can be
adapted to other EHR products per their respective reporting systems,


tables describing the investment required to develop the interdisciplinary team structure,



decision trees delineating processes and interdisciplinary team members needed to
address abnormal results or quality indicators that require interventions identified by the
population report,



a step-by-step example of how processes flow through the interdisciplinary team to
address one patient’s needs while meeting nearly every Stage 2 objective, and



a discussion delineating how the remaining Stage 2 objectives can be met through this
interdisciplinary team model.
These documents emphasize the need for the advanced training and education of nursing

roles within the ambulatory care setting based on the demand for processes essential to achieving
Meaningful Use Stage 2. Practices wishing to obtain outcomes similar to those achieved by the
exemplar practice can utilize this process improvement toolkit to guide the replication of
structures and processes that have been vital to the success of the exemplar practice.
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Frequently Used Abbreviations
Accountable Care Organization

ACO

Blue Cross Blue Shield of Michigan

BCBSM

Centers for Medicare and Medicaid Services

CMS

Certified Medical Assistant

CMA

Computerized Provider Order Entry

CPOE

Department of Transportation

DOT

Electronic Health Record

EHR

Electronically Protected Health Information

ePHI

Eligible Professional

EP

Health Insurance Portability and
Accountability Act

HIPPA

Health Level 7

HL7

Hemoglobin A1c

A1c

Information Technology

IT

Licensed Practical Nurse

LPN

Michigan Care Improvement Registry

MCIR

Meaningful Use Stage 2 Objective

MUO

National Committee for Quality Assurance

NCQA

Patient-Centered Medical Home

PCMH

Physician Health Organization

PHO

Physician Quality Reporting System

PQRS

Registered Nurse

RN
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Meaningful Use Stage 2 Core Objectives
1. Computerized provider order entry (CPOE)
2. Generate and transmit prescriptions electronically, when permissible
3. Record patient demographics, including sex, ethnicity, race, preferred language,
and date of birth, within the EHR
4. Within the EHR, record vital signs, including height/length, weight, blood
pressure (if over the age of 3), BMI, and plot growth charts that can be displayed
for patients under the age of 21
5. Record smoking status for patients over the age of 12
6. Utilize clinical decision support tools for high-priority health conditions
7. Provide patients the ability to download, view, and transmit their personal health
information
8. Provide patients with a clinical summary after each visit
9. Protect electronic health information
10. Incorporate clinical lab-test results as structured data within the EHR
11. Generate lists of patients with specific conditions as a means of monitoring and
improving population health
12. Identify patients, utilizing clinically relevant information, who should receive
reminders for preventive and follow-up care, per patient preference
13. Identify resources for patient-specific education utilizing certified EHR
technology
14. Perform medication reconciliation
15. Provide a summary care record for each care transition or referral
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16. Submit electronic data regarding immunizations to registries
17. Utilize secure electronic messaging to communicate relevant health information
to patients
(CMS, 2012b)
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An Interdisciplinary PCMH Model
The model of the Patient-Centered Medical Home that is applied at the exemplar practice
utilizes an interdisciplinary team. The image below depicts this model.

(Conrad, 2014)
This model is not hierarchical. It is patient-centered. In this way, the right team member
can provide the patient with appropriate, timely care, within the scope of the team member’s
education and training. Therefore, if a patient calls requesting a same-day appointment for a sick
visit, the scheduler has the autonomy to fit the patient in the schedule. If a patient is diabetic and
due for a foot exam, the CMA or nurse rooming the patient can ensure easy access to the
patient’s feet for the foot exam. If a patient calls needing a refill of a chronic care medication, the
phone nurse is also enabled to fulfill this task under the guide of specified protocols. Such a
foundation enables team members to enact all facets of the PCMH delivery model without direct
10

supervision from a provider.
In addition, each member of the team has access to the EHR. Through the portal, the
patient is enabled to take an active role in promoting his or her health and is able to view
personal health information. The EHR also enables communication with the broader healthcare
neighborhood through health information exchanges and registries. This heightened
communication enhances care coordination and, therefore, quality.
As depicted in the image, incentive programs provided by payers assist in bridging the
payment gap that exists for value-based services, enabling survival of the interdisciplinary
PCMH model. Currently, incentive programs provide added reimbursement to the traditional feefor-service payment structure. As reimbursement continues to evolve, payment structures will
shift to reimburse practices for quality and value added services. Practices will be expected to
provide care meeting quality and outcome standards or risk payment reduction penalties from
insurers who once provided the incentives. Therefore, it is imperative to create the structures and
processes that will be required for sustainability.
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Roles within the Interdisciplinary Team
In the interdisciplinary model of the PCMH, each team member is highly valued for their
unique skill set and abilities. This diagram below provides a depiction of the various possible
nursing roles. Each team member can access the EHR when necessary for patient care, direct or
indirect. This enables the effective transfer of information and enhances the team approach to
patient care delivery.

CMA

CMA

CMA
IT Nurse

Note: Adapted from “An innovative model utilizing the interdisciplinary healthcare team in the
primary care patient centered medical home” by Conrad, 2014.
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Role Descriptions
Role descriptions for the staff members utilized in the interdisciplinary team at the
exemplar practice are described in this section as they are uniquely utilized to conduct processes
resulting in Stage 2 Meaningful Use attainment. These role descriptions can assist with
replicating an interdisciplinary team model that uses nursing personnel. They also promote
conversation regarding the use of staff to the fullest extent of their education and training and
exploration regarding how all staff members can best be utilized to promote the delivery of cost
and quality effective care.
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ROLE: Information Technology Nurse
GENERAL RESPONSIBILITIES: Under the direct supervision of the Practice Administrator
to perform specific tasks related to patient care and the effective operations of the Practice.
SPECIFIC RESPONSIBILITIES:

















Create and run population health management reports to be addressed by the quality
team.
Manage PCMH requirements and capabilities, assuring standards continue to be meet.
Maintain PCMH NCQA requirements for certifications and prepares for annual audits.
Works in collaboration with the PHO on various projects and initiatives.
Annually reviews care standards and standing orders with providers to assure they are
up-to-date based on most recent clinical guidelines.
Acts as a liaison for quality improvement projects, such as the PQRS between the
practice, PHO, and ACO.
Coordinate MU processes throughout the practice, responsible for determining how
each measure can be achieved, modify policies and workflow as necessary to meet
these measures.
Provides ongoing education to staff and providers regarding necessary processes to
achieve MU requirements.
Acts as an onsite IT resource for staff regarding issues encountered on a daily basis.
Customizes the EHR to enhance workflow, optimize reimbursement and capture
processes meeting incentive criteria.
Schedules upgrades and updates for the EHR and practice management side.
Coordinates with IT consultant to assure maintenance of onsite technology.
Attends conferences for continuing education of the EHR and discusses IT with
vendors to broaden understanding of latest capabilities.
Maintain HIPPA and strict security of access codes, logins, and electronic health
information.
Take initiative to perform additional responsibilities as identified as necessary.
Perform additional responsibilities assigned by the Practice Administrator.

QUALIFICATIONS: RN or LPN credentials required with a minimum of two years of
experience in the clinic settings.
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ROLE: Clinical Quality Coordinator
GENERAL RESPONSIBILITIES: Under the direct supervision of the Practice Administrator
to provide clinical coordination of all Practice Quality Measures.
SPECIFIC RESPONSIBILITIES:

Provide monthly assessment of national care standards and care standards set by
insurers along with an assessment of the measures taken to ensure their adherence.

In conjunction with the Practice Administrator, develop new care standards and clinical
protocols with defined processes meeting newly identified standards.

Assessment, improvement, and development of current EHR adaptations as they relate
to quality patient care with trainings for providers and staff.

Provide yearly assessment of payer quality programs and incentives and develop action
plan to ensure practice processes in place to capture available monies.

Provides leadership and direction to the Nursing Team Coordinators for the daily
huddles. (alerts, referrals, labs needed, care standards, refills, vitals, other)

Supervision of Quality Team; including Scheduling Supervisor, CMA, Patient
Coordinator, and all clinical staff.

Provide clinical supervision of patient portal.

Provide monthly reporting to Practice Administrator and providers as to quality
measures and processes.

Supervise and provide Medicare Wellness Visits; including requirements governed by
CMS, update and maintain current policy and procedures for the appointment.

Develop and initiate group visits for chronic conditions; specifically diabetes and other
conditions with Practice Care Standards in place.

Provide Chronic Care Coordination, including; patient education via billable phone
encounters, nurse office visits, e-visits, and co-ordination of patient self-management
goals in conjunction with providers.

Assist with clinical supervision.

Performs additional responsibilities as directed by the Practice Administrator, and the
Physicians.
QUALIFICATIONS: RN Credentials required. Experience is preferred.
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ROLE: Nursing Team Coordinator
GENERAL RESPONSIBILITIES: Under the direct supervision of the Nursing Supervisors
and the Clinical Quality Coordinator to provide supervision and management of the daily
workflow and the staffing needed to perform effective patient services for the providers.
SPECIFIC RESPONSIBILITIES:
















Provides leadership and direction for the clinical staff assigned in their work area;
specifically, supervising the daily huddles, maintaining communication with all team
members, and providing oversight for the assessment and provision of services which
meet all Practice Clinical Standards of Care.
Ensures that the daily flow of the scheduled patients and the efficiencies of the staff are
maximized. Works in conjunction with other supervisory staff promoting teamwork
and comprehensive quality services to the patients. Assigns specific work tasks to staff
in their work area as time permits.
Communicates to the Providers, Supervisors, and Practice Administrator any needs for
patient service; both immediate and long-term. Engage in quality oversight of the Care
Standards with other team members.
Supervises and assists the other clinical staff in the assessment, preparation and
administration of immunizations and their documentation. Specifically, supervising the
MCIR paperwork, the orders in the charts, the drawing up of immunizations, the
administering of the immunizations and the completion of all documentation.
Working in conjunction with the Clinical Supervisors and the Quality Coordinator,
responsible for the day-to-day mentoring, training and evaluation of new staff and
students. Responsible for assisting and training on new office procedures and
equipment as needed.
Supervises all provider communication to patients pertinent to specific work area and
daily needs; specifically all emergent faxes, phone calls for patient education, refills
and any daily paperwork which needs completion.
Supervises and ensures that patients receiving narcotic prescriptions have a current
narcotic contract and all office procedures are followed for random drug screening and
oversight of narcotic use.
Assists Providers with examinations and procedures as needed. Update all health
maintenance items for the patients and order testing and procedures as outlined by
Practice Standards of Care.
Schedules same day appointments for outpatient procedures and communicates dates,
times and patient prep information to the patient.
Performs all aspects of the RN/LPN job responsibilities as described in those job
descriptions.
Performs additional responsibilities as directed by the Clinical Supervisor, Practice
Administrator, Team Leaders and/or the Providers.

QUALIFICATIONS: RN or LPN credentials required. Experience in the Practice is required.
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ROLE: Quality Team Member
GENERAL RESPONSIBILITIES: Under the direct supervision of the Practice Administrator
and the Quality Clinical Coordinator, to perform patient related duties which increase the
effective operations of the Practice.
SPECIFIC RESPONSIBILITIES:

Receives monthly performance reports from the Reporting Module regarding patient
needs based on a variety of chronic illness care standards and insurance requirements.
Works these reports by monitoring charts and outside consults, calling patients and
generating reminders to the providers.

Receives insurance qualification forms after patient visits to be verified and processed
according to insurer’s guidelines.

Follows up daily with Central Scheduling at the local hospital to make certain patients’
ordered test has been scheduled and patients notified. Checks the Queue in the EHR to
keep abreast of daily orders from the providers as well.

As needed, schedules appointments for outpatient procedures at out-lying hospitals and
offices, and communicates dates, times and patient prep information to the patient.

Follows up with ordered hospital tests to make sure they were performed, that the
Provider saw the results and that the patients were notified. Accesses the hospital EHR,
as needed, to obtain necessary records.

Makes certain the procedure box in the patients’ EHR chart shows that the order was
final and reviewed. Checks the aggregate procedure box daily for tests which have not
been resulted. Follows up as necessary.

Performs a daily check of the Output Queue to find patients’ orders which may need
prior authorizations for testing. Contacts appropriate prior authorization management
company via phone, fax, or webpage to obtain the prior authorization. As needed,
contacts the patient and/or the facility regarding the decision.

Working in conjunction with the IT nurse, performs a periodic immunization audit
which includes searching MCIR records, running office reports on immunizations
scheduled and given, searching charts for proper documentation and correcting as
needed.

Prints out MCIR reports for new patient office visits, records immunization history in
the EHR and prints out MCIR reports for patients as requested.

Maintains system for accurately recording and reporting patient conditions in the
medical record.

Maintains confidentiality of patient information according to Practice policies and
governmental regulations such as HIPAA and others.

Follows provider’s directives regarding communication to patient; i.e. test results,
provider orders, and patient education.

Participates in all training and monthly clinical meetings as required for clinical staff.

Performs additional responsibilities as directed by the Clinical Supervisor, Practice
Administrator, Team Leaders and/or the Providers.
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QUALIFICATIONS: CMA, LPN or RN credentials required. At least two years of experience
is required. Must have successfully completed the Drug Screening Training given at the Practice.
Demonstrated ability in computer skills and knowledge of internet is necessary.
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ROLE: Phone Nurse
GENERAL RESPONSIBILITIES: Under the direct supervision of the Clinical Supervisor to
receive incoming requests from patients, relay messages to providers, and follow up by making
return calls with advice or results from providers in order to increase the effective operations of
the Practice.
SPECIFIC RESPONSIBILITIES:












Takes incoming calls, as able, pulls charts, and maintains system for accurately
recording and reporting patient information, conditions, and/or requests in the medical
record.
Retrieves messages from the phone audix in a timely manner so that patient issues are
addressed as soon as possible.
Maintains confidentiality of patient information according to Practice policies and
governmental regulations such as HIPAA and others. Reports all reportable diseases to
the Health Department.
Handles problems or requests from patients who walk into the office without an
appointment. Reads TB tests, documents results, and gives patient the needed proof of
results.
Make action items to alert phone nurse of procedures and testing needing to be
scheduled. Calls patients to assure appointments have been scheduled for repeat tests.
Daily checks nurse message box for charts containing prior authorizations awaiting
approval and those awaiting patient response.
When caught up on phone nurse inbox, checks for messages in message nurse inbox
that which need to be addressed. Assists nurses in clinical area if necessary.
Makes effort to contact patients in message nurse inbox every other day to weekly until
patients are notified of results or provider instructions are received.
Schedules appointments for outpatient procedures and communicates dates, times and
prep information to patients. Records pertinent test in Providers’ appointment book.
Follows providers’ directives regarding communication to patient; i.e., normal and
abnormal test results, Providers’ orders and patient education. Explains abnormal test
findings. Calls medical prescriptions to pharmacies.
Performs additional responsibilities as directed by the Clinical Supervisor, Practice
Administrator, Team Leaders and/or the Providers.

QUALIFICATIONS: RN or LPN Credentials required. Experience with the Providers and
with this Practice is required.
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ROLE: Point of Care Registered Nurse/Licensed Practical Nurse
GENERAL RESPONSIBILITIES: Under the direct supervision of the Clinical Supervisor to
perform patient related duties which increase the effective operations of the Practice.
SPECIFIC RESPONSIBLITIES:


















Performs routine pre-examination procedures including taking vital signs and assessing
and recording objective and subjective data concerning patient’s presenting condition.
Assists Providers with examinations and procedures.
Prepares charts for upcoming patient visits. Identifies patient needs that must be updated
such as annual blood work or annual physical. Based on protocols, orders appropriate
testing. Communicates with scheduling, as appropriate, to coordinate changes in plan of
care with patient.
Performs patient care measures including injections, minor dressing changes and routine
laboratory tests and treatments as directed by providers and standing orders.
Prepares and cleans the patient area; sets up equipment, cleans and facilitates room set up
after procedure. Maintains a clean and safe environment for patients and co-workers.
Calibrates and checks equipment according to schedule or prior to use.
Maintains system for accurately recording and reporting patient conditions in the medical
record; verifying patient insurance and demographic information.
Maintains confidentiality of patient information according to Practice policies and
governmental regulations such as HIPAA and others.
Follows provider’s directives regarding communication to patient; i.e., normal and
abnormal test results, provider orders, and patient education. Explains abnormal test
findings.
Calls Medical prescriptions to pharmacies either by phone or using e-prescribe.
Work from protocols and utilize CPOE, as needed.
Schedules appointments for outpatient procedures and communicates dates, times and
patient prep information to the patient.
Performs substance abuse testing consistent with non-DOT and DOT guidelines and
Practice Policies and Procedures. Works with occupational clients to perform these tests
as ordered. Communicates appropriately with occupational clients regarding patient
issues.
Obtain updated patient narcotic contracts, as needed.
Performs additional responsibilities as directed by the Clinical Supervisor, Practice
Administrator, Team Leaders and/or the Providers.

Qualifications: RN or LPN credentials required. Experience is preferred.

ROLE: Point of Care Certified Medical Assistant
GENERAL RESPONSIBILITIES: Under the direct supervision of the Clinical Supervisor to
20

perform patient related duties which increase the effective operations of the Practice.
SPECIFIC RESPONSIBILITIES:











Performs routine pre-examination procedures including taking vital signs and assessing
and recording objective and subjective data concerning patient’s presenting condition.
Assists Providers with examinations and procedures.
Performs Patient care measures including injections, minor dressing changes and
routine laboratory tests and treatments as directed by Providers.
Prepares and cleans the patient area; sets up equipment, cleans and facilitates room set
up after procedure. Maintains a clean and safe environment for patients and co-workers.
Maintains system for accurately recording and reporting patient conditions in the
medical record; verifying patient insurance and demographic information.
Work from protocols and utilize CPOE, as needed.
Maintains confidentiality of patient information according to Practice policies and
governmental regulations such as HIPAA and others.
Follows provider’s directives regarding communication to patient; i.e. test results,
provider orders, and patient education.
Schedules appointments for outpatient procedures and communicates dates, times and
patient prep information to the patient.
Performs additional responsibilities as directed by the Clinical Supervisor, Practice
Administrator, Team Leaders and/or the Providers.

QUALIFICATIONS: CMA credentials required. Experience is preferred.
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ROLE: Referral Specialist
GENERAL RESPONSIBILITIES: Under the direct supervision of the Practice Administrator,
will assist in the effective operation of the practice by serving in the front office.
SPECIFIC RESPONSIBILITIES:













Assures the receipt of referral notes, correspondence, surgical notes, consultations, test
interpretations, and other medical information
Verifies accuracy of patient information, such as name, numbers and dates for
recording on transcribed reports
Responsible for data entry and maintenance via Michigan Health Connect
Send electronic clinical record via e-fax to offices receiving patient referrals
Fax authorizations for medical information release to noted destinations
Ensures correct grammar, punctuation and spelling while maintaining the meaning of
the sentence in transcribed reports
Request referral consultations for patients as directed by providers by sending a patient
summery via eFax if the receiving facility has the capability of receiving ePHI
For facilities not capable of receiving ePHI, referral consultations are to be requested
over the phone and faxed
Once a referral is accepted, documents the date, time, and location in the patient chart
Maintaining an up-to-date referral resource book so that appropriate referral
information is available
Responsible for ordering office supplies as needed
Perform additional responsibilities as directed by the Practice Administrator and/or the
team leaders and the physicians

QUALIFICATIONS: At least 2 years of experience in transcription as well as competencies in
Word and other basic computer software. Must have excellent communication skills.

Please Note: Role descriptions have been modified and updated from those provided by the
Clinic to meet the needs of this project.
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Example of the Investment of an Interdisciplinary Team Model
Implementing an interdisciplinary team is an investment. There are upfront costs to hiring
highly trained personal above the standard staffing grid. The exemplar practice gradually
increased the number of FTEs allotted for various types of staff members. In this way, an abrupt
increased toll on the staffing budget was avoided as the model developed and was personalized
to the needs of the practice. Table 1 depicts the number of staff members employed by the
exemplar practice during the model development. Table 2 provides the cost of investment for
each position based on year while Table 3 reveals overall payroll expenses for this model each
year. This information is included to serve as a guide. Payroll expenses should be reflective of
standards based on geographical location and other extenuating factors.
Table 1
Number of FTEs by Year
Title/Credential
MA
Quality
Department MA
LPN
RN

For the Year
2009
5.1
1.25

For the Year
2010
5.4
1.25

For the Year
2011
5.6
1.5

For the Year
2012
5.9
1.5

For the Year
2013
5.7
2

3
3.85

3
5

3.5
5.4

3.3
6.2

3.4
6.3

For the Year
2010
$25,005.90
$37,983.82

For the Year
2011
$25,926.37
$34,686.34

For the Year
2012
$26,537.78
$32,906.65

For the Year
2013
$27,249.69
$30,219.13

$37,808.80
$42,023.36

$36,957.98
$41,486.84

$37,428.76
$41,260.73

$41,652.84
$42,632.70

Table 2
Average Wage per FTE
Title/Credential

For the Year
2009
$25,430.17
$37,458.38

MA
Quality
Department MA
LPN
$38,154.41
RN
$43,823.19
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Table 3
Payroll Expense
Title/Credential For the Year
2009
MA
$129,693.85
Quality
$46,822.98
Department
MA
LPN
$114,463.22
RN
$169,104.29
Total Payroll
$460,084.34
Expense

For the Year
2010
$135,031.88
$47,479.77

For the Year
2011
$145,187.66
$52,029.51

For the Year
2012
156,572.91
$49440.98

For the Year
2013
$155,323.21
$60,438.25

$113,426.40
$210,116.81
$506,054.86

$129,352.93
$224,028.91
$550,599.01

$123,514.91
$255,816.52
$585,345.32

$141,619.65
$268,586.02
$625,967.13
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Utilizing the Interdisciplinary Team to Conduct Processes Vital to Stage 2 Attainment
There are a number of ways a practice can meet the requirements of Stage 2 Meaningful
Use objectives (MUOs). The following documents demonstrate how the exemplar practice was
able to do so. This practice not only created an innovative interdisciplinary staffing structure that
supports the demands of Meaningful Use Stage 2 as described in the previous sections, but
developed processes that utilize each team member to the fullest extent of their education and
training, enabling the fulfillment of Stage 2 objectives. The following documents describe some
of these processes and reveal a need for an interdisciplinary team approach to care delivery.
From these documents, parties interested in this interdisciplinary model are able to identify
staffing roles needed for the various processes to be successful. Doing so can inform the
translation of these processes into a format that would be successful within their particular EHR.
The following documents are presented in the order the practice would approach a patient
who has diabetes mellitus (DM), beginning with the identification of patients with DM who have
an elevated A1c and require a follow-up visit. Decision trees are included that demonstrate how
staff members approach these patients to bring them in to that appointment. A step-by-step guide
revealing how the exemplar practice meets the needs of Stage 2 Meaningful Use during the
patient visit through discharge is provided. Lastly, a description of processes utilized to satisfy
the requirements of Stage 2 Meaningful Use that were not addressed by the DM example is
included. Through the use of these processes, the exemplar practice has been able to meet all the
demands of Stage 2 Meaningful Use Menu Objectives. Interested parties are able to use these
documents for replication purposes with the goal of Stage 2 attainment.
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How the IT Nurse Creates a Report: A1c as an Example in the Allscripts EHR
Patients with diabetes mellitus (DM) are closely monitored regarding the control of their A1c
levels. This document provides step-by-step instructions regarding the creation of a population
report (Objective 11) in the Allscripts EHR. This list enables close monitoring of patients with
DM and a way to identify patients in need of follow-up care based on uncontrolled A1c levels.
1.
2.
3.
4.
5.

Open the Reporting Module in Allscripts
Login as System Manager
Click on the Green Plus Sign with symbolizes “Add Report”
A new screen will open entitled “Report Properties”
Fill in the Appropriate Sections
a. Title: Diabetes Mellitus with A1C >= 7 within the past year
b. Status: Enabled (active – working, usable report)
c. Keep for: 365 days (Enables you to see trends on a chart)
d. Segment: All active patients, non-occupational, not deceased (segment =
denominator of report)
e. Criterion: Diagnosis ICD-9 250.
f. Encounter: Not needed if within so many days
or
Within the past year
g. Labs:
Lab Result Value

Days

Most Recent

365

Not Needed If Using
Most Recent

i. Lab Test:
1. Search Term: “A1c” include appropriate lab tests
2. Search Term (LOINC): “4548-4” include appropriate lab tests
3. Search Term (CPT Code): “83036” include appropriate lab tests
6. If “Lab Result Value, Days” was selected, remove “Last Year” from the report as it is
now imbedded within the report. If “Within the Past Year” was selected for the
encounter, keep “Last Year” in the report as this is where the time frame comes from.
7. Assign Action: Potential Actions Include
a. Send Web Message to let Patient Know of Abnormal Lab (Not generally done but
can help qualify for Meaningful Use sending medically relevant messages if
patient responds)
b. Display in Patient Manager (Lets whoever opens the chart that the patient has
been identified as having an A1c out of range in the past year. This can help meet
the clinical decision support tool MUO)
c. Send Messages (To whatever staff is involved in addressing the issue, ie. quality
department)
8. Click on Schedule
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a. Schedule report to be run (Most reports are run on the first of each month and sent
to quality to address those that are not sent to quality are often quarterly)
9. Click Execute to run report for the first initial time (after that it runs automatically)
a. Execute with actions (will create reminders, messages, patient manager)
10. Click Results to view Report
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Quality Department Decision Tree: A1c as an Example
From this point on, each team member who comes in contact with the EHR of a patient who has
been identified by the report as needing a repeat A1c has a responsibility in assuring this is done.
However, after the report runs, it is automatically sent to the quality team. The quality team
examines the report and each patient identified as having an elevated A1c to determine if a
patient-visit is necessary.
CMA in Quality Department
receives report in CERT for
those not meeting goal of an A1c
below 7% in the past 12 months
Was the Last A1c below 7%?
Yes

No

No Further Action Required
Is the last A1c greater than 10%?
Does the patient have an upcoming
office visit of lab work scheduled?
No

Yes

Continue on to
scheduled
appointment

No

Scheduler or quality department
member attempts to contact patient
using the patient’s preferred contact
method to schedule an appointment

Yes

Quality department member creates
an action reminder to follow up
regarding the outcome of the patient
appointment
Was the
patient successfully
contacted?

Yes

Clinical staff sees need for
A1c based on timeframe of
last A1c and puts in a CPOE
for this to be completed

Was the patient
successfully
scheduled?

Yes

No

A1c Normal
Process complete until
next report is run

No

Attempt to contact
patient again using
preferred method or
alternative method

Attempt to contact patient
again using preferred method
or alternative method

A1c Abnormal

Contact patient regarding
elevated A1c and the
process begins again

No

Was the patient
successfully scheduled?

Send message to provider explaining issue with contacting patient. Question whether
discharging patient should be considered. Put a compliance note in the chart.
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Phone Nurse Decision Tree: A1c as an Example
Simultaneously, the phone nurses remain cognizant of patient needs. When a patient calls the
office, the phone nurse is not only addressing the patient’s reason for calling, but is also looking
at the patient’s EHR for notes produced by the report and/or identified by the quality team
pointing to outcome measures that are outside of normal limits, requiring follow up.
Patient calls the office to speak with the phone nurse or the
phone nurse contacts the patient regarding an issue

Phone nurse opens the patient’s chart

Does the Patient Manager show the
patient is in need of an updated A1c?
Yes

No

Continue phone call addressing the
initial reason for the phone call

Is the patient scheduled for an
appointment?
No

Yes

Has a future order already been
created for an A1c to be drawn at that
time?
Yes

No

Notify patient while on the phone that
he/she is due for an A1c.

Does the patient agree to schedule an
appointment?
Yes

No further
action is
required

The phone
nurse utilizes
protocols and
orders the
A1c through
the CPOE

No

The phone nurse
utilizes protocols and
orders the A1c
through the CPOE

The phone nurse makes a note of
this interaction in the patient’s
chart

After the reason for the phone
call is addressed, the patient
phone call is transferred to the
scheduler who will assist the
patient in making an appointment
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Point of Care Nurse Decision Tree: A1c as an Example
When a patient does come to the office for a visit, regardless of the reason, the point of care
nurses are the make sure an up-to-date A1c level is available for the provider for all diabetic
patients.
Patient comes into the office for a
scheduled appointment

Is the patient a diabetic?
No

Yes

Does the Patient Manager
Clinical Decision Support
Tool show a need for an
A1c to be drawn during
this visit?
No

Yes

Is there a future order for
an A1c?
Yes

No need to continue

Did the patient have an A1c
greater than 7% between 3 and
6 months ago?

No
Yes

No

No need to
continue
Utilizing protocols, the
clinical staff member
orders the A1c through the
CPOE

An A1c is drawn by the clinical staff
member when rooming the patient. The
new A1c is then available to the provider
at the beginning of the patient visit.
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No need to continue

An Interdisciplinary Team Approach to meeting Stage 2 Meaningful Use Requirements:
A1c as an Example
The following provides an example of how visit for a patient with diabetes progresses in terms of
meeting Meaningful Use Stage 2 objectives. Please Note: Not all of the Stage 2 Meaningful Use
Objectives (MUOs) are addressed by this example.
1. A report is created by the Project Manager LPN to run at the first of each month to
identify patients active within the practice who have an A1c greater than or equal to 7%
in the past year (Information Technology Nurse) (MUO 11)
2. This list identifying patients who have had an A1c greater than or equal to 7% in the past
year is sent to the quality department (MUO 12)
3. The quality team identifies patients on this list who do not have an upcoming
appointment or blood work ordered (MUO 12)
4. Through the CPOE system, based on standing protocols, a future order for an A1c is
created for patients in in need of a repeat A1c blood draw that is not yet ordered (Quality
Team Member, Point of Care Nurse, or Point of Care CMA) (MUO 1)
5. Those who do not have an upcoming office visit or lab appointment scheduled are
contacted via their preferred method (phone, secure message, etc.) as deemed appropriate
regarding the need for follow up care by scheduling or the quality team (MUO 12)
6. Patient contacted and agrees to schedule an appointment
7. Patient comes in for an office visit
8. Demographic info is recorded/updated (Front Desk) (MUO 3)
9. The patient is brought back to a room (Point of Care Nurse or Point of Care CMA)
10. Vital signs are charted (Point of Care Nurse or Point of Care CMA) (MUO 4)
11. An A1c is run (Point of Care Nurse or Point of Care CMA)
12. The result of the A1c is documented in the EHR for the provider to view upon entering
the room (Point of Care Nurse or Point of Care CMA) (MUO 10)
13. Smoking status for patients greater than 13 years or older is updated/documented (Point
of Care Nurse, CMA, or Provider) (MUO 5)
14. Medication reconciliation is completed (Point of Care Nurse, Point of Care CMA, or
Provider) (MUO 14)
15. Visit is conducted (Provider)
16. Orders for new prescriptions or adjustments in medications are transmitted via eprescribe to the patient’s pharmacy (Provider) (MUO 2)
17. Additional lab work is ordered as deemed appropriate via CPOE (Provider) (MUO 1)
18. The patient is encouraged to sign up for the patient portal (Point of Care Nurse, Point of
Care CMA, Provider, or Clerical Staff) (MUO 7)
19. The patient agrees to sign up for the patient portal and provides their email
20. Patient-specific educational resources are identified through the EHR and given to patient
upon discharge (Point of Care Nurse, Point of Care CMA, or Provider) (MUO 13)
21. The patient is offered a clinical summary of the visit during checkout. This is
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automatically sent to the patient via the portal if the patient has one. A printed copy is
provided if the patient would like a clinical summary but does not have a portal. If the
patient does not wish to receive a clinical summary, the summary is saved to the log and
a note placed in the patient’s chart regarding this (Checkout Desk) (MUO 8)
22. The patient leaves the office
23. The patient is sent an invitation to sign up for the patient portal via the email address
provided during the appointment (Patient Service Representative) (MUO 7)
24. The patient signs up for the portal and has the ability to view, download, and transmit
their health information (MUO 7)
25. The patient receives a secure message in the portal from the Patient Service
Representative notifying patient of lab results and further instruction as necessary. The
patient is asked to send a secure message back to the provider (MUO 17)
26. Patient sends secure message back (MUO 17)
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Meeting the Remaining Meaningful Use Stage 2 Objectives
Objectives 9 and 15: Protect Electronic Health Information and Provide a Summary Care
Record for Each Care Transition or Referral
When the referral specialist makes a referral, if the receiving facility has the capability to
receive the electronically protected health information (ePHI) (MUO 9), a patient summary
regarding what prompted the referral is electronically sent via Consolidated-Clinical Data
Architecture (C-CDA) for practices that have the capability to receive such data or sent through
eFax by the referral specialist to the receiving facility (MUO 15). The receiving office then
contacts the patient regarding the referral if the patient has been accepted and an appointment is
set. A confirmation receipt of the referral and acceptance or decline of the request is then sent
back to the referral specialist from the receiving facility via phone, fax, or, occasionally, via eFax
or C-CDA. A comment regarding this appointment is then attached to the referral order. After
the date of the set appointment, the referral specialist confirms that a consultation note has been
received and makes a note of this, completing the referral process. In this way, pertinent
information is efficiently communicated between facilities and the referral loop is closed.
The health information exchange is also enhancing the referral process and, more
broadly, interoperability (MUOs 9 and 15). Through a health information exchange, the secure
transfer of electronic information across organizations within a particular geographical location
or healthcare system is made possible. Referrals can be made through the health information
exchange used by organizations within the same geographical vicinity. To do so, the referral
specialist sends pertinent patient’s information to the receiving facility through the EHR. Using a
secure login, the referral specialist then accesses the exchange. A referral form is then completed
containing additional information and notifying the receiving facility they have access to patient
information through the EHR. The referral specialist and receiving facility are then able to
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communicate via secure messaging through the health information exchange as needed. Clinic
team members then have access to the patient note after the referral visit is complete through the
EHR to close the loop.
Objectives 9 and 16: Protect Electronic Health Information and Submit Electronic Data
Regarding Immunizations to Registries
The MCIR for immunizations is currently being utilized to communicate data in a oneway fashion (MUO 16) (MCIR, 2015). When an individual is immunized or an immunization is
updated, clinical staff accesses the MCIR through a secure login and, from the EHR, enters the
immunization information. Because the Clinic has an HL7 interface that enables communication
to the registry, this information is automatically transferred from the EHR and recorded in the
MCIR to meet the requirement of core objective 16 in Stage 2 Meaningful Use. As technology
and software continues to advance, communication between healthcare entities and registries will
continue to move toward true interoperability where two-way communication will be possible, a
goal of Stage 3 Meaningful Use.
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Model Replication Guidelines
For practices interested in model replication, a phased-in approach to model replication
may be financially advisable. Users interested in such an approach may consider adding, based
on the potential return-on-investment, an information technology nurse first, followed by a
quality nurse, and then add to the quality team with certified medical assistants (CMAs). A
phone nurse or phone nurses (versus the use of CMAs on the phone) and point of care nurses
may then also be considered. Such a phased-in approach would ease the initial financial burden
inherited with this model and aid users in tailoring the model to meet the needs of a particular
practice.
When examining the investment of diversifying the interdisciplinary team with these staff
members, toolkit users must take note that FTEs and wages should be adjusted when replicating
this model to remain effective and competitive in the market. Therefore, geographical location,
demand, and the size of the practice should be considered. Following such guidelines are
presumed to smooth the transition to this interdisciplinary team model of primary care delivery.

For questions pertaining to this model and its replication, the author of this toolkit, Katie
Alfredson, can be contacted via email: alfredsk@mail.gvsu.edu
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Appendix
The Medicare and Medicaid Electronic Health Record (EHR) Incentive Programs: Stage 2
Toolkit
Please Note: The following document was created by the Centers for Medicare & Medicaid
Services (2013) and can be found on the website http://www.cms.gov/Regulations-andGuidance/Legislation/EHRIncentivePrograms/Downloads/Stage2_Toolkit_EHR_0313.pdf
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About this Toolkit

This Stage 2 Toolkit is an interactive document that provides users with resources
and information about Stage 2 of the EHR Incentive Programs and 2014 Clinical
Quality Measure requirements. The toolkit includes materials for eligible
professionals (EPs), eligible hospitals, and critical access hospitals (CAHs).

Table of Contents

The table of contents is interactive and includes bookmarks. Users can click on a
resource to be directed to that section of the PDF. By clicking on the title of the
resource, users can return to the table of contents.
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EHR Incentive Programs
Stage 2
The Basics


Stage 2 Overview Tipsheet – provides an overview of the major provisions
included in the Stage 2 rule



Stage 1 Changes Tipsheet – focuses on the changes that were made to Stage 1
of meaningful use in the Stage 2 rule



2014 Clinical Quality Measures Tipsheet – provides information on the next
phase of Clinical Quality Measures (CQMs) and how to report them to meet
meaningful use in 2014 and beyond
Stage 2 FAQs – provides answers to questions about the Stage 2 rule and how
it affects hospitals and EPs
2014 eCQM Resources – lists all of the 2014 CQM webpages and resources




Resources for Eligible Professionals (EPs)
Stage 2 Details


Stage 2 Meaningful Use Specification Sheet Table of Contents for Eligible
Professionals – lists all the core and menu objectives for EPs, with direct links
to each individual measure specification sheet (requires internet access to view
spec sheets)



Stage 1 vs. Stage 2 Comparison Table for Eligible Professionals – compares core
and menu measures from Stage 1 with measures for Stage 2 of meaningful use
for EPs



Payment Adjustments & Hardship Exceptions Tipsheet for Eligible Professionals
– provides an overview of the payment adjustment and hardship exceptions
included in the Stage 2 rule for EPs
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– contains information about changes made to 2011 CQMs for the measures
that were kept as part of the 2014 CQMs for EPs


Full Table of Recommended Adult Measures – lists the 9 CQMs in the
recommended core set for the adult population



Full Table of Recommended Pediatric Measures – lists the 9 CQMs in the
recommended core set for the pediatric population

Resources for Eligible Hospitals & Critical Access Hospitals(CAHs)
Stage 2 Details


Stage 2 Meaningful Use Specification Sheet Table of Contents for Eligible
Hospitals and CAHs – lists all the core and menu objectives for eligible hospitals
and CAHs, with direct links to each individual measure specification sheet
(requires internet access to view spec sheets)



Stage 1 vs. Stage 2 Comparison Table for Eligible Hospitals and CAHs –
compares core and menu measures from Stage 1 with measures for Stage 2 of
meaningful use for eligible hospitals and CAHs



Payment Adjustments & Hardship Exceptions Tipsheet for Eligible Hospitals and
CAHs – provides an overview of the payment adjustment and hardship
exceptions included in the Stage 2 rule for eligible hospitals and CAHs

2014 CQMs


2014 CQMs for Eligible Hospitals [PDF, 377KB] – provides the description and
definition statements for the 64 CQMs for use by eligible hospitals in the EHR
Incentive Programs beginning in 2014



Technical Release Note 2014 eCQMs for Eligible Hospitals [PDF, 362KB] –
contains information about changes made to 2011 CQMs for the measures
that were kept as part of the 2014 CQMs for eligible hospitals
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Stage 2 Overview Tipsheet

THE BASICS
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Stage 2 Overview Tipsheet

Last Updated: August, 2012

Overview
CMS recently published a final rule that specifies the Stage 2 criteria that eligible professionals (EPs),
eligible hospitals, and critical access hospitals (CAHs) must meet in order to continue to participate in
the Medicare and Medicaid Electronic Health Record (EHR) Incentive Programs.
If you have not participated in the Medicare or Medicaid EHR Incentive Programs previously, or if you
have never achieved meaningful use under the Stage 1 criteria, please visit the CMS EHR Incentive
Programs website (www.cms.gov/EHRIncentivePrograms) for more information about how to take part
in the program.
Stage 2 Timeline
In the Stage 1 meaningful use regulations, CMS had established a timeline that required providers to
progress to Stage 2 criteria after two program years under the Stage 1 criteria. This original timeline
would have required Medicare providers who first demonstrated meaningful use in 2011 to meet the
Stage 2 criteria in 2013.
However, we have delayed the onset of Stage 2 criteria. The earliest that the Stage 2 criteria will be
effective is in fiscal year 2014 for eligible hospitals and CAHs or calendar year 2014 for EPs. The table
below illustrates the progression of meaningful use stages from when a Medicare provider begins
participation in the program.
Stage of Meaningful Use
1st Year

2011
2012
2013
2014
2015

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

1

1

1

2

2

3

3

TBD

TBD

TBD

TBD

1

1

2

2

3

3

TBD

TBD

TBD

TBD

1

1

2

2

3

3

TBD

TBD

TBD

1

1

2

2

3

3

TBD

TBD

1

1

2

2

3

3

TBD

1

1

2

2

3

3

1

1

2

2

3

2016
2017

Note that providers who were early demonstrators of meaningful use in 2011 will meet three
consecutive years of meaningful use under the Stage 1 criteria before advancing to the Stage 2 criteria in
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2014. All other providers would meet two years of meaningful use under the Stage 1 criteria before advancing to
the Stage 2 criteria in their third year.
In the first year of participation, providers must demonstrate meaningful use for a 90-day EHR reporting
period; in subsequent years, providers will demonstrate meaningful use for a full year EHR reporting
period (an entire fiscal year for hospitals or an entire calendar year for EPs) except in 2014, which is
described below. Providers who participate in the Medicaid EHR Incentive Programs are not required to
demonstrate meaningful use in consecutive years as described by the table above, but their progression
through the stages of meaningful use would follow the same overall structure of two years meeting the
criteria of each stage, with the first year of meaningful use participation consisting of a 90-day EHR
reporting period.
For 2014 only

All providers regardless of their stage of meaningful use are only required to demonstrate meaningful
use for a three-month EHR reporting period.
o

o

For Medicare providers, this 3-month reporting period is fixed to the quarter of either the
fiscal (for eligible hospitals and CAHs) or calendar (for EPs) year in order to align with
existing CMS quality measurement programs, such as the Physician Quality Reporting
System (PQRS) and Hospital Inpatient Quality Reporting (IQR).
For Medicaid providers only eligible to receive Medicaid EHR incentives, the 3-month
reporting period is not fixed, where providers do not have the same alignment needs.

CMS is permitting this one-time three-month reporting period in 2014 only so that all providers who
must upgrade to 2014 Certified EHR Technology will have adequate time to implement their new
Certified EHR systems.
Core and Menu Objectives
Stage 1 established a core and menu structure for objectives that providers had to achieve in order to
demonstrate meaningful use. Core objectives are objectives that all providers must meet. There are also
a predetermined number of menu objectives that providers must select from a list and meet in order to
demonstrate meaningful use.
For many of the core and menu objectives, exclusions were provided that would allow providers to
achieve meaningful use without having to meet those objectives that were outside of their normal
scope of clinical practice. Under the Stage 1 criteria, EPs had to meet 15 core objectives and 5 menu
objectives that they selected from a total list of 10. Eligible hospitals and CAHs had to meet 14 core
objectives and 5 menu objectives that they selected from a total list of 10.
Stage 2 retains this core and menu structure for meaningful use objectives. Although some Stage 1
objectives were either combined or eliminated, most of the Stage 1 objectives are now core objectives
under the Stage 2 criteria. For many of these Stage 2 objectives, the threshold that providers must meet
for the objective has been raised. We expect that providers who reach Stage 2 in the EHR Incentive
Programs will be able to demonstrate meaningful use of their Certified EHR Technology for an even
larger portion of their patient populations.
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Some new objectives were also introduced for Stage 2, and most of these were introduced as menu
objectives for Stage 2. As with the previous stage, many of the Stage 2 objectives have exclusions that
allow providers to achieve meaningful use without having to meet objectives outside their normal scope
of clinical practice.
To demonstrate meaningful use under Stage 2 criteria—

 EPs must meet 17 core objectives and 3 menu objectives that they select from a total list of 6,
or a total of 20 core objectives.
 Eligible hospitals and CAHs must meet 16 core objectives and 3 menu objectives that they
select from a total list of 6, or a total of 19 core objectives.
The end of this tipsheet contains a complete list of the Stage 2 core and menu objectives for both EPs
and eligible hospitals and CAHs. Providers can also download a table of the Stage 2 core and menu
objectives and measures by clicking on the links below:
 Stage 1 vs. Stage 2 Comparison Table for Eligible Professionals
 Stage 1 vs. Stage 2 Comparison Table for Eligible Hospitals and CAHs
New Objectives & New Measures
Though most of the new objectives introduced for Stage 2 are menu objectives, EPs and eligible
hospitals each have a new core objective that they must achieve. CMS believes that both of these
objectives will have a positive impact on patient care and safety and are therefore requiring all providers
to meet the objectives in Stage 2.
Use secure
messaging to communicate with patients on relevant health
New
Stage 2electronic
Core Objectives:
information (for EPs only)

Automatically track medications from order to administration using assistive technologies in
conjunction with an electronic medication administration record (eMAR) (for Eligible
Hospitals/CAHs only)

45

Stage 2 also replaces the previous Stage 1 objectives to provide electronic copies of health information
or discharge instructions and provide timely access to health information with objectives that allow
patients to access their health information online.
Stage 2 Patient Access Objectives:

Provide patients the ability to view online, download and transmit their health information
within four business days of the information being available to the EP (for EPs only)

Provide patients the ability to view online, download and transmit their health information
within 36 hours after discharge from the hospital (for Eligible Hospitals/CAHs only)

In addition, the Stage 2 criteria place an emphasis on health information exchange between providers to
improve care coordination for patients. One of the core objectives for both EPs and eligible hospitals and
CAHs requires providers who transition or refer a patient to another setting of care or provider of care to
provide a summary of care record for more than 50% of those transitions of care and referrals.
Additionally, there are new requirements for the electronic exchange of summary of care documents:
 For more than 10% of transitions and referrals, EPs, eligible hospitals, and CAHs that transition or
refer their patient to another setting of care or provider of care must provide a summary of care
record electronically.
 The EP, eligible hospital, or CAH that transitions or refers their patient to another setting of care
or provider of care must either a) conduct one or more successful electronic exchanges of a
summary of care record with a recipient using technology that was designed by a different EHR
developer than the sender's, or b) conduct one or more successful tests with the CMSdesignated test EHR during the EHR reporting period.

46

There are also new Stage 2 menu objectives for EPs, eligible hospitals, and CAHs:
Record electronic notes in patient records

Imaging results accessible through CEHRT
Record patient family health history

Identify and report cancer cases to a State cancer registry (for EPs only)
Identify and report specific cases to a specialized registry (other than a cancer registry) (for
EPs only)
Generate and transmit permissible discharge prescriptions electronically (eRx) (new for
eligible hospitals and CAHs only)
Provide structured electronic lab results to ambulatory providers (for eligible hospitals
and CAHs only)
Finally, there are new Stage 2 measures for several objectives that require patients to use health
information technology in order for providers to achieve meaningful use. CMS believes that EPs, eligible
hospitals, and CAHs are in the best position to encourage the use of health IT by patients to further their
own health care.

Under the Stage 2 core objectives to provide patients the ability to view online, download and transmit
their health information, more than 5 percent of patients seen by the EP or admitted to an inpatient
(Place of Service 21) or emergency department (Place of Service 23) of an eligible hospital or CAH view,
download, or transmit to a third party their health information.
Under the Stage 2 core objective to use secure electronic messaging to communicate with patients on
relevant health information, a secure message must be sent using the electronic messaging function of
Certified EHR Technology by more than 5 percent of unique patients seen by an EP during the EHR
reporting period.
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Stage 1 Changes Tipsheet
Last Updated: August, 2012
Overview
CMS recently announced some changes to the Stage 1 meaningful use objectives, measures, and
exclusions for eligible professionals (EPs), eligible hospitals, and critical access hospitals (CAHs). Some of
these changes will take effect as early as October 1, 2012, for eligible hospitals and CAHs, or January 1,
2013, for EPs. Other Stage 1 changes will not take effect until the 2014 fiscal or calendar year and will be
optional in 2013. The table at the end of this publication summarizes the changes to the Stage 1
meaningful use objectives.
Exclusions for Menu Objectives
Beginning in 2014, EPs, eligible hospitals, and CAHs will no longer be permitted to count an exclusion
toward the minimum of 5 menu objectives on which they must report if there are other menu objectives
which they can select. In other words, a provider cannot select a menu objective and claim an exclusion
for it if there are other menu objectives they can meet.
EPs, eligible hospitals, and CAHs will not be penalized for selecting a menu objective and claiming the
exclusion if they would also qualify for the exclusions for all the remaining menu objectives. For
example, EPs who must select to test the capability to submit data to either an immunization registry or
a syndromic surveillance database as one of their menu objectives can select the menu objective for
submitting data to an immunization registry and claim the exclusion if they would also be able to claim
the exclusion for submitting data to a syndromic surveillance database. They would not be penalized for
claiming this exclusion.
Computerized Provider Order Entry (CPOE)
Beginning in 2013, CMS is adding an optional alternate measure to the objective for computerized
provider order entry (CPOE). The current measure for CPOE is based on the number of unique patients
with a medication in their medication list that was entered using CPOE. The new, alternate measure is
based on the total number of medication orders created during the EHR reporting period. An EP, eligible
hospital, or CAH may select either measure for this objective in Stage 1 in order to achieve meaningful
use. (Note that this alternative measure will be required for all providers in Stage 2.)
Alternate Measure: More than 30 percent of medication orders created by the EP or authorized
providers of the eligible hospital's or CAH's inpatient or emergency department (POS 21 or 23)
during the EHR reporting period are recorded using CPOE.
Electronic Prescribing
Beginning in 2013, CMS is adding an additional exclusion to the objective for electronic prescribing for
providers who are not within a 10 mile radius of a pharmacy that accepts electronic prescriptions.
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CMS is changing the measure of the objective for recording and charting changes in vital signs for EPs,
eligible hospitals, and CAHs. The current measure specifies that vital signs must be recorded for more
than 50 percent of all unique patients ages 2 and over. The new measure amends that age limit to
recording blood pressure for patients ages 3 and over and height and weight for patients of all ages.
The exclusions for this objective for EPs are also changing. The current exclusions only allow an EP to
claim the exclusion if all three vital signs (height, weight, blood pressure) are not relevant to their scope
of practice or if the EP sees no patients 2 years or older. However, under the new Stage 1 changes, an EP
can claim an exclusion if the EP sees no patients 3 years or older (the EP would not have to record blood
pressure), if all three vital signs are not relevant to their scope of practice (the EP would not record any
vital signs), if height and weight are not relevant to their scope of practice (the EP would still record
blood pressure), or if blood pressure is not relevant to their scope of practice (the EP would still record
height and weight).
This new measure and these new exclusions are optional in 2013 but will be required in 2014 and
beyond.

New Measure: More than 50 percent of all unique patients seen by the EP or admitted to the
eligible hospital's or CAH's inpatient or emergency department (POS 21 or 23) during the EHR
reporting period have blood pressure (for patients age 3 and over only) and height and weight (for
all ages) recorded as structured data.
New Exclusion: Any EP who
1. Sees no patients 3 years or older is excluded from recording blood pressure;
2. Believes that all three vital signs of height, weight, and blood pressure have no relevance
to their scope of practice is excluded from recording them;
3. Believes that height and weight are relevant to their scope of practice, but blood pressure
is not, is excluded from recording blood pressure; or
4. Believes that blood pressure is relevant to their scope of practice, but height and weight
are not, is excluded from recording height and weight.
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Electronic Exchange of Key Clinical Information
Beginning in 2013, the objective for electronic exchange of key clinical information will no longer be
required for Stage 1 for EPs, eligible hospitals, and CAHs. Providers faced numerous challenges in
understanding the requirements for this objective, so we are moving instead to a more robust
requirement for electronic health information exchange as a part of the Stage 2 objective for providing a
summary of care record following a transition of care or referral.
Report Clinical Quality Measures
Beginning in 2013, there will no longer be a separate objective for reporting ambulatory or hospital
clinical quality measures as a part of meaningful use. It is important to note, however, that EPs, eligible
hospitals, and CAHs will still be required to report on clinical quality measures in order to achieve
meaningful use. CMS is simply removing the standalone objective that requires providers to attest that
they plan to report on clinical quality measures because it is redundant.
Electronic Copy of and Electronic Access to Health Information
In order to better align Stage 1 objectives with the new 2014 capabilities of Certified EHR Technology,
CMS is replacing several Stage 1 objectives for providing electronic copies of and electronic access to
health information with objectives to provide patients the ability to view, download, or transmit their
health information or hospital admission information online. The capability to provide patients online
access to this information will be a part of Certified EHR Technology beginning in 2014, therefore the
new Stage 1 objectives will be required beginning in 2014.
The following current Stage 1 objectives will be replaced beginning in 2014:
 EPs/Hospital Stage 1 Core Objective: Provide patients with an electronic copy of their health
information (including diagnostics test results, problem list, medication lists, medication
allergies, discharge summary, procedures) upon request.
 Hospital Stage 1 Core Objective: Provide patients with an electronic copy of their discharge
instructions at time of discharge, upon request.
 EP Stage 1 Menu Objective: Provide patients with timely electronic access to their health
information (including lab results, problem list, medication lists, and allergies) within 4 business
days of the information being available to the EP.
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New Objectives and Measures

New EP Objective: Provide patients the ability to view online, download and transmit their
health information within 4 business days of the information being available to the EP.
New EP Measure: More than 50 percent of all unique patients seen by the EP during the
EHR reporting period are provided timely (within 4 business days after the information is
available to the EP) online access to their health information subject to the EP's discretion
to withhold certain information.
New Hospital Objective: Provide patients the ability to view online, download and
transmit information about a hospital admission.
New Hospital Measure: More than 50 percent of all patients who are discharged from
the inpatient or emergency department (POS 21 or 23) of an eligible hospital or CAH
have their information available online within 36 hours of discharge.
Public Health Reporting Objectives
Beginning in 2013, all of the Stage 1 public health objectives (submitting data to an immunization
registry, submitting data to a syndromic surveillance database, or submitting reportable lab results to a
public health agency) will require that providers perform at least one test of their Certified EHR
Technology’s capability to send data to public health agencies, except where prohibited. The intent of
this modification is to encourage all EPs, eligible hospitals, and CAHs to submit public health data, even
when not required by State/local law. Therefore, if providers are authorized to submit the data, they
should do so even if it is not required by either law or practice. If the test of submission is successful,
provider should institute regular reporting with the entity with whom the successful test was conducted.
Stage 1 Objective

Use CPOE for medication orders
directly entered by any licensed
healthcare professional who
can enter orders into the
medical record per State, local
and professional guidelines
Generate and transmit
permissible prescriptions
electronically (eRx)

Changes to Objective

Change: Addition of an alternative measure
More than 30 percent of medication orders created by the
EP or authorized providers of the eligible hospital's or CAH's
inpatient or emergency department (POS 21 or 23) during
the EHR reporting period are recorded using CPOE
Change: Addition of an additional exclusion
Any EP who: does not have a pharmacy within their
organization and there are no pharmacies that accept
electronic prescriptions within 10 miles of the EP's practice
location at the start of his/her EHR reporting period.
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Effective
Year
(CY/FY)
2013 - Onward
(Optional)

2013 –
Onward
(Required)

Stage 1 Objective

Changes to Objective

Record and chart changes in
vital signs

Change: Age Limitations on Growth Charts and
Blood Pressure

Public Health Objectives:

Record and chart changes in
vital signs

More than 50 percent of all unique patients seen by the EP
or admitted to the eligible hospital's or CAH's inpatient or
emergency department (POS 21 or 23) during the EHR
reporting period have blood pressure (for patients age 3
and over only) and height and weight (for all ages)
recorded as structured data
Change: Addition of "except where prohibited" to the
objective regulation text for the public health
objectives under § 495.6
Change: Changing the age and splitting the EP
exclusion Any EP who
(1) Sees no patients 3 years or older is excluded
from recording blood pressure;

Effectiv
e Year
(CY/FY
)
2013 Only
(Optional)

2014 –
Onward
(Required)
2013 –
Onward
(Require
d)
2013 Only
(Optional)
2014 –
Onward
(Required)

(2) Believes that all three vital signs of height, weight,
and blood pressure have no relevance to their scope of
practice is excluded from recording them;
(3) Believes that height and weight are relevant to
their scope of practice, but blood pressure is not, is
excluded from recording blood pressure; or
(4) Believes that blood pressure is relevant to their
scope of practice, but height and weight are not, is
excluded from recording height and weight.
Capability to exchange key
clinical information (for
example, problem list,
medication list, medication
allergies, and diagnostic test
results), among providers of
care and patient authorized
entities electronically

Change: Objective is no longer required
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2013 –
Onward
(Require
d)

Stage 1 Objective

Changes to Objective

Effective
Year
(CY/FY)

Report ambulatory/hospital
clinical quality measures to
CMS or the States

Change: Objective is incorporated directly into the
definition of a meaningful EHR user and eliminated as an
objective

2013 –
Onward
(Required)

EP and Hospital Objectives:
Provide patients with an
electronic copy of their health
information (including
diagnostics test results,
problem list, medication lists,
medication allergies, discharge
summary, procedures) upon
request.

Change: Replace these four objectives with the Stage 2
objective and one of the two Stage 2 measures.

2014 –
Onward
(Required)

EP Objective: Provide patients
with timely electronic access to
their health information
(including lab results, problem
list, medication lists, and
allergies) within 4business days
of the information being
available to the EP.

EP Objective: Provide patients the ability to view online,
download and transmit their health information within 4
business days of the information being available to the EP.

Hospital Objective: Provide
patients with an electronic copy
of their discharge instructions
at time of discharge, upon
request.

Hospital Objective: Provide patients the ability to view
online, download and transmit information about a
hospital admission.

EP Measure: More than 50 percent of all unique patients
seen by the EP during the EHR reporting period are
provided timely (within 4 business days after the
information is available to the EP) online access to their
health information subject to the EP's discretion to
withhold certain information.

Hospital Measure: More than 50 percent of all patients
who are discharged from the inpatient or emergency
department (POS 21 or 23) of an eligible hospital or CAH
have their information available online within 36 hours of
discharge.
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2014 Clinical Quality
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Criteria for Reporting Clinical Quality Measures
Medicare EHR Incentive Program
Beginning in 2014, the reporting of clinical quality measures (CQMs) will change for all providers. EHR
technology that has been certified to the 2014 standards and capabilities will contain new CQM criteria,
and eligible professionals (EPs), eligible hospitals, and critical access hospitals (CAHs) will report using
the new 2014 criteria regardless of whether they are participating in Stage 1 or Stage 2 of the Medicare
and Medicaid Electronic Health Record (EHR) Incentive Programs. Although clinical quality measure
(CQM) reporting has been removed as a core objective for both EPs and eligible hospitals and CAHs, all
providers are required to report on CQMs in order to demonstrate meaningful use.
2013
 Eligible Professionals (EPs), will continue to report from the 44 measures finalized for Stage 1 in the
same schema laid out for Stage 1
 3 core/alternate core
 3 additional measures for EPs
 Eligible hospitals and CAHs will continue to report the 15 measures finalized for Stage 1
 Beginning in 2012 and continuing in 2013, there are two reporting methods available for reporting
the Stage 1 measures:
 Attestation (https://ehrincentives.cms.gov/)
 eReporting Pilots:
o Physician Quality Reporting System EHR Incentive Program Pilot for EPs
o eReporting Pilot for eligible hospitals and CAHs
2014 and Beyond
 EPs must report on 9 of the 64 approved CQMs
 Recommended core CQMs – encouraged but not required
o 9 CQMs for the adult population
o 9 CQMs for the pediatric population
o NQF 0018 strongly encouraged since controlling blood pressure is high priority goal
in many national health initiatives, including the Million Hearts campaign
 Selected CQMs must cover at least 3 of the National Quality Strategy domains (See
“Measure Selection Process” below.)
 Eligible Hospitals and CAHs must report on 16 of the 29 approved CQMs
 Selected CQMs must cover at least 3 of the National Quality Strategy domains (See
“Measure Selection Process” below.)
 Beginning in 2014, all Medicare-eligible providers beyond their first year of demonstrating
meaningful use must electronically report their CQM data to CMS. (Medicaid EPs and hospitals that
are eligible only for the Medicaid EHR Incentive Program will electronically report their CQM data to
their state.) See “Reporting Options for EPs” and “Reporting Options for Eligible Hospitals and C!Hs”
below for more information.
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Measure Selection Process
CMS selected the recommended core set of CQMs for EPs based on analysis of several factors:
 Conditions that contribute to the morbidity and mortality of the most Medicare and
Medicaid beneficiaries
 Conditions that represent national public health priorities
 Conditions that are common to health disparities
 Conditions that disproportionately drive healthcare costs and could improve with better
quality measurement
 Measures that would enable CMS, States, and the provider community to measure quality
of care in new dimensions, with a stronger focus on parsimonious measurement
 Measures that include patient and/or caregiver engagement
In addition, CMS selected all CQMs to align with the Department of Health and Human Services’
National Quality Strategy priorities for health care quality improvement. These domains include:
 Patient and Family Engagement
 Patient Safety
 Care Coordination
 Population and Public Health
 Efficient Use of Healthcare Resources
 Clinical Processes/Effectiveness
When selecting their CQMs to report, EPs, eligible hospitals, and CAHs must select CQMs that cover at
least three of these six domains. A complete list of 2014 CQMs and their associated National Quality
Strategy domains will be posted on the CMS EHR Incentive Programs website
(www.cms.gov/EHRIncentivePrograms) in the future. CMS will also post the recommended core set of
CQMs for EPs.
Reporting and submission periods for EPs, Eligible Hospitals, and CAHs in their first year of Meaningful
Use submitting CQMs via attestation beginning with CY/FY 2014
Provider
Type

Reporting Period for First Year of
Meaningful Use (Stage 1)

Submission Period for First Year of
Meaningful Use (Stage 1)*

90 consecutive days

Anytime immediately following the end of the
90-day reporting period, but no later than
February 28 of the following calendar year.

Eligible
90 consecutive days
Hospital/CAH

Anytime immediately following the end of the
90-day reporting period, but no later than
November 30 of the following fiscal year.

EP

*For purposes of avoiding a payment adjustment, Medicare EPs and eligible hospitals that are in their first year of
demonstrating meaningful use in the year immediately preceding a payment adjustment year must submit their CQM data no
later than October 1 (EPs) or July 1 (eligible hospitals) of such preceding year.
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Reporting and submission periods for EPs, Eligible Hospitals, and CAHs beyond their first year of Meaningful
Use submitting CQMs electronically beginning with CY/FY 2014
For 2014 only, all providers regardless of their stage of meaningful use are only required to demonstrate
meaningful use for a three-month EHR reporting period. Medicare providers can either report their
CQMs for the entire year or select an optional three-month reporting period for CQMs that is identical
to their three-month reporting period for meaningful use.

For Medicare providers, this 3-month reporting period is fixed to the quarter of either the fiscal (for
eligible hospitals and CAHs) or calendar (for EPs) year in order to align with existing CMS quality
measurement programs, such as the Physician Quality Reporting System (PQRS) and Hospital Inpatient
Quality Reporting (IQR). CMS is permitting this one-time three-month reporting period in 2014 only so
that all providers who must upgrade to 2014 Certified EHR Technology will have adequate time to
implement their new Certified EHR systems.
In subsequent years, the reporting period for clinical quality measures would be the entire calendar year
(for EPs) or fiscal year (for eligible hospitals and CAHs).
Provider
Type

EP

Optional Reporting Period in
2014*

Calendar year quarter:
January 1 – March 31
April 1 – June 30
July 1 – September 30
October 1 – December 31

Eligible
Fiscal year quarter:
Hospital/CAH October 1 – December 31
January 1 – March 31
April 1 – June 30
July 1 – September 30

Reporting Period for
Subsequent Years of
Meaningful Use (Stage
1 and Subsequent
Stages)

Submission Period for
Subsequent Years of
Meaningful Use (Stage
1 and Subsequent
Stages)

1 calendar year
(January 1 - December
31)

2 months following the
end of the reporting
period
(January 1 - February 28)

1 fiscal year
(October 1 - September
30)

2 months following the
end of the reporting
period
(October 1 - November
30)

*NOTE: The optional quarter reporting periods have the same submission period as a full year reporting period for electronic
submission.
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Reporting Options for EPs
Category

Data
Leve
l
Aggregate

Paye
r
AllLevel
payer

Submission
Type

Reporting Schema

EPs in First
Attestation
Year of
Demonstrating
Meaningful
Use*
EPs Beyond the First Year of Demonstrating Meaningful Use

Submit 9 CQMs (includes adult and
pediatric recommended core CQMs),
covering at least 3 NQS domains

Option 1

Aggregate

All payer

Electronic

Option 2

Patient

Medicare
Only

Electronic

Submit 9 CQMs (includes adult and
pediatric recommended core CQMs),
covering at least 3 NQS domains
Satisfy requirements of PQRS
reporting options using CEHRT

Group Reporting (only EPs Beyond the First Year of Demonstrating Meaningful Use)**
EPs in an ACO
(Medicare
Shared Savings
Program or
Pioneer ACOs)
EPs
satisfactorily
reporting via
PQRS group
reporting
options

Patient

Medicare
Only

Electronic

Satisfy requirements of Medicare Shared
Savings Program of Pioneer ACOs using
CEHRT

Patient

Medicare
Only

Electronic

Satisfy requirements of PQRS group
reporting options using CEHRT

*Attestation is required for EPs in their first year of demonstrating meaningful use because it is the only reporting method that
would allow them to meet the submission deadline of October 1 to avoid a payment adjustment.
**Groups with EPs in their first year of demonstrating meaningful use can report as a group, however individual EPs who are in
their first year must attest to their CQM results by October 1 to avoid a payment adjustment.
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Reporting Options for Eligible Hospitals and Critical Access Hospitals
Category

Data
Leve
l
Aggregate

Paye
r
All Level
payer

Submission
Type

Reporting Schema

Option 1

Aggregate

All payer

Electronic

Submit 16 CQMs, covering at least 3 NQS
domains

Option 2

Patient

Sample all payer

Electronic

Submit 16 CQMs, covering at least 3 NQS
domains
 Manner similar to the 2012
Medicare EHR Incentive Program
Electronic Reporting Pilot

Eligible
Submit 16 CQMs, covering at least 3 NQS
Attestation
domains
Hospitals in
First Year of
Demonstrating
Meaningful
Use*
Eligible Hospitals/CAHs Beyond the First Year of Demonstrating Meaningful Use

*Attestation is required for eligible hospitals in their first year of demonstrating meaningful use because it is the only reporting
method that would allow them to meet the submission deadline of July 1 to avoid a payment adjustment.

2. Medicaid EHR Incentive Program
2013 and Beyond
 EPs, eligible hospitals, and CAHs participating only in a Medicaid EHR Incentive Program will submit
their CQM data directly to their State.
 Each State is responsible for sharing the details on the process for electronic reporting with its
provider community.
 Subject to CMS’s prior approval, the process and the timeline are within the States’ purview.
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Stage 2 FAQs
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II. Questions about Stage 2 Meaningful Use Measures &
Objectives
III. Questions about changes to the Medicare EHR Incentive
Program from Stage 2
IV. Questions about changes to the Medicaid EHR Incentive
Program from Stage 2
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The August 23, 2012, final rule includes some changes to the Stage 1
meaningful use objectives, measures, and exclusions for eligible
professionals, eligible hospitals, and critical access hospitals. Some of
these changes will take effect as early as October 1, 2012, for eligible
hospitals and critical access hospitals, or January 1, 2013, for eligible
professionals.
Stage
1 changes
notoftake
effect until
2014 objectives,
Please
see the Other
full FAQ
online
to see a will
chart
the changes
tothe
specific
fiscal
or
calendar
year,
and
will
be
optional
in
2013.
measures and policies: https://questions.cms.gov/faq.php?id=5005&faqId=7527
Date Updated: 8/23/2012
New ID #7527

2) What is Stage 2 for the Medicare and Medicaid EHR Incentive Programs?
In August 2012, CMS published a final rule that specifies the Stage 2 meaningful use
criteria that eligible professionals, eligible hospitals, and critical access hospitals must
meet to continue to participate in the Medicare and Medicaid Electronic Health
Record (EHR) Incentive Programs and avoid payment adjustments.
Stage 2 retains the core and menu structure for meaningful use objectives. Although
some Stage 1 objectives were either combined or eliminated, most of the Stage 1
objectives are now core objectives under the Stage 2 criteria. For many of these
Stage 2 objectives, the threshold that providers must meet for the objective has
been raised.
New objectives are also introduced for Stage 2, and most of these are introduced as
menu objectives. As with the previous stage, many of the Stage 2 objectives have
exclusions that allow providers to achieve meaningful use without having to meet
objectives outside of their normal scope of clinical practice.
To demonstrate meaningful use under Stage 2 criteria—
• Eligible professionals must meet 17 core objectives and 3 menu objectives they
select from a list of 6, for a total of 20 core objectives (the same number of
objectives that had to be met in Stage 1).
• Eligible hospitals and critical access hospitals must meet 16 core objectives and 3
menu objectives they select from a list of 6, for a total of 19 core objectives (the
same number of objectives that had to be met in Stage 1).
Please note, providers who were early demonstrators of meaningful use in 2011 will
meet three consecutive years of meaningful use under the Stage 1 criteria before
advancing to the Stage 2 criteria in 2014. All other providers would meet two years
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of meaningful use under the Stage 1 criteria before advancing to the Stage 2 criteria
in their third year, regardless of the year in which you begin participation.
The Stage 2 final rule also includes some changes to the Stage 1 meaningful use
objectives, measures, and exclusions. Some of the changes to Stage 1 will take
effect as early as October 1, 2012, for eligible hospitals and critical access hospitals,
or January 1, 2013, for eligible professionals. Other changes to Stage 1 will not be
required until FY 2014 (for hospitals) or CY 2014 (for EPs), but will be optional in FY 2013
(for hospitals) or CY 2013 (for EPs).

Date Updated: 8/23/2012
New ID #7529

II.

Questions about Stage 2 Meaningful Use Measures &
Objectives
3) For meaningful use Stage 2's transitions of care and referrals objective, in what ways
can I meet the second measure that requires more than 10% of the summary care
records I provide for transitions of care and referrals to be electronically transmitted?
An EP, eligible hospital, or CAH could use 3 distinct approaches (which could also be
used in combination) to meet this measure. The first two rely solely on the use of
CEHRT, while the third is slightly different.
For the first two approaches, this measure can only be met if the EP, eligible hospital,
or CAH uses the capabilities and standards included as part of its Certified EHR
Technology (CEHRT) to electronically transmit summary care records for transitions of
care and referrals (specifically those capabilities certified to the certification
criterion adopted by ONC at 45 CFR 170.314(b)(2) “transitions of care – create and
transmit transition of care/referral summaries,” which specifies standards for data
content and transport).
For the third approach, the EP, eligible hospital, or CAH must use its CEHRT to create
a summary care record for transitions of care and referrals, but instead of using a
transport standard specified in ONC’s certification criterion at 45 CFR 170.314(b)(2)
(included as part of its CEHRT) to electronically transmit the summary care record,
the EP, eligible hospital, or CAH may use a NwHIN Exchange participant to facilitate
the electronic transmission to the recipient. The NwHIN Exchange is now known as
“eHealth Exchange” and a list of participants can be found here.
The following are more detailed explanations of each permitted approach. We also
emphasize that regardless of the way an EP, eligible hospital, or CAH chooses to
transmit the summary of care record, such a transmission will only count in the
numerator if it is received by the provider to whom the sending provider is referring or
transferring the patient.
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1. Use of the transport standard capability required for certification. As required by
ONC to meet the CEHRT definition, every EP, eligible hospital, and CAH, must have
EHR technology that is capable of electronically transmitting a summary care record
for transitions of care and referrals according to the primary Direct Project
specification (the Applicability Statement for Secure Health Transport). Thus, EPs,
eligible hospitals, or CAHs that electronically transmit summary care records using
their CEHRT’s “Direct” capability (natively or combined with an intermediary) would
be able to count all such electronic transmissions in their numerator.
2. Use of the SOAP-based optional transport standard capability permitted for
certification. As part of certification, ONC permits EHR technology developers to
voluntarily seek certification for their EHR technology’s capability to perform SOAPbased electronic transmissions. EHR technology developers who take this approach
would enable their customers to also use this approach to meet the measure. Thus,
EPs, eligible hospitals, or CAHs that electronically transmit summary care records
using their CEHRT’s “SOAP-based” capability (natively or combined with an
intermediary) would be able to count all of those transmissions in their numerator.
3. Use of CEHRT to create a summary care record in accordance with the required
standard (i.e., Consolidated CDA as specified in 45 CFR 170.314(b)(2)), and the
electronic transmission is accomplished through the use of an eHealth Exchange
participant who enables the electronic transmission of the summary care record to
its intended recipient. Thus, EPs, eligible hospitals, or CAHs who create standardized
summary care records using their CEHRT and then use an eHealth Exchange
participant to electronically transmit the summary care record would be able to
count all of those transmissions in their numerator.
We note that for this third approach, the regulation also permits an EP, eligible
hospital, or CAH to count in their numerator instances where a summary care record
for transitions of care or referrals was received via electronic exchange facilitated in
a manner consistent with the governance mechanism ONC establishes for the
nationwide health information network. ONC has not yet established a governance
mechanism for the nationwide health information network. Until ONC establishes
such a governance mechanism, this specific option will not be available.
Date Updated: 11/5/2012
New ID #7697

4) What are the specific medical specialty codes associated with anesthesiology,
radiology and pathology for the specialty-based determination for the granting of a
hardship exception from the payment adjustments in the Medicare Electronic Health
Record (EHR) Incentive Program?
The included Medicare Specialty Codes are diagnostic radiology (30), nuclear
medicine (36), interventional radiology (94), anesthesiology (30), and pathology (22).
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Radiation oncology, together with surgical and medical oncology, is one of the 3
primary disciplines involved in cancer treatment according to the American College
of Radiology practice guidelines. Radiation oncologists are therefore specialized
oncologists as opposed to specialized radiologists and are not eligible for the
specialty-based exception. If a radiation oncologist believes they meet the hardship
exception criteria for lack of face-to-face patient interaction and lack of need for
follow-up care they may apply for that exception, as can any eligible professional
regardless of specialty.
Date Updated: 1/2/2013
New ID #7731

5) If multiple eligible professionals contribute information to a shared portal or to a
patient's online personal health record (PHR), how is it counted for meaningful use
when the patient accesses the information on the portal or PHR?
The answer is relevant to the following meaningful use measure for eligible
professionals (EPs): “More than 5 percent of all unique patients seen by the EP during
the EHR reporting period (or their authorized representatives) view, download or
transmit to a third party their health information.”
If the patient was seen by the EP during the EHR reporting period, the patient would
be counted in the EP’s numerator for this measure if the patient (or his/her authorized
representatives) views online, downloads, or transmits to a third party any of the
health information from the shared portal or online PHR, regardless of whether the EP
contributed the particular information that was viewed, downloaded, or transmitted
by the patient. However, the EP must have contributed at least some of the
information identified in the Stage 2 final rule to the shared portal or online PHR for
the patient.
Date Updated: 1/2/2013
New ID #7735

6) To meet the third measure of the objective of providing “a summary of care record
for each transition of care or referral" for the Medicare and Medicaid Electronic
Health Record (EHR) Incentive Programs, must the electronic exchange with a
recipient using technology designed by a different EHR developer occur for each
provider or can there be one exchange per location? What if the provider chooses
instead to exchange information with the CMS test EHR?
If a summary of care record used for an actual transition of care or referral is
electronically exchanged with a recipient who has EHR technology that was
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developed designed by a different EHR technology developer than the sender's EHR
technology, then that exchange can be considered to have met the third measure
of the objective for all providers involved in that transition of care and referral using
the same Certified EHR Technology.
If the provider chooses instead to meet this third measure by exchanging with the
CMS test EHR, we clarify that the use of test information about a fictional patient that
would be identical in form to what would be sent about an actual patient (e.g.,
"dummy data") must be used for the purposes of conducting the test. Providers that
use the same EHR technology and share a network for which their organization
either has operational control of or license to use can conduct one test that covers
all providers in the organization. For example, if a large group of EPs with multiple
physical locations use the same EHR technology and those locations are connected
using a network that the group has either operational control of or license to use,
then a single test would cover all EPs in that group. Similarly, if a provider uses an EHR
technology that is hosted (cloud-based) on the developer's network, then a single
test would allow all EPs, eligible hospitals, and CAHs using the EHR technology that is
hosted (cloud-based) on the developer's network to meet the measure.
Date Updated: 1/2/2013
New ID #7729

III.

Questions about changes to the Medicare EHR Incentive
Program from Stage 2
7) What are the payment adjustments for eligible professionals who are not
participating in the Medicare EHR Incentive Program? Are there any hardship
exceptions?
As part of the American Recovery and Reinvestment Act of 2009 (ARRA), Congress
mandated payment adjustments to be applied to Medicare eligible professionals
(EPs) who are not meaningful users of Certified Electronic Health Record (EHR)
Technology under the Medicare EHR Incentive Programs. These payment
adjustments will be applied beginning on January 1, 2015, for Medicare EPs.
Medicaid EPs who can only participate in the Medicaid EHR Incentive Program and
do not bill Medicare are not subject to these payment adjustments.
EPs who can participate in either the Medicare or Medicaid EHR Incentive Programs
will be subject to the payment adjustments unless they are meaningful users under
one of the EHR Incentive Programs in the time periods specified below.
Medicare EPs who are not meaningful users will be subject to a payment adjustment
beginning on January 1, 2015.
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8) What are the payment adjustments for eligible hospitals and critical access hospitals
that are not participating in the Medicare EHR Incentive Program? Are there any
hardship exceptions?
As part of the American Recovery and Reinvestment Act of 2009 (ARRA), Congress
mandated payment adjustments to be applied to Medicare eligible hospitals, and
critical access hospitals (CAHs) that are not meaningful users of Certified Electronic
Health Record (EHR) Technology under the Medicare EHR Incentive Programs. These
payment adjustments will be applied beginning on October 1, 2014, for Medicare
eligible hospitals. Payment adjustments for CAHs will be applied beginning with the
fiscal year 2015 cost reporting period. Medicaid eligible hospitals that can only
participate in the Medicaid EHR Incentive Program and do not bill Medicare are not
subject to these payment adjustments.
Eligible hospitals and CAHs that can participate in either the Medicare or Medicaid
EHR Incentive Programs will be subject to the payment adjustments unless they are
meaningful users under one of the EHR Incentive Programs in the time periods
specified below.
Medicare Subsection (d) eligible hospitals that are not meaningful users will be
subject to a payment adjustment beginning on October 1, 2014. Critical Access
Hospitals (CAHs) that are not meaningful users will be subject to a payment
adjustment for fiscal year 2015.
For additional information on payment adjustments and hardship exceptions for
eligible hospitals and CAHs, please review the Payment Adjustments and Hardship
Exceptions Tip Sheet for Eligible Hospitals and CAHs which will be available on our
website.
Date Updated: 8/23/2012
New ID #7533

IV.

Questions about changes to the Medicaid EHR Incentive
Program from Stage 2
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9) The EHR Incentive Programs Stage 1 Rule stated that, in order for a Medicaid
encounter to count towards the patient volume of an eligible provider, Medicaid had
to either pay for all or part of the service, or pay all or part of the premium,
deductible or coinsurance for that encounter. The Stage 2 Rule now states that the
Medicaid encounter can be counted towards patient volume if the patient is
enrolled in the state’s Medicaid program
(either through the state’s fee-forservice programs or the state’s Medicaid managed care programs) at the time of
service without the requirement of
Medicaid payment liability. How will this
change affect patient volume calculations for Medicaid eligible providers?
Importantly, this change affecting the Medicaid patient volume calculation is
applicable to all eligible providers, regardless of the stage of the Medicaid EHR
Incentive Program they are participating in. Billable services provided by an eligible
provider to a patient enrolled in Medicaid would count toward meeting the
minimum Medicaid patient volume thresholds. Examples of Medicaid encounters
under this expanded definition that could be newly eligible might include:
behavioral health services, HIV/AIDS treatment, or other services that might not be
billed to Medicaid/managed care for privacy reasons, but where the provider has a
mechanism to verify eligibility. Also, services to a Medicaid-enrolled patient that
might not have been reimbursed by Medicaid (or a Medicaid managed care
organization) may now be included in the Medicaid patient volume calculation
(e.g., oral health services, immunization, vaccination and women’s health services, ,
telemedicine/telehealth, etc.).
Providers who are not currently enrolled with their state Medicaid agency who might
be newly eligible for the incentive payments due to these changes should note that
they are not necessarily required to fully enroll with Medicaid in order to receive the
payment.
In some instances, it may now be appropriate to include services denied by
Medicaid in calculating patient volume. It will be appropriate to review denial
reasons. If Medicaid denied the service for timely filing or because another payer’s
payment exceeded the potential Medicaid payment, it would be appropriate to
include that encounter in the calculation. If Medicaid denied payment for the
service because the beneficiary has exceeded service limits established by the
Medicaid program, it would be appropriate to include that encounter in the
calculation. If Medicaid denied the service because the patient was ineligible for
Medicaid at the time of service, it would not be appropriate to include that
encounter in the calculation.
Further guidance regarding this change will be distributed to the states as
appropriate.
Date Updated: 8/23/2012
New ID #7535
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States that have offered CHIP as part of a Medicaid expansion under Title 19 or Title
21 can include those patients in their provider’s Medicaid patient volume
calculation as there is cost liability to the Medicaid program in either case (under the
Stage 1 Rule, only CHIP programs created under a Medicaid expansion via Title 19
were eligible). Patients in standalone CHIP programs established under Title 21 are
not to be considered part of the patient volume total (in Stage 1 or Stage 2). This
change to the patient volume calculation is applicable to all eligible providers,
regardless of the stage of the Medicaid EHR Incentive Program they are
participating in.

Date Updated: 8/23/2012
New ID #7537

11) Are there any changes in the EHR Incentive Programs Stage 2 Rule to the base year
for the Medicaid hospital incentive payment calculation?
Yes. Previously Medicaid eligible hospitals calculated the base year using a 12
month period ending in the Federal fiscal year before the hospital's fiscal year that
serves as the first payment year. In an effort to encourage timely participation in the
program, §495.310(g)(1)(i)(B) of the Stage 2 Rule was amended to allow hospitals to
use the most recent continuous 12 month period for which data are available prior
to the payment year. This change went into effect upon publication of the Stage 2
Rule. Only hospitals that begin participation in the program after the publication
date of the Stage 2 Rule (i.e., program years 2013 and later) will be affected by this
change. Hospitals that began participation in the program prior to the Stage 2 Rule
will not have to adjust previous calculations.

Date Updated: 8/23/2012
New ID #7539
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2014 Clinical Quality Measures
(CQMS) & eCQM Resources
Web Pages

Name
Stage 2 EHR Incentive
Program

Description
This page provides information about Stage 2 of meaningful use, including
a wide range of resources, tipsheets, reporting requirements, and an
overview of the program timeline.

Clinical Quality Measures

This page provides information about CQMs including how they are
derived, the purposes they serve, reporting requirements for the EHR
Incentive Programs, and how to access the electronic specifications
(eCQMs) for electronic reporting through Certified EHR Technology.

Clinical Quality Measures
through 2013

This page provides information about how the program will work and
what the requirements are for reporting CQMs through 2013.

2014 Clinical Quality
Measures

This page provides information and resources about the CQMs finalized in
the Stage 2 rule which will be in effect beginning in 2014 for all
practitioners regardless of what stage of meaningful use they are in. It
also provides the finalized CQMs, reporting requirements, and access to
the eCQMs.

Recommended Core Set

This page provides information about the adult and pediatric
recommended core sets finalized in Stage 2 of meaningful use for 2014.

Electronic Specifications
(eCQMs)

This page provides information about electronic specifications, the
various formats of the eSpecification files, technical release notes,
guidance for understanding eCQMs, and access to the electronic
specifications and value sets.

Value Set Authority Center
(VSAC)

This page is supported by the National Library of Medicine and contains
the value sets for each of the 64 eCQMs for eligible professional for 2014
and the 29 eCQMs for eligible hospitals for 2014. A free license is
required to access the value sets.

October 2012
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2014 Clinical Quality Measures
(CQMS) & eCQM Resources

Publications

Name
2014 Clinical Quality
Measures Tip Sheet

Description
This document provides an overview of the 2014 CQMs for use in the EHR
Incentive Programs, including reporting requirements, reporting time
period, submission options, and background on the measure selection
process.

2014 CQMs for Eligible
Professionals

This table contains the description and definition statements for the 64
CQMs for use by eligible professionals in the EHR Incentive Programs
beginning in 2014.

2014 CQMs for Eligible
Hospitals

This table contains the description and definition statements for the 64
CQMs for use by eligible hospitals and CAHs in the EHR Incentive
Programs beginning in 2014.

Adult Recommended Core
Set

This table contains the 9 CQMs in the recommended core set for the adult
population.

Pediatric Recommended
Core Set

This table contains the 9 CQMs in the recommended core set for the
pediatric population.

EP Technical Release Notes

This document contains information about changes made to 2011 CQMs
for the measures that were kept as part of the 2014 CQMs.

EH Technical Release Notes

This document contains information about changes made to 2011 CQMs
for the measures that were kept as part of the 2014 CQMs.

eSpecifications for 2014
eCQMs for Eligible
Professionals

This .zip file contains the electronic specifications in a machine readable
(xml) and human readable (html) format for the 2014 eCQMs for eligible
professionals. To obtain the related value sets please visit the VSAC.

eSpecifications Navigator
2014 eCQMs for Eligible
Hospitals

The eSpec Navigator provides access to the electronic specifications in a
machine readable (xml) and human readable (html) format for the 2014
eCQMs for eligible hospitals. To obtain the related value sets please visit
the VSAC.

Guide to Reading EP and
Hospital eCQMs

This document contains helpful information about understanding and
implementing eCQMs for the EHR Incentive Program.

October 2012
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Stage 2

Date issued: October, 2012
Eligible Professional Core Objectives

(1)

Use computerized provider order entry (CPOE) for medication, laboratory and radiology orders
directly entered by any licensed healthcare professional who can enter orders into the medical
record per state, local and professional guidelines.

(2)

Generate and transmit permissible prescriptions electronically (eRx).

(3)

Record the following demographics: preferred language, sex, race, ethnicity, date of birth.

(4)

Record and chart changes in the following vital signs: height/length and weight (no age limit);
blood pressure (ages 3 and over); calculate and display body mass index (BMI); and plot and
display growth charts for patients 0-20 years, including BMI.

(5)

Record smoking status for patients 13 years old or older.

(6)

Use clinical decision support to improve performance on high-priority health conditions.

(7)

Provide patients the ability to view online, download and transmit their health information
within four business days of the information being available to the EP.

(8)

Provide clinical summaries for patients for each office visit.

(9)

Protect electronic health information created or maintained by the Certified EHR Technology
through the implementation of appropriate technical capabilities.

(10)

Incorporate clinical lab-test results into Certified EHR Technology as structured data.

(11)

Generate lists of patients by specific conditions to use for quality improvement, reduction of
disparities, research, or outreach.

(12)

Use clinically relevant information to identify patients who should receive reminders for
preventive/follow-up care and send these patients the reminders, per patient preference.

(13)

Use clinically relevant information from Certified EHR Technology to identify patient-specific
education resources and provide those resources to the patient.

(14)

The EP who receives a patient from another setting of care or provider of care or believes an
encounter is relevant should perform medication reconciliation.

(15)

The EP who transitions their patient to another setting of care or provider of care or refers their
patient to another provider of care should provide a summary care record for each transition of
care or referral.

(16)

Capability to submit electronic data to immunization registries or immunization information
systems except where prohibited, and in accordance with applicable law and practice.

(17)

Use secure electronic messaging to communicate with patients on relevant health information.
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Eligible Professional Menu Objectives

(1)

Capability to submit electronic syndromic surveillance data to public health agencies except
where prohibited, and in accordance with applicable law and practice.

(2)

Record electronic notes in patient records.

(3)

Imaging results consisting of the image itself and any explanation or other accompanying
information are accessible through CEHRT.

(4)

Record patient family health history as structured data.

(5)

Capability to identify and report cancer cases to a public health central cancer registry, except
where prohibited, and in accordance with applicable law and practice.

(6)

Capability to identify and report specific cases to a specialized registry (other than a cancer
registry), except where prohibited, and in accordance with applicable law and practice.

View or download all of the EP Stage 2 Core and Menu Objectives for Stage 2.
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Stage 1 vs. Stage 2 Comparison
Table for Eligible Professionals
CORE OBJECTIVES (17 total)

Stage 1 Objective

Stage 1 Measure

Stage 2 Objective

Stage 2 Measure

Use CPOE for medication
orders directly entered
by any licensed
healthcare professional
who can enter orders
into the medical record
per state, local and
professional guidelines

More than 30% of unique
patients with at least one
medication in their
medication list seen by
the EP have at least one
medication order
entered using CPOE

Use computerized
provider order entry
(CPOE) for medication,
laboratory and radiology
orders directly entered by
any licensed healthcare
professional who can
enter orders into the
medical record per state,
local and professional
guidelines

More than 60% of
medication, 30% of
laboratory, and 30% of
radiology orders created by
the EP during the EHR
reporting period are recorded
using CPOE

Implement drug-drug
and drug-allergy
interaction checks

The EP has enabled
this functionality for
the entire EHR
reporting period

No longer a separate
objective for Stage 2

This measure is incorporated
into the Stage 2 Clinical
Decision Support measure

Generate and transmit
permissible
prescriptions
electronically (eRx)

More than 40% of all
permissible
prescriptions written
by the EP are
transmitted
electronically using
certified EHR
technology

Generate and transmit
permissible prescriptions
electronically (eRx)

More than 50% of all
permissible prescriptions
written by the EP are
compared to at least one
drug formulary and
transmitted electronically
using Certified EHR
Technology

Record demographics

More than 50% of all
unique patients seen by
the EP have
demographics recorded
as structured data

Record the following
demographics

More than 80% of all unique
patients seen by the EP have
demographics recorded as
structured data

More than 80% of all
unique patients seen

No longer a separate
objective for Stage 2







Preferred language
Gender
Race
Ethnicity
Date of birth

Maintain an up-to-date
problem list of current
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Preferred
language
Gender
Race
Ethnicity
Date of birth

This measure is incorporated
into the Stage

and active diagnoses

by the EP have at least
one entry or an
indication that no
problems are known
for the patient
recorded as structured
data

Maintain
active
medication list

More than 80% of all
unique patients seen
by the EP have at least
one entry (or an
indication that the
patient is not currently
prescribed any
medication) recorded
as structured data

No longer a separate
objective for Stage 2

This measure is
incorporated into the Stage
2 measure of Summary of
Care Document at
Transitions of Care and
Referrals

Maintain active
medication allergy list

More than 80% of all
unique patients seen
by the EP have at least
one entry (or an
indication that the
patient has no known
medication allergies)
recorded as structured
data

No longer a separate
objective for Stage 2

This measure is
incorporated into the Stage
2 measure of Summary of
Care Document at
Transitions of Care and
Referrals

Record and chart
changes in vital signs:

For more than 50% of
all unique patients age
2 and over seen by the
EP, blood pressure,
height and weight are
recorded as structured
data

Record and chart
changes in vital signs:

More than 80% of all unique
patients seen by the EP have
blood pressure (for patients
age 3 and over only) and
height and weight (for all
ages) recorded as structured
data







Height
Weight
Blood pressure
Calculate
and display
BMI
Plot and display
growth charts for
children 2-20 years,
including BMI

2 measure of Summary of
Care Document at
Transitions of Care and
Referrals







Height
Weight
Blood pressure (age
3 and over)
Calculate and display
BMI
Plot and display
growth charts for
patients 0-20 years,
including BMI

Record smoking status
for patients 13 years old

More than 50% of all
unique patients 13

Record smoking status
for patients 13 years old

More than 80% of all unique
patients 13 years old or

or older

years old or older seen
by the EP have
smoking status

or older

older seen by the EP have
smoking status recorded as
structured data
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recorded as structured
data
Implement one clinical
decision support rule
relevant to specialty or
high clinical priority along
with the ability to track
compliance that rule

Implement one clinical
decision support rule

Use clinical decision
support to improve
performance on highpriority health conditions

1. Implement 5 clinical
decision support
interventions related to 4
or more clinical quality
measures, if applicable, at
a relevant point in patient
care for the entire EHR
reporting period.

2. The EP, eligible hospital, or
CAH has enabled the
functionality for drugdrug and drug-allergy
interaction checks for the
entire EHR reporting
period
Report clinical quality
measures (CQMs) to
CMS or the States

Provide aggregate
numerator,
denominator, and
exclusions through
attestation or through
the PQRS Electronic
Reporting Pilot

No longer a separate
objective for Stage 2, but
providers must still
submit CQMs to CMS or
the States in order to
achieve meaningful use

Starting in 2014, all CQMs
will be submitted
electronically to CMS

Provide patients with an
electronic copy of their
health information
(including diagnostic test
results, problem list,
medication lists,
medication allergies),
upon request

More than 50% of all
patients of the EP who
request an electronic
copy of their health
information are
provided it within 3
business days

Provide patients the ability
to view online, download
and transmit their health
information within four
business days of the
information being available
to the EP

i. More than 50% of all
unique patients seen by
the EP during the EHR
reporting period are
provided timely (available
to the patient within 4
business days after the
information is available to
the EP) online access to
their health information

ii. More than 5% of all
unique patients seen by
the EP during the EHR
reporting period (or their
authorized
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representatives)
view, download, or
transmit to a third
party their health
information
Provide clinical
summaries for
patients for each
office visit

Clinical summaries
provided to patients
for more than 50% of
all office visits within
3 business days

Provide clinical
summaries for
patients for each
office visit

Clinical summaries
provided to patients within
one business day for more
than 50% of office visits

Capability to exchange
key clinical information
(for example, problem
list, medication list,
medication allergies,

Performed at least one
test of certified EHR

This objective is
eliminated from Stage 1

This measure is eliminated
from Stage 1 in 2013 and is

technology's capacity
to electronically
exchange key clinical

in 2013 and is no longer
an objective for Stage 2

no longer a measure for
Stage 2

diagnostic test results),
among providers of
care and patient

information

Conduct or review a
security risk analysis

Protect electronic health
information created or

Conduct or review a
security risk analysis in

per 45 CFR 164.308
(a)(1) and implement
security updates as

maintained by the
Certified EHR Technology
through the

accordance with the
requirements under 45 CFR
164.308 (a)(1), including

necessary and correct
identified security
deficiencies as part of

implementation of
appropriate technical
capabilities.

addressing the
encryption/security of data
at rest and implement

authorized entities
electronically
Protect electronic
health information
created or maintained
by the certified EHR
technology through the
implementation of
appropriate technical
capabilities

its risk management
process

security updates as
necessary and correct
identified security
deficiencies as part of its
risk management process

Implement drugformulary checks

The EP has enabled
this functionality and

No longer a separate
objective for Stage 2

has access to at least
one internal or

This measure is
incorporated into the ePrescribing measure for
Stage 2

external drug
formulary for the
entire EHR reporting
period
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Incorporate clinical labtest results into certified

More than 40% of all
clinical lab tests results

Incorporate clinical labtest results into Certified

More than 55% of all clinical
lab tests results ordered by

EHR technology as

ordered by the EP

EHR Technology as

the EP during the EHR

structured data

during the EHR

structured data

reporting period whose

reporting period

results are either in a

whose results are

positive/negative or

either in a

numerical format are

positive/negative or

incorporated in Certified

numerical format are

EHR Technology as

incorporated in

structured data

certified EHR
technology as
Generate lists of
patients by specific

structured data
Generate at least one
report listing patients

Generate lists of patients
by specific conditions to

Generate at least one

conditions to use for

of the EP with a

use for quality

EP with a specific condition

quality improvement,

specific condition

improvement, reduction

reduction of disparities,

of disparities, research,

research or outreach

or outreach

report listing patients of the

Send reminders to
patients per patient

More than 20% of all
unique patients 65

Use clinically relevant

Use EHR to identify and

information to identify

provide reminders for

preference for

years or older or 5

patients who should

preventive/follow-up care

preventive/ follow up

years old or younger

receive reminders for

for more than 10% of

care

were sent an

preventive/follow-up

patients with two or more

appropriate reminder

care

office visits in the last 2

during the EHR

years

reporting period
Provide patients with
timely electronic access

More than 10% of all
unique patients seen

This objective is

This measure is eliminated

eliminated from Stage 1

from Stage 1 in 2014 and is

to their health

by the EP are provided

in 2014 and is no longer

no longer a measure for

information (including

timely (available to the

an objective for Stage 2

Stage 2

lab results, problem list,

patient within four

medication lists,

business days of being

medication allergies)

updated in the

within four business

certified EHR

days of the information

technology) electronic

being available to the EP

access to their health
information subject to
the EP’s discretion to
withhold certain
information

82

Use certified EHR
technology to identify
patient-specific
education resources and
provide those resources
to the patient if
appropriate

More than 10% of all
unique patients seen
by the EP are provided
patient-specific
education resources

Use certified EHR
technology to identify
patient-specific
education resources and
provide those resources
to the patient if
appropriate

The EP who receives a
patient from another
setting of care or
provider of care or
believes an encounter is
relevant should perform
medication
reconciliation
The EP who transitions
their patient to another
setting of care or
provider of care or
refers their patient to
another provider of care
should provide
summary of care record
for each transition of
care or referral

The EP performs
medication
reconciliation for more
than 50% of transitions
of care in which the
patient is transitioned
into the care of the EP

The EP who receives a
patient from another
setting of care or
provider of care or
believes an encounter is
relevant should perform
medication reconciliation

The EP who transitions
or refers their patient
to another setting of
care or provider of
care provides a
summary of care
record for more than
50% of transitions of
care and referrals

The EP who transitions
their patient to another
setting of care or
provider of care or refers
their patient to another
provider of care should
provide summary of care
record for each
transition of care or
referral
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Patient-specific education
resources identified by
CEHRT are provided to
patients for more than 10%
of all unique patients with
office visits seen by the EP
during the EHR reporting
period
The EP performs medication
reconciliation for more than
50% of transitions of care in
which the patient is
transitioned into the care of
the EP

1. The EP who transitions
or refers their patient to
another setting of care
or provider of care
provides a summary of
care record for more
than 50% of transitions
of care and referrals
2. The EP who transitions
or refers their patient to
another setting of care
or provider of care
provides a summary of
care record either a)
electronically
transmitted to a
recipient using CEHRT
or b) where the
recipient receives the
summary of care record
via exchange facilitated
by an organization that
is a NwHIN Exchange
participant or is
validated through an

ONC‑established
governance mechanism
to facilitate exchange for
10% of transitions and
referrals
3. The EP who transitions or
refers their patient to
another setting of care or
provider of care must
either a) conduct one or
more successful electronic
exchanges of a summary
of care record with a
recipient using technology
that was designed by a
different EHR developer
than the sender's, or b)
conduct one or more
successful tests with the
CMS-designated test EHR
during the EHR reporting
period

Capability to submit
electronic data to
immunization registries
or Immunization
Information Systems and
actual submission except
where prohibited and in
accordance with
applicable law and
practice

NEW

Performed at least one
test of certified EHR
technology's capacity to
submit electronic data to
immunization registries
and follow up
submission if the test is
successful (unless none
of the immunization
registries to which the EP
submits such
information have the
capacity to receive the
information
electronically)
NEW

Capability to submit
electronic data to
immunization registries or
Immunization Information
Systems and actual
submission except where
prohibited and in
accordance with applicable
law and practice

Successful ongoing submission
of electronic immunization
data from Certified EHR
Technology to an
immunization registry or
immunization information
system for the entire EHR
reporting period

Use secure electronic
messaging to

A secure message was sent
using the electronic
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communicate with
patients on relevant
health information
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messaging function of
Certified EHR Technology by
more than 5% of unique
patients seen during the
EHR reporting period

MENU OBJECTIVES (EPs must select 3 of 6 menu objectives)
Stage 1 Objective

Stage 1 Measure

Stage 2 Objective

Stage 2 Measure

Capability to submit
electronic syndromic
surveillance data to public
health agencies and actual
submission except where
prohibited and in
accordance with applicable
law and practice

Performed at least one
test of certified EHR
technology's capacity to
provide electronic
syndromic surveillance
data to public health
agencies and follow-up
submission if the test is
successful (unless none
of the public health
agencies to which an EP,
eligible hospital or CAH
submits such
information have the
capacity to receive the
information
electronically)

Capability to submit
electronic syndromic
surveillance data to public
health agencies and actual
submission except where
prohibited and in
accordance with applicable
law and practice

Successful ongoing submission of
electronic syndromic surveillance
data from Certified EHR
Technology to a public health
agency for the entire EHR
reporting period

NEW

NEW

Record electronic notes in
patient records

Enter at least one electronic
progress note created, edited
and signed by an EP for more
than 30% of unique patients

NEW

NEW

Imaging results
consisting of the image
itself and any
explanation or other
accompanying
information are
accessible through
CEHRT

More than 10% of all scans and
tests whose result is an image
ordered by the EP for patients
seen during the EHR reporting
period are incorporated into or
accessible through Certified EHR
Technology

NEW

NEW

Record patient family
health history as
structured data

More than 20% of all unique
patients seen by the EP during
the EHR reporting period have a
structured data entry for one or
more first-degree relatives or an
indication that family health
history has been

86

reviewed
NEW

NEW

NEW

NEW

Capability to identify and
report cancer cases to a
State cancer registry,
except where prohibited,
and in accordance with
applicable law and
practice
Capability to identify and
report specific cases to a
specialized registry
(other than a cancer
registry), except where
prohibited, and in
accordance with
applicable law and
practice
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Successful ongoing submission
of cancer case information
from Certified EHR Technology
to a cancer registry for the
entire EHR reporting period

Successful ongoing submission
of specific case information
from Certified EHR Technology
to a specialized registry for the
entire EHR reporting period
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Payment Adjustments & Hardship
Exceptions Tipsheet for Eligible
Professionals
Overview

Last Updated: August, 2012

As part of the American Recovery and Reinvestment Act of 2009 (ARRA), Congress mandated payment
adjustments to be applied to Medicare eligible professionals (EPs) who are not meaningful users of
Certified Electronic Health Record (EHR) Technology under the Medicare EHR Incentive Programs. These
payment adjustments will be applied beginning on January 1, 2015, for Medicare EPs. Medicaid EPs who
can only participate in the Medicaid EHR Incentive Program and do not bill Medicare are not subject to
these payment adjustments.
EPs who can participate in either the Medicare or Medicaid EHR Incentive Programs will be subject to
the payment adjustments unless they are meaningful users under one of the EHR Incentive Programs in
the time periods specified below.
Payment Adjustments for Medicare EPs
Medicare EPs who are not meaningful users will be subject to a payment adjustment beginning on
January 1, 2015.
This payment adjustment will be applied to the Medicare physician fee schedule (PFS) amount for
covered professional services furnished by the EP during the year (including the fee schedule amount for
purposes of determining a payment based on the fee schedule amount). The payment adjustment is 1%
per year and is cumulative for every year that an EP is not a meaningful user. Depending on the total
number of Medicare EPs who are meaningful users under the EHR Incentive Programs after 2018, the
maximum cumulative payment adjustment can reach as high as 5%. The table below illustrates the
potential application of payment adjustments to covered professional services for a Medicare EP who is
not a meaningful user beginning in 2014.

% ADJUSTMENT ASSUMING LESS THAN 75 PERCENT OF EPs ARE MEANINGFUL USERS
2015

2016

2017

2018

2019

2020+

EP is not subject to the payment adjustment for the e
Rx in 2014

99%

98%

97%

96%

95%

95%

EP is subject to the payment adjustment for the e Rx in
2014

98%

98%

97%

96%

95%

95%

89

% ADJUSTMENT ASSUMING MORE THAN 75 PERCENT OF EPs ARE MEANINGFUL USERS

EP is not subject to the payment adjustment for the e
Rx in 2014
EP is subject to the payment adjustment for the e Rx in
2014

2015

2016

2017

2018

2019

2020+

99%

98%

97%

97%

97%

97%

98%

98%

97%

97%

97%

97%

Because payment adjustments are mandated to begin on the first day of the 2015 calendar year, CMS
will apply a prospective determination for payment adjustments. Therefore Medicare EPs must
demonstrate meaningful use prior to the 2015 calendar year in order to avoid the adjustments.
EPs who first demonstrated meaningful use in 2011 or 2012 must demonstrate meaningful use for a full
year in 2013 to avoid payment adjustments in 2015. They must continue to demonstrate meaningful use
every year to avoid payment adjustments in subsequent years. The table below illustrates the timeline
to avoid payment adjustments for EPs who must demonstrate meaningful use for a full year in 2013.

Payment Adjustment Year

2015

2016

2017

2018

2019

2020

Full Year EHR Reporting Period

2013

2014

2015

2016

2017

2019

EPs who first demonstrate meaningful use in 2013 must demonstrate meaningful use for a 90-day
reporting period in 2013 to avoid payment adjustments in 2015. They must continue to demonstrate
meaningful use every year to avoid payment adjustments in subsequent years. The table below
illustrates the timeline to avoid payment adjustments for EPs who demonstrate meaningful use for a 90day reporting period in 2013.
Payment Adjustment Year

2015

90 day EHR Reporting Period

2013

Full Year EHR Reporting Period

90

2016

2017

2018

2019

2020

2014

2015

2016

2017

2019
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Payment Adjustment Year

2015

90 day EHR Reporting Period

2013

Full Year EHR Reporting Period

l

l
i

i

2016

2017

2018

2019

2020

2014

2015

2016

2017

2019

EPs who first demonstrate meaningful use in 2014 must demonstrate meaningful use for a 90-day
reporting period in 2014 to avoid payment adjustments in 2015. This reporting period must occur in the
first 9 months of calendar year 2014, and EPs must attest to meaningful use no later than October 1,
2014, in order to avoid the payment adjustments. EPs must continue to demonstrate meaningful use
every year to avoid payment adjustments in subsequent years. The table below illustrates the timeline
to avoid payment adjustments for EPs who first demonstrate meaningful use in 2014.
Payment Adjustment Year

2015

2016

90 day EHR Reporting Period

2014*

2014

Full Year EHR Reporting Period

2017

2018

2019

2020

2015

2016

2017

2019

*EPs must attest to meaningful use no later than October 1, 2014.
Hardship Exceptions for Medicare EPs
EPs may apply for hardship exceptions to avoid the payment adjustments described above. Hardship
exceptions will be granted only under specific circumstances and only if CMS determines that providers
have demonstrated that those circumstances pose a significant barrier to their achieving meaningful
use. Information on how to apply for a hardship exception will be posted on the CMS EHR Incentive
Programs website (www.cms.gov/EHRIncentiveProgram) in the future.
EPs can apply for hardship exceptions in the following categories:
 Infrastructure — EPs must demonstrate that they are in an area without sufficient internet
access or face insurmountable barriers to obtaining infrastructure (e.g., lack of broadband).
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 New EPs — Newly practicing EPs who would not have had time to become meaningful
users can apply for a 2-year limited exception to payment adjustments. Thus EPs who
begin practice in calendar year 2015 would receive an exception to the penalties in 2015
and 2016, but would have to begin demonstrating meaningful use in calendar year 2016
to avoid payment adjustments in 2017.
 Unforeseen Circumstances — Examples may include a natural disaster or other unforeseeable
barrier. We also solicited comment on a fourth category of hardship exception as follows:
 By Specialist/Provider Type — EPs must demonstrate that they meet all three of the following
criteria:
1. Lack of face-to-face or telemedicine interaction with patients
2. Lack of follow-up need with patients
3. Lack of control over the availability of Certified EHR Technology at their practice
location. (EPs who practice at multiple locations may be granted a hardship exception
solely for lack of control over the availability of Certified EHR Technology)
Frequently Asked Questions
Do I have to be a meaningful user each year to avoid the payment adjustments or can I avoid the
payment adjustments by achieving meaningful use only once?
You must demonstrate meaningful use every year according to the timelines detailed above in order to
avoid Medicare payment adjustments. For example, an EP who demonstrates meaningful use for the
first time in 2013 will avoid the payment adjustment in 2015, but will need to demonstrate meaningful
use again in 2014 in order to avoid the payment adjustment in 2016.
If I am an EP who is eligible for both the Medicare and Medicaid EHR Incentive Programs, but I register
to participate in the Medicaid EHR Incentive Program, do I still have to be a meaningful user to avoid
the payment adjustments?
Yes. If you are eligible to participate in both the Medicare and Medicaid EHR Incentive Programs, you
must demonstrate meaningful use according to the timelines detailed above to avoid the payment
adjustments. You may demonstrate meaningful use under either Medicare or Medicaid.
If I am an EP who is eligible for both the Medicare and Medicaid EHR Incentive Programs, will I avoid
the payment adjustments during a calendar year when I receive an incentive payment for adopting,
implementing, or upgrading my Certified EHR Technology?
No. Congress mandated that an EP must be a meaningful user in order to avoid the payment
adjustment; therefore receiving a Medicaid EHR incentive payment for adopting, implementing, or
upgrading your Certified EHR Technology would not exempt you from the payment adjustments. You
must demonstrate meaningful use according to the timelines detailed above to avoid the payment
adjustments. You may demonstrate meaningful use under either Medicare or Medicaid.
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If I am a hospital-based Medicare EP, am I subject to the payment adjustments?
No. If you perform 90% or more of your covered professional services in either the inpatient (Place of
Service 21) or emergency department (Place of Service 23) of a hospital, then you will be determined to
be hospital-based and are not eligible to receive an EHR incentive and will not be subject to the payment
adjustments.
However, your hospital-based status can change from year to year. For example, an EP who is
determined to be hospital-based for the 2015 program year would not be subject to the payment
adjustments in 2017. But if that EP is determined not to be hospital-based for the 2016 and the 2017
program year, then he or she could be subject to the payment adjustments in 2018 if the EP does not
demonstrate meaningful use. Therefore it is important to check your hospital-based status at the
beginning of each year. You can check your hospital-based status by visiting the Medicare EHR Incentive
Programs Registration System (https://ehrincentives.cms.gov/).
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ADDITIONAL INFORMATION REGARDING EP CLINICAL QUALITY MEASURES FOR 2014 EHR INCENTIVE PROGRAMS

The table below entitled “Clinical Quality Measures for 2014 CMS EHR Incentive Programs for Eligible Professionals” contains additional upto-date information for the EP clinical quality measures finalized in the Medicare and Medicaid Programs; Electronic Health Record Incentive
Program; Final Rule. Because measure specifications may need to be updated more frequently than our expected rulemaking cycle will allow for, this
table provides updates to the specifications. Subsequent updates will be provided in a new version of this table at least 6 months prior to the
beginning of the calendar year for which the measure will be required, and CMS will maintain and publish an archive of each update.

Please note the titles and descriptions for the clinical quality measures included in this table were updated by the measure stewards and therefore
may not match the information provided on the NQF website. Measures that do not have an NQF number are measures that are not currently
endorsed.

Last updated October 2012
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CLINICAL QUALITY MEASURES FOR 2014 CMS EHR INCENTIVE PROGRAMS FOR ELIGIBLE PROFESSIONALS

CMS
eMeasure ID

NQF #

CMS146v1

0002

CMS137v1

0004

Measure Title

Measure Description

Numerator Statement

Appropriate
Testing for
Children with
Pharyngitis

Percentage of children 218 years of age who
were diagnosed with
pharyngitis, ordered an
antibiotic and received a
group A streptococcus
(strep) test for the
episode.

Children with a group A
streptococcus test in the 7day period from 3 days
prior through 3 days after
the diagnosis of pharyngitis

Initiation and
Engagement of
Alcohol and Other
Drug Dependence
Treatment

Percentage of patients
13 years of age and older
with a new episode of
alcohol and other drug
(AOD) dependence who
received the following.
Two rates are reported.
a. Percentage of patients
who initiated treatment
within 14 days of the
diagnosis.

Denominator
Statement

Measure Steward

Link to NQF website

Children age 2-18
years who had an
outpatient or
emergency department
(ED) visit with a
diagnosis of pharyngitis
during the
measurement period
and an antibiotic
ordered on or three
days after the visit

National
Committee for
Quality Assurance

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=370

Numerator 1: Patients who
initiated treatment within 14
days of the diagnosis
Numerator 2: Patients who
initiated treatment and who
had two or more additional
services with an AOD
diagnosis within 30 days of
the initiation visit

Patients age 13 years
of age and older who
were diagnosed with a
new episode of alcohol
or drug dependency
during a visit in the first
11 months of the
measurement period

National
Committee for
Quality Assurance

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=1245

Patients whose most recent
blood pressure is
adequately controlled

Patients 18-85 years of
age who had a
diagnosis of essential

National
Committee for
Quality Assurance

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis

b. Percentage of patients
who initiated treatment
and who had two or more
additional services with
an AOD diagnosis within
30 days of the initiation
visit.
CMS165v1

0018

Controlling High
Blood Pressure

Percentage of patients
18-85 years of age who
had a diagnosis of
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hypertension and whose
blood pressure was
adequately controlled
(<140/90mmHg) during
the measurement period.
CMS
eMeasure ID

NQF #

CMS156v1

0022

CMS155v1

0024

Measure Title
Use of High-Risk
Medications in the
Elderly

Weight
Assessment and
Counseling for
Nutrition and
Physical Activity
for Children and
Adolescents

Measure Description
Percentage of patients
66 years of age and older
who were ordered highrisk medications. Two
rates are reported.
a. Percentage of patients
who were ordered at
least one high-risk
medication.
b. Percentage of patients
who were ordered at
least two different
high-risk medications.
Percentage of patients 317 years of age who had
an outpatient visit with a
Primary Care Physician
(PCP) or Obstetrician/
Gynecologist (OB/GYN)
and who had evidence of
the following during the
measurement period.
Three rates are reported.
Numerator 2: Patients
with an order for at least
two different high-risk
medications during the
measurement period.

(systolic blood pressure <
140 mmHg and diastolic
blood pressure < 90
mmHg) during the
measurement period.

Numerator Statement
Numerator 1: Patients with
an order for at least one
high-risk medication during
the measurement period.
Numerator 2: Patients who
had counseling for nutrition
during the measurement
period

hypertension within the
first six months of the
measurement period or
any time prior to the
measurement period
Denominator
Statement
Patients 66 years and
older who had a visit
during the
measurement period

Patients 3-17 years of
age with at least one
outpatient visit with a
primary care physician
(PCP) or an
obstetrician/
gynecologist (OB/GYN)
during the
measurement period

Numerator 1: Patients
who had a height, weight
and body mass index
(BMI) percentile recorded
during the measurement
period
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sionId=1236#p=1&s=n&so=a

Measure Steward

Link to NQF website

National
Committee for
Quality Assurance

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=273#p=-

National Committee for
Quality Assurance
http://www.qualityforum.org/
MeasureDetails.aspx?actid=
0&amp;SubmissionId=1247
%23p%3D1&amp;s=n&amp;so=a

 Percentage of patients
 with height, weight,
and body mass index
(BMI) with percentile
documentation
 Percentage of patients
with counseling for
nutrition
 Percentage of patients
with counseling for
physical activity
Numerator 3: Patients
who had counseling for
physical activity during
the measurement period
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CMS
eMeasure ID

NQF #

CMS138v1

0028

CMS125v1

Measure Title

Denominator
Statement

Measure Description

Numerator Statement

Preventive Care
and Screening:
Tobacco Use:
Screening and
Cessation
Intervention

Percentage of patients
aged 18 years and older
who were screened for
tobacco use one or more
times within 24 months
AND who received
cessation counseling
intervention if identified
as a tobacco user

Patients who were
screened for tobacco use at
least once within 24 months
AND who received tobacco
cessation counseling
intervention if identified as a
tobacco user

All patients aged 18
years and older

American Medical
Associationconvened
Physician
Consortium for
Performance
Improvement®
(AMA-PCPI)

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=391#p=1&s=n&so=a

0031

Breast Cancer
Screening

Percentage of women
40-69 years of age who
had a mammogram to
screen for breast cancer.

Women with one or more
mammograms during the
measurement period or the
year prior to the
measurement period

Women 42-69 years of
age with a visit during
the measurement
period

National
Committee for
Quality Assurance

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=392#p=1&s=n&so=a

CMS124v1

0032

Cervical Cancer
Screening

Percentage of women
21-64 years of age, who
received one or more
Pap tests to screen for
cervical cancer.

Women with one or more
Pap tests during the
measurement period or the
two years prior to the
measurement period

Women 24–64 years of
age with a visit during
the measurement
period

National
Committee for
Quality Assurance

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=393#p=1&s=n&so=a

CMS153v1

0033

Chlamydia
Screening for
Women

Percentage of women
16- 24 years of age who
were identified as
sexually active and who
had at least one test for
chlamydia during the
measurement period.

Women with at least one
chlamydia test during the
measurement period

Women 16-24 years of
age who are sexually
active and who had a
visit in the
measurement period

National
Committee for
Quality Assurance

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=1253#p=1&s=n&so=a
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Measure Steward

Link to NQF website

CMS
eMeasure ID

NQF #

CMS130v1

CMS126v1

Measure Title

Measure Description

Numerator Statement

0034

Colorectal Cancer
Screening

Percentage of adults 5075 years of age who had
appropriate screening for
colorectal cancer.

Patients with one or more
screenings for colorectal
cancer. Appropriate
screenings are defined by
any one of the following
criteria below:
- Fecal occult blood test
(FOBT) during the
measurement period
- Flexible sigmoidoscopy
during the measurement
period or the four years
prior to the measurement
period
- Colonoscopy during the
measurement period or
the nine years prior to the
measurement period

0036

Use of
Appropriate
Medications for
Asthma

Percentage of patients 564 years of age who
were identified as having
persistent asthma and
were appropriately
prescribed medication
during the measurement
period.

Patients who were
dispensed at least one
prescription for a preferred
therapy during the
measurement period

100

Denominator
Statement

Measure Steward

Link to NQF website

Patients 51-75 years of
age with a visit during
the measurement
period

National
Committee for
Quality Assurance

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=394#p=1&s=n&so=a

Patients 5-64 years of
age with persistent
asthma and a visit
during the
measurement period

National
Committee for
Quality Assurance

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=367#p=1&s=n&so=a

CMS
eMeasure ID

NQF #

CMS117v1

0038

CMS147v1

Measure Title

Measure Description

Numerator Statement

Childhood
Immunization
Status

Percentage of children 2
years of age who had
four diphtheria, tetanus
and acellular pertussis
(DTaP); three polio (IPV),
one measles, mumps
and rubella (MMR); three
H influenza type B (HiB);
three hepatitis B (Hep B);
one chicken pox (VZV);
four pneumococcal
conjugate (PCV); one
hepatitis A (Hep A); two
or three rotavirus (RV);
and two influenza (flu)
vaccines by their second
birthday.

Children who have
evidence showing they
received recommended
vaccines, had documented
history of the illness, had a
seropositive test result, or
had an allergic reaction to
the vaccine by their second
birthday

0041

Preventive Care
and Screening:
Influenza
Immunization

Percentage of patients
aged 6 months and older
seen for a visit between
October 1 and March 31
who received an
influenza immunization
OR who reported
previous receipt of an
influenza immunization

CMS127v1

0043

Pneumonia
Vaccination
Status for Older
Adults

CMS166v1

0052

Use of Imaging
Studies for Low
Back Pain

Denominator
Statement

Measure Steward

Link to NQF website

Children who turn 2
years of age during the
measurement period
and who have a visit
during the
measurement period

National
Committee for
Quality Assurance

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=395#p=1&s=n&so=a

Patients who received an
influenza immunization OR
who reported previous
receipt of an influenza
immunization

All patients aged 6
months and older and
seen for a visit between
October 1 and March
31

American Medical
Associationconvened
Physician
Consortium for
Performance
Improvement®
(AMA-PCPI)

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=397#p=1&s=n&so=a

Percentage of patients
65 years of age and older
who have ever received
a pneumococcal vaccine.

Patients who have ever
received a pneumococcal
vaccination

Patients 65 years of
age and older with a
visit during the
measurement period

National
Committee for
Quality Assurance

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=492#p=1&s=n&so=a

Percentage of patients
18-50 years of age with a
diagnosis of low back
pain who did not have an
imaging study (plain Xray, MRI, CT scan) within
28 days of the diagnosis.

Patients with an imaging
study conducted on the
date of the outpatient or
emergency department visit
or in the 28 days following
the outpatient or
emergency department visit

Patients 18-50 years of
age with a diagnosis of
low back pain during an
outpatient or
emergency department
visit

National
Committee for
Quality Assurance

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=1220#p=1&s=n&so=a
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CMS
eMeasure ID

NQF #

CMS131v1

0055

CMS123v1

Measure Title

Measure Description

Numerator Statement

Diabetes: Eye
Exam

Percentage of patients
18-75 years of age with
diabetes who had a
retinal or dilated eye
exam by an eye care
professional during the
measurement period or a
negative retinal exam (no
evidence of retinopathy)
in the 12 months prior to
the measurement period

Patients with an eye
screening for diabetic
retinal disease. This
includes diabetics who had
one of the following:
A retinal or dilated eye
exam by an eye care
professional in the
measurement period or a
negative retinal exam (no
evidence of retinopathy) by
an eye care professional in
the year prior to the
measurement period

0056

Diabetes: Foot
Exam

Percentage of patients
aged 18-75 years of age
with diabetes who had a
foot exam during the
measurement period.

CMS122v1

0059

Diabetes:
Hemoglobin A1c
Poor Control

CMS148v1

0060

Hemoglobin A1c
Test for Pediatric
Patients

Denominator
Statement

Measure Steward

Link to NQF website

Patients 18-75 years of
age with diabetes with
a visit during the
measurement period

National
Committee for
Quality Assurance

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=1223#p=1&s=n&so=a

Patients who received a
foot exam (visual inspection
with either a sensory exam
or pulse exam) during the
measurement period

Patients 18-75 years of
age with diabetes with
a visit during the
measurement period

National
Committee for
Quality Assurance

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=1224#p=1&s=n&so=a

Percentage of patients
18-75 years of age with
diabetes who had
hemoglobin A1c > 9.0%
during the measurement
period.

Patients whose most recent
HbA1c level (performed
during the measurement
period) is >9.0%

Patients 18-75 years of
age with diabetes with
a visit during the
measurement period

National
Committee for
Quality Assurance

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=1225#k=0059&
e=1&st=&sd=&mt=&cs
=&ss=&s=n&so=a&p=
1

Percentage of patients 517 years of age with
diabetes with an HbA1c
test during the
measurement period

Patients with
documentation of date and
result for a HbA1c test
during the measurement
period

Patients 5 to17 years of
age with a diagnosis of
diabetes and a face-toface visit for diabetes
care between the
physician and the
patient that predates
the most recent visit by
at least 12 months

National
Committee for
Quality Assurance

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=851#k=0060&e
=1&st=&sd=&mt=&cs=
&ss=&s=n&so=a&p=1
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CMS
eMeasure ID

NQF #

CMS134v1

Measure Title

Measure Description

Numerator Statement

0062

Diabetes: Urine
Protein Screening

The percentage of
patients 18-75 years of
age with diabetes who
had a nephropathy
screening test or
evidence of nephropathy
during the measurement
period.

Patients with a screening
for nephropathy or
evidence of nephropathy
during the measurement
period

CMS163v1

0064

Diabetes: Low
Density
Lipoprotein (LDL)
Management

Percentage of patients
18-75 years of age with
diabetes whose LDL-C
was adequately
controlled (<100 mg/dL)
during the measurement
period.

CMS164v1

0068

Ischemic Vascular
Disease (IVD):
Use of Aspirin or
Another
Antithrombotic

Percentage of patients
18 years of age and older
who were discharged
alive for acute myocardial
infarction (AMI), coronary
artery bypass graft
(CABG) or percutaneous
coronary interventions
(PCI) in the 12 months
prior to the measurement
period, or who had an
active diagnosis of
ischemic vascular
disease (IVD) during the
measurement period,
and who had
documentation of use of
aspirin or another
antithrombotic during the
measurement period.

Denominator
Statement

Measure Steward

Link to NQF website

Patients 18-75 years of
age with diabetes with
a visit during the
measurement period

National
Committee for
Quality Assurance

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=1226#k=0062&
e=1&st=&sd=&s=n&so
=a&p=1&mt=&cs=&ss
=

Patients whose most recent
LDL-C level performed
during the measurement
period is < 100 mg/dL

Patients 18-75 years of
age with diabetes with
a visit during the
measurement period

National
Committee for
Quality Assurance

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=1228#k=0064&
e=1&st=&sd=&mt=&cs
=&ss=&s=n&so=a&p=
1

Patients who have
documentation of use of
aspirin or another
antithrombotic during the
measurement period

Patients 18 years of
age and older with a
visit during the
measurement period,
and an active diagnosis
of ischemic vascular
disease (IVD) or who
were discharged alive
for acute myocardial
infarction (AMI),
coronary artery bypass
graft (CABG) or
percutaneous coronary
interventions (PCI) in
the 12 months prior to
the measurement
period

National
Committee for
Quality Assurance

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=1229#k=0068&
e=1&st=&sd=&mt=&cs
=&ss=&s=n&so=a&p=
1
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CMS
eMeasure ID

NQF #

CMS154v1

Measure Title

Measure Description

Numerator Statement

0069

Appropriate
Treatment for
Children with
Upper Respiratory
Infection (URI)

Percentage of children 3
months-18 years of age
who were diagnosed with
upper respiratory
infection (URI) and were
not dispensed an
antibiotic prescription on
or three days after the
episode.

Children without a
prescription for antibiotic
medication on or 3 days
after the outpatient or ED
visit for an upper respiratory
infection

CMS145v1

0070

Coronary Artery
Disease (CAD):
Beta-Blocker
Therapy—Prior
Myocardial
Infarction (MI) or
Left Ventricular
Systolic
Dysfunction
(LVEF <40%)

Percentage of patients
aged 18 years and older
with a diagnosis of
coronary artery disease
seen within a 12 month
period who also have a
prior MI or a current or
prior LVEF <40% who
were prescribed betablocker therapy

Patients who were
prescribed beta blocker
therapy

CMS182v1

0075

Ischemic Vascular
Disease (IVD):
Complete Lipid
Panel and LDL
Control

Percentage of patients
18 years of age and older
who were discharged alive
for acute myocardial
infarction (AMI), coronary
artery bypass graft (CABG)
or percutaneous coronary
interventions (PCI) in the 12
months prior to the
measurement period, or
who had an active diagnosis
of ischemic vascular
disease (IVD) during the
measurement period, and
who had a complete lipid
profile performed during the
measurement period and
whose LDL-C was
adequately controlled(< 100
mg/dL).

Numerator 1: Patients with
a complete lipid profile
performed during the
measurement period
Numerator 2: Patients whose
most recent LDL-C level
performed during the
measurement period is <100
mg/dL
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Denominator
Statement

Measure Steward

Link to NQF website

Children age 3 months
to 18 years who had an
outpatient or
emergency department
(ED) visit with a
diagnosis of upper
respiratory infection
(URI) during the
measurement period

National
Committee for
Quality Assurance

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=369#k=0069&e
=1&st=&sd=&s=n&so=
a&p=1&mt=&cs=&ss=

All patients aged 18
years and older with a
diagnosis of coronary
artery disease seen
within a 12 month
period who also have
prior MI or a current or
prior LVEF <40%

American Medical
Associationconvened
Physician
Consortium for
Performance
Improvement ®
(AMA-PCPI)

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=377#k=0070&e
=1&st=&sd=&mt=&cs=
&ss=&s=n&so=a&p=1

National
Committee Quality
Assurance

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&amp;Su
bmissionId=1232%23k
%3D0075&amp;e=1&a
mp;st&amp;sd&amp;m
t&amp;cs&amp;ss&am
p;s=n&amp;so=a&amp
;p=1

Patients 18 years of
age and older with a
visit during the
measurement period,
and an active diagnosis of
ischemic vascular disease
(IVD) during the
measurement period, or
who were discharged alive
for acute myocardial
infarction (AMI), coronary
artery bypass graft (CABG)
or percutaneous coronary
intervensions (PCI) in the
12 months prior to the
measurement period

k

CMS
eMeasure ID

NQF #

CMS135v1

Measure Title

Measure Description

Numerator Statement

0081

Heart Failure
(HF): AngiotensinConverting
Enzyme (ACE)
Inhibitor or
Angiotensin
Receptor Blocker
(ARB) Therapy for
Left Ventricular
Systolic
Dysfunction
(LVSD)

Percentage of patients
aged 18 years and older
with a diagnosis of heart
failure (HF) with a current
or prior left ventricular
ejection fraction (LVEF) <
40% who were
prescribed ACE inhibitor
or ARB therapy either
within a 12 month period
when seen in the
outpatient setting OR at
each hospital discharge

Patients who were
prescribed ACE inhibitor or
ARB therapy either within a
12 month period when seen
in the outpatient setting or
at hospital discharge

CMS144v1

0083

Heart Failure
(HF): BetaBlocker Therapy
for Left Ventricular
Systolic
Dysfunction
(LVSD)

Percentage of patients
aged 18 years and older
with a diagnosis of heart
failure (HF) with a current
or prior left ventricular
ejection fraction (LVEF) <
40% who were
prescribed beta-blocker
therapy either within a 12
month period when seen
in the outpatient setting
OR at each hospital
discharge

CMS143v1

0086

Primary Open
Angle Glaucoma
(POAG): Optic
Nerve Evaluation

Percentage of patients
aged 18 years and older
with a diagnosis of
POAG who have an optic
nerve head evaluation
during one or more office
visits within 12 months

Denominator
Statement

Measure Steward

Link to NQF website

All patients aged 18
years and older with a
diagnosis of heart
failure with a current or
prior LVEF < 40%

American Medical
Associationconvened
Physician
Consortium for
Performance
Improvement ®
(AMA-PCPI)

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=383#k=0081&e
=1&s=n&so=a&p=1&st
=&sd=&mt=&cs=&ss=

Patients who were
prescribed beta-blocker
therapy either within a 12
month period when seen in
the outpatient setting or at
hospital discharge

All patients aged 18
years and older with a
diagnosis of heart
failure with a current or
prior LVEF < 40%

American Medical
Associationconvened
Physician
Consortium for
Performance
Improvement ®
(AMA-PCPI)

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=384#k=0083&e
=1&st=&sd=&mt=&cs=
&ss=&s=n&so=a&p=1

Patients who have an optic
nerve head evaluation
during one or more office
visits within 12 months

All patients aged 18
years and older with a
diagnosis of primary
open-angle glaucoma

American Medical
Associationconvened
Physician
Consortium for
Performance
Improvement ®
(AMA-PCPI)

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=436#k=0086&e
=1&st=&sd=&mt=&cs=
&ss=&s=n&so=a&p=1
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CMS
eMeasure ID

NQF #

CMS167v1

Denominator
Statement

Measure Title

Measure Description

Numerator Statement

0088

Diabetic
Retinopathy:
Documentation of
Presence or
Absence of
Macular Edema
and Level of
Severity of
Retinopathy

Percentage of patients
aged 18 years and older
with a diagnosis of
diabetic retinopathy who
had a dilated macular or
fundus exam performed
which included
documentation of the
level of severity of
retinopathy and the
presence or absence of
macular edema during
one or more office visits
within 12 months

Patients who had a dilated
macular or fundus exam
performed which included
documentation of the level
of severity of retinopathy
AND the presence or
absence of macular edema
during one or more office
visits within 12 months

All patients aged 18
years and older with a
diagnosis of diabetic
retinopathy

American Medical
Associationconvened
Physician
Consortium for
Performance
Improvement ®
(AMA-PCPI)

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=438#k=0088&e
=1&st=&sd=&mt=&cs=
&ss=&s=n&so=a&p=1

CMS142v1

0089

Diabetic
Retinopathy:
Communication
with the Physician
Managing
Ongoing Diabetes
Care

Percentage of patients
aged 18 years and older
with a diagnosis of
diabetic retinopathy who
had a dilated macular or
fundus exam performed
with documented
communication to the
physician who manages
the ongoing care of the
patient with diabetes
mellitus regarding the
findings of the macular or
fundus exam at least
once within 12 months

Patients with
documentation, at least
once within 12 months, of
the findings of the dilated
macular or fundus exam via
communication to the
physician who manages the
patient’s diabetic care

All patients aged 18
years and older with a
diagnosis of diabetic
retinopathy who had a
dilated macular or
fundus exam
performed

American Medical
Associationconvened
Physician
Consortium for
Performance
Improvement ®
(AMA-PCPI)

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=439#k=0089&e
=1&st=&sd=&mt=&cs=
&ss=&s=n&so=a&p=1

CMS139v1

0101

Falls: Screening
for Future Fall
Risk

Percentage of patients
65 years of age and older
who were screened for
future fall risk during the
measurement period.

Patients who were
screened for future fall risk
at least once within the
measurement period

Patients aged 65 years
and older with a visit
during the
measurement period

National
Committee for
Quality Assurance

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=445#k=0101&e
=1&st=&sd=&mt=&cs=
&ss=&s=n&so=a&p=1
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Measure Steward

Link to NQF website

CMS
eMeasure ID

NQF #

CMS161v1

CMS128v1

Denominator
Statement

Measure Title

Measure Description

Numerator Statement

0104

Major Depressive
Disorder (MDD):
Suicide Risk
Assessment

Percentage of patients
aged 18 years and older
with a new diagnosis or
recurrent episode of
MDD who had a suicide
risk assessment
completed at each visit
during the measurement
period.

Patients who had suicide
risk assessment completed
at each visit

All patients aged 18
years and older with a
new diagnosis or
recurrent episode of
MDD

American Medical
Associationconvened
Physician
Consortium for
Performance
Improvement ®
(AMA-PCPI)

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=1238#k=0104&
e=1&st=&sd=&mt=&cs
=&ss=&s=n&so=a&p=
1

0105

Anti-depressant
Medication
Management

Percentage of patients
18 years of age and older
who were diagnosed with
major depression and
treated with
antidepressant
medication, and who
remained on
antidepressant
medication treatment.
Two rates are reported.

Numerator 1: Patients who
have received
antidepressant medication
for at least 84 days (12
weeks) of continuous
treatment during the 114day period following the
Index Prescription Start
Date

Patients 18 years of
age and older with a
diagnosis of major
depression in the 180
days (6 months) prior
to the measurement
period or the first 180
days (6 months) of the
measurement period,
who were treated with
antidepressant
medication, and with a
visit during the
measurement period

National
Committee for
Quality Assurance

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=855#k=0105&e
=1&st=&sd=&mt=&cs=
&ss=&s=n&so=a&p=1

a. Percentage of patients
who remained on an
antidepressant
medication for at least
84 days (12 weeks).
b. Percentage of patients
who remained on an
antidepressant
medication for at least
180 days (6 months).

Numerator 2: Patients who
have received
antidepressant medications
for at least 180 days (6
months) of continuous
treatment during the 231day period following the
Index Prescription Start
Date
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Measure Steward

Link to NQF website

CMS
eMeasure ID

NQF #

CMS136v1

0108

Measure Title

Measure Description

Numerator Statement

ADHD: Follow-Up
Care for Children
Prescribed
AttentionDeficit/Hyperactivi
ty Disorder
(ADHD)

Percentage of children 612 years of age and
newly dispensed a
medication for attentiondeficit/ hyperactivity
disorder (ADHD) who
had appropriate follow-up
care. Two rates are
reported.

Numerator 1: Patients who
had at least one face-toface visit with a practitioner
with prescribing authority
within 30 days after the
IPSD

Medication

a. Percentage of children
who had one follow-up
visit with a practitioner
with prescribing
authority during the
30-Day Initiation
Phase.
b. Percentage of children
who remained on
ADHD medication for
at least 210 days and
who, in addition to the
visit in the Initiation
Phase, had at least
two additional followup visits with a
practitioner within 270
days (9 months) after
the Initiation Phase
ended.

Numerator 2: Patients who
had at least one face-toface visit with a practitioner
with prescribing authority
during the Initiation Phase,
and at least two follow-up
visits during the
Continuation and
Maintenance Phase. One of
the two visits during the
Continuation and
Maintenance Phase may be
a telephone visit with a
practitioner.

108

Denominator
Statement
Denominator 1:
Children 6-12 years of
age who were
dispensed an ADHD
medication during the
Intake Period and who
had a visit during the
measurement period
Denominator 2:
Children 6-12 years of
age who were
dispensed an ADHD
medication during the
Intake Period and who
remained on the
medication for at least
210 days out of the 300
days following the
IPSD, and who had a
visit during the
measurement period.

Measure Steward

Link to NQF website

National
Committee for
Quality Assurance

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=857#k=0108&e
=1&st=&sd=&mt=&cs=
&ss=&s=n&so=a&p=1

CMS
eMeasure ID

NQF #

CMS169v1

0110

Measure Title
Bipolar Disorder
and Major
Depression:
Appraisal for
alcohol or
chemical
substance use

Measure Description

Numerator Statement

Percentage of patients
with depression or
bipolar disorder with
evidence of an initial
assessment that includes
an appraisal for alcohol
or chemical substance
use.

Patients in the denominator
with evidence of an
assessment for alcohol or
other substance use
following or concurrent with
the new diagnosis, and
prior to or concurrent with
the initiation of treatment for
that diagnosis.
(Note: the endorsed
measure calls for the
assessment to be
performed prior to
discussion of the treatment
plan with the patient, but
the current approach was
considered more feasible in
an EHR setting. The
"Assessment for Alcohol or
Other Drug Use" required in
the numerator is meant to
capture a provider's
assessment of the patient's
symptoms of substance
use. The essence of the
The intent of the measure is
measure is to avoid treating
that the appraisal be
the patient for unipolar
performed at
and
depression
oreach
bipolar
every initial assessment. It
disorder without an
is possible for there to be
assessment of their use of
one or two initial
alcohol or other drugs.)
assessments during the
measurement period. Due
to limitations in the current
measurement frameworks,
the numerator in the current
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Denominator
Statement
Patients 18 years of
age or older at the start
of the measurement
period with a new
diagnosis of unipolar
depression or bipolar
disorder during the first
323 days of the
measurement period,
and evidence of
treatment for unipolar
depression or bipolar
depression within 42
days of diagnosis. The
existence of a 'new
diagnosis' is
established by the
absence of diagnoses
and treatments of
unipolar depression or
bipolar disorder during
the 180 days prior to
the diagnosis.

Measure Steward
Center for Quality
Assessment &
Improvement in
Mental Health
(CQAIMH)

Link to NQF website
http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=1241#k=0110&
e=1&st=&sd=&mt=&cs
=&ss=&s=n&so=a&p=
1

CMS
eMeasure ID

NQF #

CMS157v1

0384

Oncology:
Medical and
Radiation – Pain
Intensity
Quantified

Percentage of patient
Patient visits in which pain
visits, regardless of
intensity is quantified
patient age, with a
diagnosis of cancer
currently receiving
chemotherapy or
radiation therapy in which
pain intensity is
quantified

All patient visits,
regardless of patient
age, with a diagnosis
of cancer currently
receiving
chemotherapy or
radiation therapy

American Medical
Associationconvened
Physician
Consortium for
Performance
Improvement ®
(AMA-PCPI)

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=621#k=0384&e
=1&st=&sd=&mt=&cs=
&ss=&s=n&so=a&p=1

CMS141v1

0385

Colon Cancer:
Chemotherapy for
AJCC Stage III
Colon Cancer
Patients

Percentage of patients
aged 18 through 80
years with AJCC Stage
III colon cancer who are
referred for adjuvant
chemotherapy,
prescribed adjuvant
chemotherapy, or have
previously received
adjuvant chemotherapy
within the 12-month
reporting period

Patients who are referred
for chemotherapy,
prescribed chemotherapy,
or who have previously
received adjuvant
chemotherapy within the
12- month reporting period

All patients aged 18
through 80 years with
AJCC Stage III colon
cancer

American Medical
Associationconvened
Physician
Consortium for
Performance
Improvement ®
(AMA-PCPI)

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=628#k=0385&e
=1&st=&sd=&mt=&cs=
&ss=&s=n&so=a&p=1

CMS140v1

0387

Breast Cancer:
Hormonal
Therapy for Stage
IC-IIIC Estrogen
Receptor/
Progesterone
Receptor (ER/PR)
Positive Breast
Cancer

Percentage of female
patients aged 18 years
and older with Stage IC
through IIIC, ER or PR
positive breast cancer
who were prescribed
tamoxifen or aromatase
inhibitor (AI) during the
12-month reporting period

Patients who were
prescribed tamoxifen or
aromatase inhibitor (AI)
during the 12-month
reporting period

All female patients
aged 18 years and
older with a diagnosis
of stage IC through
IIIC, estrogen receptor
(ER) or progesterone
receptor (PR) positive
breast cancer

American Medical
Associationconvened
Physician
Consortium for
Performance
Improvement ®
(AMA-PCPI)

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=631#k=0387&e
=1&st=&sd=&mt=&cs=
&ss=&s=n&so=a&p=1

Measure Title

Measure Description

Numerator Statement
measure definition can be
satisfied if the appraisal is
performed at ANY single
initial assessment. Future
versions, implemented with
ever improving
measurement logic
frameworks, should close
this loophole.
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Denominato
r
Statement

Measure Steward

Link to NQF website

CMS
eMeasure ID

NQF #

CMS129v1

CMS62v1

Denominator
Statement

Measure Title

Measure Description

Numerator Statement

0389

Prostate Cancer:
Avoidance of
Overuse of Bone
Scan for Staging
Low Risk Prostate
Cancer Patients

Percentage of patients,
regardless of age, with a
diagnosis of prostate
cancer at low risk of
recurrence receiving
interstitial prostate
brachytherapy, OR
external beam
radiotherapy to the
prostate, OR radical
prostatectomy, OR
cryotherapy who did not
have a bone scan
performed at any time
since diagnosis of
prostate cancer

Patients who did not have a
bone scan performed at
any time since diagnosis of
prostate cancer

All patients, regardless
of age, with a diagnosis
of prostate cancer at
low risk of recurrence
receiving interstitial
prostate brachytherapy,
OR external beam
radiotherapy to the
prostate, OR radical
prostatectomy, OR
cryotherapy

American Medical
Associationconvened
Physician
Consortium for
Performance
Improvement ®
(AMA-PCPI)

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=624#k=0389&e
=1&st=&sd=&mt=&cs=
&ss=&s=n&so=a&p=1

0403

HIV/AIDS:
Medical Visit

Percentage of patients,
regardless of age, with a
diagnosis of HIV/AIDS
with at least two medical
visits during the
measurement year with a
minimum of 90 days
between each visit.

Patients with at least two
medical visits during the
measurement year with a
minimum of 90 days
between each visit

All patients, regardless
of age, with a diagnosis
of HIV/AIDS seen
within a 12 month
period

National
Committee for
Quality Assurance

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=580#k=0403&e
=1&st=&sd=&mt=&cs=
&ss=&s=n&so=a&p=1
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Measure Steward

Link to NQF website

CMS
eMeasure ID

NQF #

CMS52v1

0405

Measure Title

Measure Description

Numerator Statement

HIV/AIDS:
Pneumocystis
jiroveci
pneumonia (PCP)
Prophylaxis

Percentage of patients
aged 6 weeks and older
with a diagnosis of
HIV/AIDS who were
prescribed Pneumocystis
jiroveci pneumonia (PCP)
prophylaxis

Numerator 1: Patients who
were prescribed
pneumocystis jiroveci
pneumonia (PCP)
prophylaxis within 3 months
of CD4 count below 200
3
cells/mm
Numerator 2: Patients who
were prescribed
pneumocystic jiroveci
pneumonia (PCP)
prophylaxis within 3 months
of CD4 count below 500
3

cells/ mm or a CD4
percentage below 15%
Numerator 3: Patients who
were prescribed
Pneumocystic jiroveci
pneumonia (PCP)
prophylaxis at the time of
diagnosis of HIV

Denominator
Statement
Denominator 1: All
patients aged 6 years
and older with a
diagnosis of HIV/AIDS
and a CD4 count below
200 cells/mm3 who had
at least two visits during
the measurement year,
with at least 90 days in
between each visit

Measure Steward

Link to NQF website

National
Committee for
Quality Assurance

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=582#k=0405&e
=1&st=&sd=&mt=&cs=
&ss=&s=n&so=a&p=1

Denominator 2: All
patients aged 1-5 years
of age with a diagnosis of
HIV/AIDS and a CD4
count below 500
cells/mm3 or a CD4
percentage below 15%
who had at least two
visits during the
measurement year, with
at least 90 days in
between each visit
Denominator 3: All
patients aged 6 weeks to
12 months with a
diagnosis of HIV who
had at least two visits
during the measurement
year, with at least 90
days in between each
visit

CMS77v1 TBD
HIV/AIDS: RNA
(Proposed control for
Patients with HIV
as
NQF0407

Percentage of 13 years
and older with a diagnosis
of HIV/AIDS, with at least
two visits during the
measurement year, with at
least 90 days between
each visit, whose most
recent HIV RNA level is
<200 copies/mL.

Patients whose most
recent HIV RNA level is
<200 copies/mL.
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All patients aged 13
years and older with a
diagnosis of HIV/AIDS
with at least two visits
during the measurement
year, with at least 90
days between each visit.

National
Committee for
Quality Assurance

CMS
eMeasure ID

NQF #

Measure Title

Measure Description

Numerator Statement

Denominator
Statement

Measure Steward

Link to NQF website

Cc cCMS2v1 0418

Preventive Care
and Screening:
Screening for
Clinical
Depression and
Follow-Up Plan

Percentage of patients
aged 12 years and older
screened for clinical
depression on the date of
the encounter using an
age appropriate
standardized depression
screening tool AND if
positive, a follow up plan
is documented on the
date of the positive
screen.

Patients screened for
clinical depression on the
date of the encounter using
an age appropriate
standardized tool AND if
positive, a follow-up plan is
documented on the date of
the positive screen

All patients aged 12
years and older before
the beginning of the
measurement period
with at least one
eligible encounter
during the
measurement period.

Quality Insights of
Pennsylvania/
Centers for
Medicare &
Medicaid Services

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=522#k=0418&e
=1&st=&sd=&mt=&cs=
&ss=&s=n&so=a&p=1

CMS68v1

Documentation of
Current
Medications in the
Medical Record

Percentage of specified
visits for patients aged 18
years and older for which
the eligible professional
attests to documenting a
list of current medications
to the best of his/her
knowledge and ability.
This list must include ALL
prescriptions, over-thecounters, herbals, and
vitamin/mineral/dietary
(nutritional) supplements
AND must contain the
medications’ name,
dosage, frequency and
route of administration.

Eligible professional attests
to documenting a list of
current medications to the
best of his/her knowledge
and ability. This list must
include ALL prescriptions,
over-the-counters, herbals
and vitamin/mineral/dietary
(nutritional) supplements
AND must contain the
medications’ name,
dosages, frequency and
route of administration.

All visits occurring
during the 12 month
reporting period for
patients aged 18 years
and older before the
start of the
measurement period

Quality Insights of
Pennsylvania/
Centers for
Medicare &
Medicaid Services

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=524#k=0419&e
=1&st=&sd=&mt=&cs=
&ss=&s=n&so=a&p=1

0419
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CMS
eMeasure ID

NQF #

CMS69v1

0421

Measure Title
Preventive Care
and Screening:
Body Mass Index
(BMI) Screening
and Follow-Up

Numerator Statement

Denominator
Statement

Percentage of patients
aged 18 years and older
with an encounter during
the reporting period with
a documented calculated
BMI during the encounter

Patients with a documented
calculated BMI during the
encounter or during the
previous six months, AND
when the BMI is outside of
normal parameters, follow-

Initial Patient
Population 1: All
patients 65 years of
age and older before
the beginning of the
measurement period

or during the previous six
months AND when the
BMI is outside of normal
parameters, follow-up
plan is documented
during the encounter or
during the previous 6
months of the encounter
with the BMI outside of
normal parameters.
Normal Parameters: Age
65 years and older BMI ≥
23 and < 30 Age 18-64
years BMI ≥18.5 and < 25

up is documented during
the encounter or during the
previous six months of the
encounter with the BMI
outside of normal
parameters

with at least one
eligible encounter
during the
measurement period
NOT INCLUDING
encounters where the
patient is receiving
palliative care, refuses
BMI measurement, the
patient is in an urgent
or emergent medical
situation where time is of
the essence and to delay
treatment would
jeopardize the patient’s
health status, or there is
any other reason
documented in the
medical record by the
provider explaining why
BMI measurement was
not appropriate. Initial
Patient Population 2: All
patients 18 through 64
years before the
beginning of the
measurement period with
at least one eligible
encounter during the
measurement period NOT
INCLUDING encounters
where the patient is
receiving palliative care,
refuses BMI
measurement, the

Measure Description
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Measure Steward
Quality Insights of
Pennsylvania/
Centers for
Medicare &
Medicaid Services

Link to NQF website
http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=526#k=0421&e
=1&st=&sd=&mt=&cs=
&ss=&s=n&so=a&p=1

CMS
eMeasure ID

NQF #

Measure Title

Measure Description

Numerator Statement

Denominator
Statement

Measure Steward

Link to NQF website

the patient is in an
urgent or emergent
medical situation where
time is of the essence
and to delay treatment
would jeopardize the
patient’s health status,
or there is any other
reason documented in
the medical record by
the provider explaining
why BMI measurement
was not appropriate.
CMS132v1

0564

Cataracts:
Complications
within 30 Days
Following
Cataract Surgery
Requiring
Additional
Surgical
Procedures

Percentage of patients
aged 18 years and older
with a diagnosis of
uncomplicated cataract
who had cataract surgery
and had any of a
specified list of surgical
procedures in the 30
days following cataract
surgery which would
indicate the occurrence
of any of the following
major complications:
retained nuclear
fragments,
endophthalmitis,
dislocated or wrong
power IOL, retinal
detachment, or wound
dehiscence.

Patients who had one or
more specified operative
procedures for any of the
following major
complications within 30
days following cataract
surgery: retained nuclear
fragments, endophthalmitis,
dislocated or wrong power
IOL, retinal detachment, or
wound dehiscence
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All patients aged 18
years and older who
had cataract surgery
and no significant preoperative ocular
conditions impacting
the surgical
complication rate

American Medical
Associationconvened
Physician
Consortium for
Performance
Improvement ®
(AMA-PCPI)

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=898#k=0564&e
=1&st=&sd=&mt=&cs=
&ss=&s=n&so=a&p=1

CMS
eMeasure ID

NQF #

CMS133v1

0565

CMS158v1

CMS159v1

Measure Title

Denominator
Statement

Measure Description

Numerator Statement

Cataracts: 20/40
or Better Visual
Acuity within 90
Days Following
Cataract Surgery

Percentage of patients
aged 18 years and older
with a diagnosis of
uncomplicated cataract
who had cataract surgery
and no significant ocular
conditions impacting the
visual outcome of
surgery and had bestcorrected visual acuity of
20/40 or better (distance
or near) achieved within
90 days following the
cataract surgery.

Patients who had bestcorrected visual acuity of
20/40 or better (distance or
near) achieved within 90
days following cataract
surgery

All patients aged 18
years and older who
had cataract surgery

American Medical
Associationconvened
Physician
Consortium for
Performance
Improvement ®
(AMA-PCPI)

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=899#k=0565&e
=1&st=&sd=&mt=&cs=
&ss=&s=n&so=a&p=1

0608

Pregnant women
that had HBsAg
testing

This measure identifies
pregnant women who
had a HBsAg (hepatitis
B) test during their
pregnancy.

Patients who were tested
for Hepatitis B surface
antigen (HBsAg) during
pregnancy within 280 days
prior to delivery.

All female patients
aged 12 and older who
had a full term delivery
during the
measurement period.

OptumInsight

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=1018#k=0608&
e=1&st=&sd=&mt=&cs
=&ss=&s=n&so=a&p=
1

0710

Depression
Remission at
Twelve Months

Adult patients age 18 and
older with major
depression or dysthymia
and an initial PHQ-9
score > 9 who
demonstrate remission at
twelve months defined as
PHQ-9 score less than 5.
This measure applies to
both patients with newly
diagnosed and existing
depression whose
current PHQ-9 score
indicates a need for
treatment.

Adults who achieved
remission at twelve months
as demonstrated by a
twelve month (+/- 30 days)
PHQ-9 score of less than
five.

Adults age 18 and
older with a diagnosis
of major depression or
dysthymia and an initial
PHQ-9 score greater
than nine during an
outpatient encounter.

MN Community
Measurement

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=55#k=0710&e=
1&st=&sd=&mt=&cs=&
ss=&s=n&so=a&p=1
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Measure Steward

Link to NQF website

CMS
eMeasure ID

NQF #

CMS160v1

0712

CMS75v1

Measure Title

Denominator
Statement

Measure Description

Numerator Statement

Depression
Utilization of the
PHQ-9 Tool

Adult patients age 18 and
older with the diagnosis
of major depression or
dysthymia who have a
PHQ-9 tool administered
at least once during a 4
month period in which
there was a qualifying
visit.

Adult patients who have a
PHQ-9 tool administered at
least once during the fourmonth period.

Adult patients age 18
and older with an office
visit and the diagnosis
of major depression or
dysthymia during each
four month period

MN Community
Measurement

TBD

Children who
have dental decay
or cavities

Percentage of children,
ages 0-20 years, who
have had tooth decay or
cavities during the
measurement period.

Children who had cavities
or decayed teeth.

Children, age 0-20
years, with a visit
during the
measurement period.

Maternal and Child
Health Bureau,
Health Resources
& Services
Administration

CMS177v1

1365

Child and
Adolescent Major
Depressive
Disorder: Suicide
Risk Assessment

Percentage of patient
visits for those patients
aged 6 through 17 years
with a diagnosis of major
depressive disorder with
an assessment for
suicide risk.

Patient visits with an
assessment for suicide risk

All patient visits for
those patients aged 6
through 17 years with a
diagnosis of major
depressive disorder

American Medical
AssociationPhysician
Consortium for
Performance
Improvement
(AMA-PCPI)

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=1365#k=1365&
e=1&st=&sd=&mt=&cs
=&ss=&s=n&so=a&p=
1

CMS82v1

1401

Maternal
depression
screening

The percentage of
children who turned 6
months of age during the
measurement year, who
had a face-to-face visit
between the clinician and
the child during child’s
first 6 months, and who
had a maternal
depression screening for
the mother at least once
between 0 and 6 months
of life.

Children with
documentation of maternal
screening or treatment for
postpartum depression for
the mother.

Children with a visit
who turned 6 months of
age in the
measurement period.

National
Committee for
Quality Assurance

http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=1401#k=1401&
e=1&st=&sd=&mt=&cs
=&ss=&s=n&so=a&p=
1
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Measure Steward

Link to NQF website
http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&Submis
sionId=56#k=0712&e=
1&st=&sd=&mt=&cs=&
ss=&s=n&so=a&p=1

Denominator
Statement

CMS
eMeasure ID

NQF #

CMS74v1

TBD

Primary Caries
Prevention
Intervention as
Offered by
Primary Care
Providers,
including Dentists

Percentage of children,
age 0-20 years, who
received a fluoride
varnish application during
the measurement period.

Children who receive a
fluoride varnish application

Children, age 0-20
years, with a visit
during the
measurement period.

University of
Minnesota

CMS61v1

TBD

Preventive Care
and Screening:
Cholesterol –
Fasting Low
Density

Percentage of patients
aged 20 through 79 years
whose risk factors have
been assessed and a
fasting LDL-C test has

Numerator 1: (High Risk)
Patients who had a fasting
LDL-C test performed or a
calculated LDL-C during the
measurement period

Denominator 1: (High
Risk) All patients aged 20
through 79 years who
have CHD or CHD Risk
Equivalent

Quality Insights of
Pennsylvania/
Centers for
Medicare &
Medicaid Services

Lipoprotein (LDL-

been performed.

Numerator 2: (Moderate
Risk) Patients who had a
fasting LDL-C test
performed or a calculated
LDL-C during the
measurement period

Denominator 2:
(Moderate Risk) All
patients aged 20 through
79 years who have
Multiple Risk Factors (2+)
of the following: Cigarette
Smoking, Hypertension,
Low High Density
Lipoprotein (HDL-C)**,
Family History of
Premature CHD, or Age
(men >= 45; women >=
55)

Measure Title

C) Test Performed

Measure Description

Numerator Statement

Numerator 3: (Low Risk)
Patients who had a fasting
LDL-C test performed or a
calculated LDL-C during the
measurement period or up to
four (4) years prior to the
current measurement period

Denominator 3: (Low Risk)
All patients aged 20
through 79 years who
have risk factors 0 or 1 of
the following risk factors:
Cigarette Smoking,
Hypertension, Low High
Density Lipoprotein (HDLC)**, Family History of
Premature CHD, or
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Measure Steward

Link to NQF website

CMS
eMeasure ID

NQF #

Measure Title

Measure Description

Numerator Statement

Denominator
Statement

Measure Steward

Age (men >= 45;
women >= 55)
**For Denominator 2
and Denominator 3,
HDL-C > or equal to 60
mg/dL subtracts 1 risk
from the above (This is
a negative risk factor.)
CMS64v1

TBD

Preventive Care
and Screening:
Risk-Stratified
Cholesterol –
Fasting Low
Density Lipoprotein
(LDL- C)

Percentage of patients
aged 20 through 79 years
who had a fasting
LDL-C test performed and
whose risk-stratified fasting
LDL-C is at or below the
recommended LDL-C goal.

Numerator 1: Patients
whose most recent fasting
LDL-C test is <100 mg/dL
Numerator 2: Patients whose
most recent fasting LDL-C
test is <130 mg/dL
Numerator 3: Patients whose
most recent fasting LDL-C
test is <160 mg/dL
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Denominator 1: (High
Risk) All patients aged
20 through 79 years
who had a fasting LDL- C
or a calculated LDL- C test
performed during the
measurement period and
have CHD or CHD Risk
Equivalent OR Have
Multiple Risk Factors (2+)
of the following: Cigarette
Smoking, Hypertension,
Low High Density
Lipoprotein (HDL-C)**,
Family History of
Premature CHD, or Age
(men >= 45; women >=
55) AND a 10-year
Framingham risk >20%
Denominator 2: (Moderate
Risk) All patients aged 20
through 79 years who had
a fasting LDL-C or a
calculated LDL-C test
performed during the
measurement period and
have Multiple Risk

Quality Insights of
Pennsylvania/
Centers for
Medicare &
Medicaid Services

Link to NQF website

CMS
eMeasure ID

NQF #

Measure Title

Measure Description

Numerator Statement

Denominator
Statement
Factors (2+) of the
following: Cigarette
Smoking,
Hypertension, Low
High Density
Lipoprotein (HDL-C)**,
Family History of
Premature CHD, or
Age (men >= 45;
women >= 55) and
AND 10-year
Framingham risk
<=20% Denominator 3:
(Low Risk) All patients
aged 20 through 79
years who have had a
fasting LDL-C or a
calculated LDL-C test
performed up to 4
years prior to the
current measurement
period and have 0 or 1
of the following risk
factors: Cigarette
Smoking,
Hypertension, Low
High Density
Lipoprotein (HDL-C)**,
Family History of
Premature CHD, or
Age (men >= 45;
women >= 55)
**HDL-C > or equal to
60 mg/dL subtracts 1
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Measure Steward

Link to NQF website

risk from the above
(This is a negative risk
factor)
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CMS
eMeasure ID

NQF #

CMS149v1

TBD

Dementia:
Cognitive
Assessment

Percentage of patients,
regardless of age, with a
diagnosis of dementia for
whom an assessment of
cognition is performed
and the results reviewed
at least once within a 12
month period.

Patients for whom an
assessment of cognition is
performed and the results
reviewed at least once
within a 12-month period

All patients, regardless
of age, with a diagnosis
of dementia.

American Medical
Associationconvened
Physician
Consortium for
Performance
Improvement ®
(AMA-PCPI)

CMS65v1

TBD

Hypertension:
Improvement in
blood pressure

Percentage of patients
aged 18-85 years of age
with a diagnosis of
hypertension whose
blood pressure improved
during the measurement
period.

Patients whose follow-up
blood pressure is at least
10 mmHg less than their
baseline blood pressure or
is adequately controlled.
If a follow-up blood
pressure reading is not
recorded during the
measurement year, the
patient’s blood pressure is
assumed not improved

All patients aged 18-85
years of age, who had
at least one outpatient
visit in the first six
months of the
measurement year,
who have a diagnosis
of hypertension
documented during that
outpatient visit, and
who have uncontrolled

Centers for
Medicare &
Medicaid Services

Measure Title

Measure Description

Numerator Statement

Denominator
Statement

Measure Steward

baseline blood
pressure at the time of
that visit
CMS50v1

TBD

Closing the
referral loop:
receipt of
specialist report

Percentage of patients
with referrals, regardless
of age, for which the
referring provider
receives a report from
the provider to whom the
patient was referred.

Number of patients with a
referral, for which the
referring provider received
a report from the provider to
whom the patient was
referred.

Number of patients,
regardless of age, who
were referred by one
provider to another
provider, and who had
a visit during the
measurement period.

Centers for
Medicare &
Medicaid Services

CMS66v1

TBD

Functional status
assessment for
knee replacement

Percentage of patients
aged 18 years and older
with primary total knee
arthroplasty (TKA) who
completed baseline and
follow-up (patientreported) functional
status assessments.

Patients with patient
reported functional status
assessment results (e.g.,
VR-12, VR-36, PROMIS-10
Global Health; PROMIS-29,
KOOS) not more than 180
days prior to the primary
TKA procedure, and at

Adults, aged 18 and
older, with a primary
total knee arthroplasty
(TKA) and who had an
outpatient encounter
not more than 180 days
prior to procedure, and
at least 60 days and

Centers for
Medicare &
Medicaid Services
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Link to NQF website

least 60 days and not more
than 180 days after TKA
procedure

123

not more than 180 days
after TKA procedure.

CMS
eMeasure ID

NQF #

CMS56v1

TBD

CMS90v1

TBD

Measure Title

Denominator
Statement

Measure Description

Numerator Statement

Functional status
assessment for
hip replacement

Percentage of patients
aged 18 years and older
with primary total hip
arthroplasty (THA) who
completed baseline and
follow-up (patientreported) functional
status assessments.

Patients with patient
reported functional status
assessment results (e.g.,
VR-12, VR-36, PROMIS10-Global Health, PROMIS29, HOOS) not more than
180 days prior to the
primary THA procedure,
and at least 60 days and
not more than 180 days
after THA procedure.

Adults aged 18 and
older with a primary
total hip arthroplasty
(THA) and who had an
outpatient encounter
not more than 180 days
prior to procedure, and
at least 60 days and
not more than 180 days
after THA procedure.

Centers for
Medicare &
Medicaid Services

Functional status
assessment for
complex chronic
conditions

Percentage of patients
aged 65 years and older
with heart failure who
completed initial and
follow-up patient-reported
functional status
assessments

Patients with patient
reported functional status
assessment results (e.g.,
VR-12; VR-36; MLHF-Q;
KCCQ; PROMIS-10 Global
Health, PROMIS-29)
present in the EHR at least
two weeks before or during
the initial encounter and the
follow-up encounter during
the measurement year.

Adults aged 65 years
and older who had two
outpatient encounters
during the
measurement year and
an active diagnosis of
heart failure.

Centers for
Medicare &
Medicaid Services
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Measure Steward

Link to NQF website

CMS
eMeasure ID

NQF #

CMS179v1

TBD

Measure Title
ADE Prevention
and Monitoring:
Warfarin Time in
Therapeutic
Range

Measure Description

Numerator Statement

Average percentage of
time in which patients
aged 18 and older with
atrial fibrillation who are
on chronic warfarin
therapy have
International Normalized
Ratio (INR) test results
within the therapeutic
range (i.e., TTR) during
the measurement period.

Average percentage of time
that patients in the measure
population have INR results
within the therapeutic range
(i.e., TTR)

Denominator
Statement
Initial Patient
Population statement:
Patients aged 18 and
older with atrial
fibrillation without
valvular heart disease
who had been on
chronic warfarin
therapy for at least 180
days before the start of
and during the
measurement period.
Patient should have at
least one outpatient
visit during the
measurement period

Measure Steward
National
Committee for
Quality Assurance

Equals All in Initial
Patient Population with
sufficient international
normalized ratio (INR)
results to calculate a
warfarin time in
therapeutic range
(TTR)
CMS22v1

TBD

Preventive Care
and Screening:
Screening for
High Blood
Pressure and
Follow-Up
Documented

Percentage of patients
aged 18 years and older
seen during the reporting
period who were
screened for high blood
pressure AND a
recommended follow-up
plan is documented
based on the current
blood pressure (BP)
reading as indicated

Patients who were
screened for high blood
pressure AND a
recommended follow-up
plan is documented as
indicated if the blood
pressure is prehypertensive or
hypertensive

125

Percentage of patients
aged 18 years and
older before the start of
the measurement
period

Quality Insights of
Pennsylvania/
Centers for
Medicare &
Medicaid Services

Link to NQF website
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Clinical Quality Measures for CMS’s 2014
EHR Incentive Program for Eligible
Professionals: Release Notes
10/1/2012

CPT only copyright 2010 American Medical Association. All rights reserved. CPT is a registered trademark of the
American Medical Association. Applicable FARS/DFARS apply to government use. Fee schedules, relative value
units, conversion factors, and/or related components are not assigned by the AMA, are not part of CPT, and the AMA
is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical
services. The AMA assumes no liability for data contained or not contained herein.
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CLINICAL QUALITY MEASURES FOR CMS’S 2014 EHR INCENTIVE PROGRAM
FOR ELIGIBLE PROFESSIONALS
RELEASE NOTES
In August 2012, the Centers for Medicare & Medicaid Services (CMS) finalized the clinical
quality measures (CQMs) for the 2014 Medicare and Medicaid Electronic Health Record (EHR)
Incentive Program for Eligible Professionals, also known as Meaningful Use Stage 2 (MU2) for
Eligible Professionals.1 This list of CQMs for MU2 includes measures retained from Meaningful
Use Stage 1 (MU1) for use in MU2. All retained MU1 measures have been updated based on
advances in technology and tools for eMeasure development, comments from stakeholders,
changes initiated by measure developers, and CMS’s standards as defined in the agency’s
Measures Management System Blueprint, Version 8 (Blueprint).2
CMS recognizes the importance of providing support, training, and information to MU
stakeholders, particularly as the EHR Incentive Programs transition to MU2. The purpose of this
document is to inform eligible providers and the vendor community about updated program
requirements related to the CQMs. T his update includes information about global changes
incorporated across all measures as well as specific changes to the measures retained in MU2.
Global changes are listed first and include structural modifications; updates to value sets; and
data elements and standards revised in accordance with the Blueprint. Specific changes to
measures include changes to measure components, such as initial patient populations,

1

CMS. “Medicare and Medicaid Programs; Electronic Health Record Incentive Program—Stage 2.” 2012.
Available
at
[http://www.ofr.gov/(X(1)S(uzclbwrx5fwqm2w2mipkysrh))/OFRUpload/OFRData/201221050_PI.pdf]. Accessed August 28, 2012.
2

CMS.

“CMS

Measure

Management

System

Blueprint,

Version

[http://www.cms.gov/Medicare/Quality-Initiatives-Patient-AssessmentInstruments/MMS/MeasuresManagementSystemBlueprint.html]. Accessed August 28, 2012.
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8.”

Available

at

denominators, numerators, exclusions, and exceptions, as well as logic changes that affect how
data elements interrelate during the measurement period.
This document is intended for readers who are familiar with eMeasure components and the
current standards for constructing an eMeasure. For more information on eMeasures, please visit
the

CMS

website

(http://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-

Instruments/QualityMeasures/Downloads/QMGuideForReadingEHR.pdf) and download

the

Guide for Reading the EHR Incentive Program EP Measures.
Global Edits










Introduced a new measure-identification scheme that combines the eMeasure
identifier, National Quality Forum (NQF) number (if applicable), and eMeasure
version number.
Updated the rationale, clinical recommendation statements, and references to
include the latest clinical guidance related to the measures.
Provided additional guidance to help implementers interpret the calculation
requirements for the measures.
Updated the eMeasure header to reflect Blueprint requirements (such as using the
initial patient population to define the denominator and including stratification
variables in the header) and modified other fields, such as population criteria, to
reflect these changes.
Changed the standardization of the measurement period from “year” to “period.”
Updated the measure logic to reflect the changes to the Quality Data Model (QDM),
to reflect consistent use of relative timing across measures (including age
calculation), occurencing, and denominator exclusions.
Assigned data elements based on version 2.1.1.1 of the QDM3 to each clinical
concept, adding attributes as needed to precisely define QDM elements.
For measures using the QDM of “Medication, Active,” added the AND / AND
NOT construct to compensate for varying interpretations of the relative timing
“during.” The ‘“Medication, Active” period can start at any time but cannot end
before “Occurrence A of Encounter, Performed.”

3

For
more
on
the
Quality
Data
Model,
visit
http://www.qualityforum.org/Projects/h/QDS_Model/QDS_Version_2_1.aspx.
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the

NQF

website

at



Incorporated supplemental data elements (race, ethnicity, sex, and payer)
required by the Blueprint.



Reorganized and retitled the encounter value sets to standardize them across
developers. Also incorporated encounter value sets using SNOMED-CT to align
with the Health Information Technology Standards Committee’s (HITSC’s)
vocabulary recommendations for the QDM data type “Encounter.”



Updated existing value sets and added new value sets to align with the transitional
and final vocabularies, based on the HITSC recommendations and required by the
Blueprint.



Fully specified ICD-9-CM and ICD-10-CM codes and, as applicable, ensured
consistency with the 2012 Physician Quality Reporting Program (PQRS) measures.



Provided grouping object identifiers for each data element.

as

NQF 0002: Appropriate Testing for Children with Pharyngitis


Clarified the initial patient population to only include the review the first episode of
tonsillitis or pharyngitis per patient.



Included only ordered medications as a criteria for the initial patient population.



Modified the denominator exclusions to only include active antibiotic medications



Added the restriction that antibiotic medication in the denominator exclusions must
be active 30 da ys before the diagnosis because the encounter is linked to the
diagnosis through the initial patient population criteria.



Required the laboratory test to have a result present to ensure that the test has been
completed.



Updated the numerator criteria to require the laboratory test for Streptococcus to
occur within three days of the episode.

NQF 0004: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment


Updated the measure title for consistency with the measure titles used in other
programs, such as the PQRS.



Updated the measure description to define “adolescent and adult patients” as
patients age 13 or older.



Modified the structure of the measure so that it is a single measure with reporting
stratified by age group.



Changed the time window for the first diagnosis of alcohol or drug dependency in
the initial patient population to the first 11 months of the measurement period.
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Updated the specifications to require use of diagnosis criteria to determine if the
patient has the condition, and to require use of encounter criteria to identify the
beginning of the episode by requiring the diagnosis to start during the encounter.



Removed acute and nonacute inpatient encounters for numerator 1.



Clarified that, to be compliant for numerator 2, the patient must meet the criteria for
both numerator 1 and 2.

NQF 0018: Controlling High Blood Pressure


Clarified that the diagnosis of hypertension could occur any time between the first
part of the measurement period to before the measurement period.



Changed the age range from age 17–84 to age 18–85.



Clarified that the denominator exclusion of pregnancy had to be in the measurement
period.



Clarified that the systolic and diastolic blood pressure reading must come from the
most recent visit.

NQF 0024: Weight Assessment and Counseling for Nutrition and Physical Activity for
Children and Adolescents


Modified the structure of the measure so it is a single measure with reporting
stratified by age groups.



Changed the age criteria of the initial patient population from patients age 2–17 to
age 3–17.



Clarified that the eligible encounter in the initial patient population should be with a
primary care physician or obstetrician/gynecologist.



Changed the denominator exclusion to only include a diagnosis of pregnancy.



Added the patient’s height and weight to numerator criteria, in addition to body
mass index.

NQF 0028: Preventive Care and Screening: Tobacco Use: Screening and Cessation
Intervention


Combined the measure pair a and b into one measure, and updated the title to reflect
this modification.



Expanded the definition of “eligible encounters” in the initial patient population.



Combined the numerator criteria from the previously paired measures.



Updated the QDM data type for “Procedure, Performed: Tobacco Use Cessation
Counseling to “Intervention, Performed: Tobacco Use Cessation Counseling.”
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Added denominator exceptions for medical reasons.

NQF 0031: Breast Cancer Screening


Added “female” sex criteria to the initial patient population.



Changed the age criteria of the initial patient population from age 41–68 to
age 42–69.



Changed the eligible time period for an encounter in the initial patient population
from two years to during the one-year measurement period.



Clarified that because we are only looking for complete mastectomies, a patient that
had two unilateral mastectomies should be excluded.



Changed the numerator criterion from “performed” to requiring a “result” to be
present.

NQF 0032: Cervical Cancer Screening


Added “female” sex criteria to the initial patient population.



Changed the eligible time period for an encounter in the initial patient population
from three years to during the one-year measurement period.



Changed the age criteria of the initial patient population from age 23–63 to
age 24–63.

NQF 0033: Chlamydia Screening for Women


Modified the structure of the measure so it is a single measure with reporting
stratified by age group.



Changed the age criteria of the initial patient population from age 15–24 to
age 16–24.



Added “female” sex criteria to the initial patient population.



Updated the categories of events that identify women as sexually active.



Removed active and dispensed medications and performed procedures from the list
of exclusions, requiring only that the procedure or medication be ordered.

NQF 0034: Colorectal Cancer Screening


Changed the eligible time period for an encounter in the initial patient population
from two years to during the one-year measurement period.



Changed the age criteria of the initial patient population from age 50–74 to
age 51–75.



Added exclusion for malignant neoplasm of the colon.
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NQF 0036: Use of Appropriate Medications for Asthma


Changed the age criteria of the initial patient population from age 5–50 to age 5–64.



Modified the structure of the measure so it is a single measure with reporting
stratified by age groups.



Clarified the eligible time window for a diagnosis of persistent asthma to any time
before or during the measurement period, with a requirement of only one encounter.



Modified the criteria for the initial patient population to require a diagnosis of
asthma (medication alone will not suffice).



Removed active and dispensed medications from the list of numerator criteria,
requiring only that the medication be ordered.

NQF 0038: Childhood Immunization Status


Modified the measure to report only one combined rate; separate rates for each
vaccine or a combination of vaccines will no longer be calculated.



Clarified that the encounter criteria for the initial patient population does not need
to be with a primary care or OB/GYN provider.



Expanded the numerator criteria to include both medication administered and the
procedure for administering the vaccine.



Changed the exclusion for “medication allergy” to be defined by an anaphylactic
reaction to the vaccine and allowed this reaction to count as numerator compliance
for each vaccine.



Combined the separate measles, mumps, and rubella (MMR) administered vaccines
into one numerator criterion. Also updated the time window for MMR vaccine
administration to occur any time before the patient’s second birthday in the
numerator.



Allowed past diagnoses of disease to count for the appropriate vaccine.



Added a laboratory test for the hepatitis A antigen to the numerator criteria for the
hepatitis A vaccine. Also updated hepatitis A medication criteria to allow only one
vaccination to count for numerator compliance.



Updated the HiB vaccine medication criteria to require three vaccinations for
compliance.



Separated two- and three-dose rotavirus vaccines to ensure the proper number of
doses is administered.
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NQF 0041: Preventive Care and Screening: Influenza Immunization


Updated the measure title to reflect the updated measure specifications.



Expanded the age group to include all patients age 6 months or older in the initial
patient population.



Changed the time window of the denominator for which the encounters must occur
to reflect the new time period for the flu season recommended by the Centers for
Disease Control and Prevention.



Added “peritoneal dialysis procedure” and “hemodialysis procedure” to the
denominator criteria.



Added to the numerator any communication from patient to provider regarding the
previous receipt of a vaccine.

NQF 0043: Pneumonia Vaccination Status for Older Adults


Restricted the time window for an encounter in the initial patient population to only
during the measurement period.



Changed the age criteria of the initial patient population from age 64 and older to
age 65 and older.



Added pneumococcal vaccine administered and history of a pneumococcal vaccine
to the numerator criteria.

NQF 0052: Use of Imaging Studies for Low-Back Pain


Rephrased the measure title.



Changed the age criteria of the initial patient population from age 18–49 to
age 18–50.



Added the eligible age of patients (18–50) to the measure description.



Specified that the low-back pain diagnosis must occur during an office or
emergency-department visit no more than 337 days after the start of the
measurement period.



Moved the exclusion criteria for the denominator to the denominator-exclusion
section, including a low-back pain diagnosis less than 180 days before occurrence A
of a low-back pain diagnosis or a diagnosis of cancer, trauma, IV drug abuse, or
neurologic impairment during the year before the measurement period.



Changed the measure to calculate the number of patients with a diagnosis of lowback pain who did have an imaging study (e.g., X-ray, MRI, CT scan) within 28
days of the diagnosis; a lower rate is thus a better score for this measure.
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NQF 0055: Eye Exam


Changed the age criteria of the initial patient population from age 18–74 to
age 18–75.



Removed from the denominator criteria any dispensed, ordered, or active
medications indicative of diabetes.



Updated the time window for an active diabetes diagnosis to any time before or
during the measurement period.



Modified the encounter criteria in the initial patient population, including limiting
the time window to the measurement period.



Modified the exclusion criteria for the denominator, including removing polycystic
ovaries diagnosis and medications indicative of diabetes as well as restricting the
time window for an active gestational-diabetes diagnosis to the measurement
period.



Limited the eye-exam procedures in the numerator to either a negative retinal exam
during the year before the measurement period or a retinal or dilated eye exam
during the measurement period.

NQF 0056: Diabetes: Foot Exam


Removed details about the type of diabetes (type 1 or 2) and type of foot exam
(visual inspection, sensory exam with monofilament, or pulse exam) from the
measure description.



Changed the age criteria of the initial patient population from age 18–74 to
age 18–75.



Removed from the denominator criteria any dispensed, ordered, or active
medications indicative of diabetes.



Updated the time window for an active diabetes diagnosis to any time before or
during the measurement period.



Modified the encounter criteria in the initial patient population, including limiting
the time window to the measurement period.



Modified the exclusion criteria for the denominator, including removing polycystic
ovaries and medications indicative of diabetes as well as restricting the time
window for an active gestational-diabetes diagnosis to the measurement period.



Modified the foot-exam criteria to include the specific components of the foot
exam, including a visual exam and either a sensory or pulse exam during the
measurement period.
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NQF 0059: Diabetes: Hemoglobin A1c Poor Control


Changed the age criteria of the initial patient population from age 18–74 to
age 18–75.



Removed from the denominator criteria any dispensed, ordered, or active
medications indicative of diabetes.



Updated the time window for a diagnosis of active diabetes to any time before or
during the measurement period.



Modified the encounter criteria in the initial patient population, including limiting
the time window to the measurement period.



Modified the exclusion criteria for the denominator, including removing polycystic
ovaries and medications indicative of diabetes as well as restricting the time
window for an active gestational-diabetes diagnosis to the measurement period.



Added the absence of an HbA1c laboratory test results during the measurement
period for eligible patients as a numerator criterion.

NQF 0062: Diabetes: Urine Protein Screening


Updated the measure title to specify protein screening.



Removed the details about the type of diabetes (type 1 or 2) from the measure
description.



Changed the age criteria of the initial patient population from age 18–74 to
age 18–75.



Removed from the denominator criteria any dispensed, ordered, or active
medications indicative of diabetes.



Updated the time window for a diagnosis of active diabetes to any time before or
during the measurement period.



Modified the encounter criteria in the initial patient population, including limiting
the time window to the measurement period.



Modified the exclusion criteria for the denominator, including removing polycystic
ovaries and medications indicative of diabetes as well as restricting the time
window for an active gestational-diabetes diagnosis to the measurement period.
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NQF 0064: Diabetes: Low-Density Lipoprotein (LDL) Management and Control


Removed “and Control” from the measure title.



Specified in the measure description that LDL-C under 100 mg/dL is considered
adequately controlled.



Changed the age criteria of the initial patient population from age 18–74 to
age 18–75.



Removed from the denominator criteria any dispensed, ordered, or active
medications indicative of diabetes.



Updated the time window for an active diabetes diagnosis to any time before or
during the measurement period.



Modified the encounter criteria in the initial patient population, including limiting
the time window to the measurement period.



Modified the exclusion criteria for the denominator, including removing polycystic
ovaries and medications indicative of diabetes as well as restricting the time
window for an active gestational-diabetes diagnosis to the measurement period.



Removed the screening indicator.

NQF 0068: Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic


Updated the measure description to reflect the change in the look-back period and
active-medication requirement.



Changed the age criteria of the initial patient population from age 17 and older to
age 18 and older.



Changed the “percutaneous transluminal cardiac angioplasty” category to the
broader category of “percutaneous coronary interventions” for the initial patient
population.



Changed the eligible time period for diagnoses and procedures for the initial patient
population from 2 to 12 months before the measurement period to the year before
the measurement period.



Removed the requirement from the initial patient population that the diagnosis and
procedures of interest needed to occur during an encounter.



Limited the numerator criteria to “medication active” (not ordered or dispensed),
and required that the medication be active at some time during the measurement
period.
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NQF 0070: Coronary Artery Disease (CAD): Beta-Blocker Therapy—Prior Myocardial
Infarction (MI) or Left-Ventricular Systolic Dysfunction (LVEF) < 40%


Revised the measure title and description to reflect the most up-to-date information
from the measure developer/steward.



Divided the calculation of the measure into two rates to reflect the two distinct
denominator populations. It is expected that the implementer will report each
population score separately and a total score.



Expanded the definition of eligible encounter in initial patient populations 1 and 2.



Added a denominator population; denominator 1 includes patients with a prior
(resolved) myocardial infarction, and denominator 2 i ncludes patients with
LVEF < 40%.



Clarified the recommended type of beta-blocker therapy for each denominator
population in the guidance statement and logic, in accordance with updated clinical
recommendations.



Added to the denominator exceptions additional methods of capturing allergies and
intolerances, based on HITSC recommendations

NQF 0075: Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control


Changed the measure title from “LDL” to “LDL-C.”



Specified in the measure description that LDL-C under 100 m g/dL is considered
adequately controlled.



Changed the age criteria of the initial patient population from age 17 and older to
age 18 and older.



Changed “percutaneous transluminal cardiac angioplasty” to the broader category
of “percutaneous coronary interventions” for the initial patient population.



Changed the eligible time period for diagnoses and procedures for the initial patient
population from 2 to 12 months before the measurement period to the year before
the measurement period.



Removed the requirement from the initial patient population that the diagnosis and
procedures of interest needed to occur during an encounter.



Included a requirement in the numerator 1 criteria that a complete lipid-panel test
result is present or all the separate components of a complete lipid panel must be
performed and have a result.



Changed numerator 2 criteria to include only a LDL-C lab test result < 100 mg/dL;
removed the other components needed to calculate the LDL-C for high
triglycerides.
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NQF 0081: Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or
Angiotensin-Receptor Blocker (ARB) Therapy for Left-Ventricular Systolic
Dysfunction (LVSD)


Revised the measure description to reflect the most up-to-date information from the
measure developer/steward.



Removed one denominator option used to capture a patient with LVSD—“LVF
ASSMT.”



Changed all denominator options for capturing a patient with LVSD from a “starts
before start of…” timing to “starts before or during….”



Added to the denominator exception additional methods of capturing allergies and
intolerances, based on HITSC recommendations.



Refined the value sets for the denominator exception.



Changed the QDM data type for “Patient reason for ACE inhibitor or ARB decline”
value set.

NQF 0083: Heart Failure (HF): Beta-Blocker Therapy for Left-Ventricular Systolic
Dysfunction (LVSD)


Revised the measure description to reflect the most up-to-date information from the
measure developer/steward.



Removed one denominator option used to capture a patient with LVSD—“LVF
ASSMT.”



Changed all denominator options for capturing a patient with LVSD from a “starts
before start of…” timing to “starts before or during….”



Refined the value sets for the denominator exception.

NQF 0086: Primary Open-Angle Glaucoma (POAG): Optic-Nerve Evaluation


Revised the measure description to reflect the most up-to-date information from the
measure developer/steward.



Expanded the “optic-nerve head evaluation” to capture its two components: cup-todisc ratio and optic-disc exam for structural abnormalities.

NQF 0088: Diabetic Retinopathy: Documentation of Presence or Absence of Macular
Edema and Level of Severity of Retinopathy


Revised the measure logic of the numerator based on t he updated QDM for type
and category of the numerator criteria.
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NQF 0089: Diabetic Retinopathy: Communication with the Physician Managing Ongoing
Diabetes Care


Updated the denominator criteria from performing a macular or fundus exam to
identifying the results of the diagnostic study.



Further defined the results of the macular exam in the numerator by separating the
findings into “present” or “absent.”

NQF 0105: Antidepressant Medication Management


Shortened the measure title.



Updated the measure description to specify the two calculated rates.



Changed the age criteria of the initial patient population from patients age 18 and
older 245 days into the measurement period to age 18 and older at the start of the
measurement period.



Changed the eligible time period for a diagnosis of major depression in the initial
patient population. The original time period was less than 245 d ays before the
measurement period starts to no more than 245 days before the measurement period
ends. The revised time period is less than 180 days before the measurement period
starts to no more than 180 days after the measurement period ends.



Removed the criterion that the depression diagnosis must occur during an
encounter.



Limited the criteria for the initial patient population to “antidepressant medication
active” (not ordered or dispensed).



Removed a denominator criterion that another diagnosis of depression not occur
sooner than 120 days before the diagnosis of depression for the episode of interest.



Added a denominator exclusion that another antidepressant medication not
active less than 90 days before the antidepressant medication of interest.



Changed the numerator criteria for numerator 1 and 2 to focus on the cumulative
amount of medication dispensed.

be

NQF 0385: Colon Cancer: Chemotherapy for Stage III Colon Cancer Patients


Revised the measure title and description to reflect the most up-to-date information
from the measure developer/steward.



Added “AJCC” to the measure title.



Revised the measure description to include an upper limit of 80 years of age. Also
revised the initial patient population to include all patients age 18 through 80 with
colon cancer.
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Removed an inactive diagnosis of colon cancer (history of colon cancer) from the
criteria for the initial patient population, as the measure is limited to patients with a
first-recorded diagnosis of colon cancer during the 12-month reporting period (that
is, during an eligible encounter between the patient and provider).



Excluded patients whose clinical-staging procedure started before the active
diagnosis of colon cancer.



Excluded patients whose diagnosis of colon cancer was more than two years before
the measurement end date.



Specified that the patient’s clinical-staging procedure resulting in “colon distant
metastasis status MO” started before the eligible encounter.



Specified the tumor sizes and lymph-node statuses following the clinical-staging
procedure that are eligible for inclusion in the denominator.



Specified the timing of ordering or administering chemotherapy eligible for
inclusion in the numerator.



Alternate methods of capturing allergies and intolerances added to denominator
exceptions to align with HITSC recommendations.

NQF 0387: Breast Cancer: Hormonal Therapy for Stage IC-IIIC
Receptor/Progesterone Receptor (ER/PR)-Positive Breast Cancer

Estrogen



Revised the measure title by deleting the term “oncology” to reflect the most up-todate information from the measure developer/steward.



Specified that an active diagnosis of breast cancer took place less than five years
before the patient-provider encounter for the initial patient population.



Removed an inactive diagnosis of breast cancer (history of breast cancer) from the
criteria for the initial patient population, as the measure is limited to patients with a
first-recorded diagnosis of breast cancer within the past five years.



Excluded patients whose clinical-staging procedure started before the active
diagnosis of breast cancer.



Specified that the patient’s clinical-staging procedure resulting in “breast distant
metastasis status MO” started before the eligible encounter.



Removed the breast cancer Stage IC-IIIC procedure from the denominator criteria
and added the clinical-staging procedure.



Specified the tumor sizes and lymph-node statuses following the clinical-staging
procedure that are eligible for inclusion in the denominator.



Specified the eligible timing of the ordering and dispensing of tamoxifen or
aromatase inhibitor therapy for numerator inclusion.
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Revised the denominator exceptions to capture clinical-trial participants and
removed adverse medication events to align with HITSC recommendations.

NQF 0389: Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low-Risk
Prostate Cancer Patients


Corrected prostate-specific criterion for antigen test results from <= 10 mg/dL to
<= 10 ng/mL.



Removed “Procedure result: AJCC cancer stage low-risk recurrence
cancer” from denominator criteria.



Added performance of a “clinical staging procedure” with result of prostate cancer
primary tumor size T1c or T2a to denominator criteria.



Added “Diagnostic Study, Order: Bone Scan (Source: ‘Other provider’)” to list of
denominator exceptions (note: MU1 denominator exclusions are now considered
denominator exceptions in MU2).

prostate

NQF 0421: Preventive Care and Screening: Body Mass Index (BMI) Screening and FollowUp


Updated the description and numerator to include timing guidance for follow-up of
“BMI outside of normal parameters” to include “in the past six months or during
the current visit.”



Added definitions for Body Mass Index (BMI), Calculated BMI, and Follow-Up
Plan.



Revised Denominator Exclusion by deleting “terminal illness” and system reasons
for not calculating BMI, added “patients receiving palliative care,” and moved
patient and medical reason for not calculating BMI to Denominator Exceptions.



Clarified patient reason for not calculating BMI to include “The patient refuses
BMI measurement.”



Clarified medical or other reason for not calculating BMI to include “If there is any
other reason documented in the medical record by the provider explaining why BMI
measurement was not appropriate” OR “If the patient is in an urgent or emergent
medical situation where time is of the essence and to delay treatment would
jeopardize the patient’s health status.”



Added Care Goal and Communication follow-up to applicable above and below
normal BMI follow-up interventions.



Added BMI interventions for “Above Normal Follow-up,” “Above Normal
Referrals,” “Above Normal Medications,” “Below Normal Follow-up,” “Below
Normal Referrals,” and “Below Normal Medications.”
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2014 Clinical Quality Measures (CQMs)
Adult Recommended Core Measures
Please note, in Stage 2 of meaningful use, the core set requirement has been removed. Instead, the Centers for
Medicare & Medicaid Services (CMS) proposed a recommended core which includes measures aligned with high priority
health care improvement goals. If one or more of these measures are not relevant for your organization, please utilize
other measures from the approved 2014 CQM set to meet the reporting requirement.

CMS
eMeasure ID &
CQM Number

Measure
Steward &
Contact
Information

CQM Title & Description

CMS165v1

Controlling High Blood Pressure

NQF 0018

Percentage of patients 18-85 years of age who
had a diagnosis of hypertension and whose
blood pressure was adequately controlled
(<140/90mmHg) during the measurement
period.

NEW: CMS156v1

Use of High-Risk Medications in the Elderly

NQF 0022

Percentage of patients 66 years of age and older
who were ordered high-risk medications. Two
rates are reported.
a.
b.

CMS138v1

Other Quality
Measure
Programs that
use the Same
CQM

Domain

National
Committee for
Quality
Assurance
(NCQA):
www.ncqa.org





NCQA:
www.ncqa.org

PQRS

Patient Safety

AMA Physician
Consortium for
Performance
Improvement
(AMA-PCPI):
cpe@ama
- assn.org





Population/
Public Health



EHR PQRS
ACO
Group
Reporting
PQRS
UDS

Clinical
Process/
Effectiveness

Percentage of patients who were ordered at
least one high-risk medication.
Percentage of patients who were ordered at
least two different high-risk medications.

Preventive Care and Screening: Tobacco Use:
Screening and Cessation Intervention

NQF 0028
Percentage of patients aged 18 years and older
who were screened for tobacco use one or more
times within 24 months AND who received
cessation counseling intervention if identified as
a tobacco user.

October 2012
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EHR PQRS
ACO
Group
Reporting
PQRS
UDS

2014 Clinical Quality Measures (CQMs)
Adult Recommended Core Measures
CMS
eMeasure ID &
CQM Number

Measure
Steward &
Contact
Information

CQM Title & Description

CMS166v1

Use of Imaging Studies for Low Back Pain

NQF 0052

Percentage of patients 18-50 years of age with a
diagnosis of low back pain who did not have an
imaging study (plain X-ray, MRI, CT scan) within 28
days of the diagnosis.
Preventive Care and Screening: Screening for
Clinical Depression and Follow-Up Plan

NEW: CMS2v1

NCQA:
www.ncqa.org

NQF 0418
Percentage of patients aged 12 years and older
screened for clinical depression on the date of the
encounter using an age appropriate standardized
depression screening tool AND if positive, a followup plan is documented on the date of the positive
screen.

NEW: CMS68v1

Other Quality
Measure
Programs that
use the Same
CQM

Documentation of Current Medications in the
Medical Record

NQF 0419
Percentage of specified visits for patients aged 18
years and older for which the eligible professional
attests to documenting a list of current
medications to the best of his/her knowledge and
ability. This list must include ALL prescriptions,
over-the-counters, herbals, and
vitamin/mineral/dietary (nutritional) supplements
AND must contain the medications' name, dosage,
frequency and route of administration.

October 2012
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CMS:
1-888-734-6433,
or
http://questions
.
cms.hhs.gov/app
/ask/p/21,26,11
39
Quality Insights
of Pennsylvania
(QIP):
www.usqualitym
easures.org
CMS:
1-888-734-6433,
or
http://questions.
cms.hhs.gov/app
/ask/p/21,26,11
39
QIP:
www.usqualitym
easures.org

Domain

Efficient Use
of Healthcare
Resources





EHR PQRS
ACO
Group
Reporting
PQRS

Population/
Public Health




PQRS
EHR PQRS

Patient Safety

2014 Clinical Quality Measures (CQMs)
Adult Recommended Core Measures
CMS
eMeasure ID &
CQM Number
CMS69v1

Measure
Steward &
Contact
Information

CQM Title & Description

Preventive Care and Screening: Body Mass Index
(BMI) Screening and Follow-Up

NQF 0421
Percentage of patients aged 18 years and older with
a calculated BMI in the past six months or during the
current reporting period documented in the medical
record AND if the most recent BMI is outside of
normal parameters, a follow-up plan is documented
within the past six months or during the current
reporting period.

CMS:
1-888-734-6433,
or
http://questions.
cms.hhs.gov/app
/ask/p/21,26,11
39

Other Quality
Measure
Programs that
use the Same
CQM






EHR PQRS
ACO
Group
Reporting
PQRS
UDS

Domain

Population/
Public Health

QIP:
www.usquality
measures.org

Normal Parameters:
 Age 65 years and older BMI ≥ 23 and < 30
 Age 18-64 years BMI ≥ 18.5 and < 25
New: CMS50v1

Closing the referral loop: receipt of specialist
report
Percentage of patients with referrals, regardless of
age, for which the referring provider receives a
report from the provider to whom the patient was
referred.

October 2012
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CMS:
1-888-734-6433,
or
http://questions.
cms.hhs.gov/app
/ask/p/21,26,11
39

Care
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2014 Clinical Quality Measures (CQMs)
Pediatric Recommended Core Measures
Please note, in Stage 2 of meaningful use, the core set requirement has been removed. Instead, the Centers for
Medicare & Medicaid Services (CMS) proposed a recommended core which includes measures aligned with high priority
health care improvement goals. If one or more of these measures are not relevant for your organization, please utilize
other measures from the approved 2014 CQM set to meet the reporting requirement.

CMS
eMeasure ID &
CQM Number

Measure
Steward &
Contact
Information

CQM Title & Description

CMS146v1

Appropriate Testing for Children with Pharyngitis

NQF 0002

Percentage of children 2-18 years of age, who
were diagnosed with pharyngitis, ordered an
antibiotic and received a group A streptococcus
(strep) test for the episode.

CMS155v1

Weight Assessment and Counseling for Nutrition
and Physical Activity for Children and
Adolescents

NQF 0024

Other Quality
Measure
Programs that
use the Same
CQM

Domain

National
Committee for
Quality
Assurance
(NCQA):
www.ncqa.org




EHR PQRS
CHIPRA

Efficient Use
of Healthcare
Resources

NCQA:
www.ncqa.org




EHR PQRS
UDS

Population/
Public Health

NCQA:
www.ncqa.org








EHR PQRS
CHIPRA
ACA 2701
HEDIS
State Use
NCQAPCMH
Recognition

Population/
Public Health

Percentage of patients 3-17 years of age who had
an outpatient visit with a Primary Care Physician
(PCP) or Obstetrician/Gynecologist (OB/GYN) and
who had evidence of the following during the
measurement period. Three rates are reported.





Percentage of patients with height, weight,
and body mass index (BMI) percentile
documentation.
Percentage of patients with counseling for
nutrition.
Percentage of patients with counseling for
physical activity.

CMS153v1

Chlamydia Screening for Women

NQF 0033

Percentage of women 16-24 years of age who
were identified as sexually active and who had at
least one test for Chlamydia during the
measurement period.

October 2012
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CMS
eMeasure ID &
CQM Number
CMS126v1

Measure
Steward &
Contact
Information

CQM Title & Description

Use of Appropriate Medications for
Asthma

Other Quality
Measure
Programs that
use the Same
CQM

Domain

NCQA:
www.ncqa.org

EHR PQRS

Clinical
Process/
Effectiveness

NCQA:
www.ncqa.org




EHR PQRS
UDS

Population/
Public Health

NCQA:
www.ncqa.org




PQRS
NCQAPCMH
Recognition

Efficient Use
of Healthcare
Resources

NQF 0036
Percentage of patients 5-64 years of age who
were identified as having persistent asthma and
were appropriately prescribed medication during
the measurement period.
CMS117v1

Childhood Immunization Status

NQF 0038

Percentage of children 2 years of age who had
four diphtheria, tetanus and acellular pertussis
(DTaP); three polio (IPV), one measles, mumps
and rubella (MMR); three H influenza type B (HiB);
three hepatitis B (Hep B); one chicken pox (VZV);
four pneumococcal conjugate (PCV); one hepatitis
A (Hep A); two or three rotavirus (RV); and two
influenza (flu) vaccines by their second birthday.

NEW: CMS154v1

Appropriate Treatment for Children with Upper
Respiratory Infection (URI)

NQF 0069
Percentage of children 3 months-18 years of age
who were diagnosed with upper respiratory
infection (URI) and were not dispensed an
antibiotic prescription on or three days after the
episode.

October 2012
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CMS
eMeasure ID &
CQM Number
NEW: CMS136v1
NQF 0108

Measure
Steward &
Contact
Information

CQM Title & Description

ADHD: Follow-Up Care for Children Prescribed
Attention Deficit/Hyperactivity Disorder (ADHD)
Medication

Other Quality
Measure
Programs that
use the Same
CQM

Domain

Clinical
Process/
Effectiveness

NCQA:
www.ncqa.org

Percentage of children 6-12 years of age and
newly dispensed a medication for attentiondeficit/hyperactivity disorder (ADHD) who had
appropriate follow-up care. Two rates are
reported.
a.

b.

NEW: CMS2v1

Percentage of children who had one followup visit with a practitioner with prescribing
authority during the 30-Day Initiation Phase.
Percentage of children who remained on
ADHD medication for at least 210 days and
who, in addition to the visit in the Initiation
Phase, had at least two additional follow-up
visits with a practitioner within 270 days (9
months) after the Initiation Phase ended.

Preventive Care and Screening: Screening for
Clinical Depression and Follow-Up Plan

NQF 0418
Percentage of patients aged 12 years and older
screened for clinical depression on the date of
the encounter using an age appropriate
standardized depression screening tool AND if
positive, a follow-up plan is documented on the
date of the positive screen.

Centers for
Medicare &
Medicaid
Services (CMS):
1-888-7346433, or
http://question
s.cms.hhs.gov/a
pp/ask/p/21,26
,1139
Quality Insights
of Pennsylvania
(QIP):
www.usquality
measures.org

October 2012
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EHR PQRS
ACO
Group
Reporting
PQRS

Population/
Public Health

2014 Clinical Quality Measures (CQMs)
Pediatric Recommended Core Measures

CMS
eMeasure ID &
CQM Number
NEW: CMS75v1

Measure
Steward &
Contact
Information

CQM Title & Description

Children who have dental decay or cavities
Percentage of children ages 0-20, who have had
tooth decay or cavities during the measurement
period.

October 2012
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Maternal and
Child Health
Bureau, Health
Resources and
Services
Administratio
n (MCHBHRSA):
http://mchb.hr
s a.gov/

Other Quality
Measure
Programs that
use the Same
CQM

Domain

Clinical
Process/
Effectiveness
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and CAHs
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Stage 2

Eligible Hospital Core Objectives

(1)

Use computerized provider order entry (CPOE) for medication, laboratory, and radiology orders
directly entered by any licensed healthcare professional who can enter orders into the medical
record per state, local, and professional guidelines.

(2)

Record all of the following demographics: preferred language, sex, race, ethnicity, date of birth, date
and preliminary cause of death in the event of mortality in the eligible hospital or CAH.

(3)

Record and chart changes in the following vital signs: height/length and weight (no age limit);
blood pressure (ages 3 and over); calculate and display body mass index (BMI); and plot and
display growth charts for patients 0-20 years, including BMI.

(4)

Record smoking status for patients 13 years old or older.

(5)

Use clinical decision support to improve performance on high-priority health conditions.

(6)

Provide patients the ability to view online, download, and transmit information about a hospital
admission.

(7)

Protect electronic health information created or maintained by the Certified EHR Technology
through the implementation of appropriate technical capabilities.

(8)

Incorporate clinical lab test results into Certified EHR Technology as structured data.

(9)

Generate lists of patients by specific conditions to use for quality improvement, reduction of
disparities, research, or outreach.

(10)

Use clinically relevant information from Certified EHR Technology to identify patient-specific
education resources and provide those resources to the patient.

(11)

The eligible hospital or CAH who receives a patient from another setting of care or provider of care
or believes an encounter is relevant should perform medication reconciliation.

(12)

The eligible hospital or CAH who transitions their patient to another setting of care or provider of
care or refers their patient to another provider of care provides a summary care record for each
transition of care or referral.

(13)

Capability to submit electronic data to immunization registries or immunization information
systems except where prohibited, and in accordance with applicable law and practice.

(14)

Capability to submit electronic reportable laboratory results to public health agencies, where
except where prohibited, and in accordance with applicable law and practice.

(15)

Capability to submit electronic syndromic surveillance data to public health agencies, except
where prohibited, and in accordance with applicable law and practice.

(16)

Automatically track medications from order to administration using assistive technologies in
conjunction with an electronic medication administration record (eMAR).
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Eligible Hospital Menu Objectives

(1)

Record whether a patient 65 years old or older has an advance directive.

(2)

Record electronic notes in patient records.

(3)

Imaging results consisting of the image itself and any explanation or other accompanying
information are accessible through CEHRT.

(4)

Record patient family health history as structured data.

(5)

Generate and transmit permissible discharge prescriptions electronically (eRx).

(6)

Provide structured electronic lab results to ambulatory providers.

View or download all of the eligible hospital and CAH Stage 2 Core and Menu Objectives for Stage 2.
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Stage 1 vs. Stage 2

Comparison Table for Eligible
Hospitals and CAHs
CORE OBJECTIVES (16 total)
Stage 1
Objective
Use CPOE for
medication orders
directly entered by
any licensed
healthcare
professional who
can enter orders
into the medical
record per state,
local and
professional
guidelines
Implement drugdrug and drugallergy interaction
checks

Record
demographics
 Preferred
language
 Gender
 Race
 Ethnicity
 Date of birth
 Date and
preliminary
cause of death
in the event of
mortality in the
eligible hospital
or CAH

Stage 1 Measure

Stage 2 Objective

Stage 2 Measure

More than 30% of
unique patients with at
least one medication in
their medication list
admitted to the
eligible hospital’s or
CAH’s inpatient or
emergency
department (POS 21 or
23) have at least one
medication order
entered using CPOE
The eligible
hospital/CAH has
enabled this
functionality for the
entire EHR reporting
period
More than 50% of all
unique patients
admitted to the
eligible hospital’s or
CAH’s inpatient or
emergency
department (POS 21 or
23) have demographics
recorded as structured
data

Use computerized
provider order entry
(CPOE) for medication,
laboratory and radiology
orders directly entered by
any licensed healthcare
professional who can
enter orders into the
medical record per state,
local and professional
guidelines

More than 60% of
medication, 30% of
laboratory, and 30% of
radiology orders created
by authorized providers of
the eligible hospital's or
CAH's inpatient or
emergency department
(POS 21 or 23) during the
EHR reporting period are
recorded using CPOE

No longer a separate
objective for Stage 2

This measure is
incorporated into the
Stage 2 Clinical Decision
Support measure

Record the following
demographics
 Preferred
language
 Gender
 Race
 Ethnicity
 Date of birth
 Date and
preliminary cause
of death in the
event of mortality
in the eligible
hospital or CAH

More than 80% of all
unique patients admitted
to the eligible hospital's or
CAH's inpatient or
emergency department
(POS 21 or 23) have
demographics recorded as
structured data
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Maintain an up-todate problem list of
current and active
diagnoses

Maintain active
medication list

Maintain active
medication allergy
list

More than 80% of all
unique patients
admitted to the
eligible hospital’s or
CAH’s inpatient or
emergency
department (POS 21 or
23) have at least one
entry or an indication
that no problems are
known for the patient
recorded as structured
data
More than 80% of all
unique patients
admitted to the
eligible hospital’s or
CAH’s inpatient or
emergency
department (POS 21 or
23) have at least one
entry (or an indication
that the patient is not
currently prescribed
any medication)
recorded as structured
data
More than 80% of all
unique patients
admitted to the
eligible hospital’s or
CAH’s inpatient or
emergency
department (POS 21 or
23) have at least one
entry (or an indication
that the patient has no
known medication
allergies) recorded as
structured data

No longer a separate
objective for Stage 2

This measure is
incorporated into the
Stage 2 measure of
Summary of Care
Document at Transitions
of Care and Referrals

No longer a separate
objective for Stage 2

This measure is
incorporated into the
Stage 2 measure of
Summary of Care
Document at Transitions
of Care and Referrals

No longer a separate
objective for Stage 2

This measure is
incorporated into the
Stage 2 measure of
Summary of Care
Document at Transitions
of Care and Referrals
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Record and chart
changes in vital
signs:
 Height
 Weight
 Blood pressure
 Calculate and
display BMI
 Plot and display
growth charts
for children 220 years,
including BMI
Record smoking
status for patients
13 years old or
older

Implement one
clinical decision
support rule
relevant to
specialty or high
clinical priority
along with the
ability to track
compliance that
rule

More than 50% of all
unique patients age 2
and over admitted to
eligible hospital’s or
CAH’s inpatient or
emergency
department (POS 21 or
23), blood pressure
height and weight are
recorded as structured
data

Record and chart changes
in vital signs:
 Height
 Weight
 Blood pressure (age 3
and over)
 Calculate and display
BMI
 Plot and display
growth charts for
patients 0-20 years,
including BMI

More than 80% of all
unique patients admitted
to the eligible hospital's or
CAH's inpatient or
emergency department
(POS 21 or 23) have blood
pressure (for patients age
3 and over only) and
height and weight (for all
ages) recorded as
structured data

More than 50% of all
unique patients 13
years old or older
admitted to the
eligible hospital’s or
CAH’s inpatient or
emergency
department (POS 21 or
23) have smoking
status recorded as
structured data
Implement one clinical
decision support rule

Record smoking status for
patients 13 years old or
older

More than 80% of all
unique patients 13 years
old or older admitted to
the eligible hospital's or
CAH's inpatient or
emergency department
(POS 21 or 23) have
smoking status recorded
as structured data

Use clinical decision
support to improve
performance on highpriority health conditions

1. Implement 5 clinical
decision support
interventions related
to 4 or more clinical
quality measures, if
applicable, at a
relevant point in
patient care for the
entire EHR reporting
period.
2. The eligible hospital or
CAH has enabled the
functionality for drugdrug and drug-allergy
interaction checks for
the entire EHR
reporting period
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Report clinical
quality measures
(CQMs) to CMS or
the States

Provide patients
with an electronic
copy of their health
information
(including
diagnostic test
results, problem
list, medication
lists, medication
allergies), upon
request

For 2011, provide
aggregate numerator,
denominator, and
exclusions through
attestation or
electronically through
the Hospital Reporting
Pilot
More than 50% of all
patients of the
inpatient or
emergency
departments of the
eligible hospital or CAH
(POS 21 or 23) who
request an electronic
copy of their health
information are
provided it within 3
business days

No longer a separate
objective for Stage 2, but
providers must still submit
CQMs to CMS or the
States in order to achieve
meaningful use

Starting in 2014, all CQMs
will be submitted
electronically to CMS.

Provide patients the ability
to view online, download
and transmit their health
information within 36
hours after discharge from
the hospital

i. More than 50% of all
unique patients
discharged from the
inpatient or
emergency
departments of the
eligible hospital or CAH
(POS 21 or 23) during
the EHR reporting
period are provided
timely (available to the
patient within 36
hours after discharge
from the hospital.)
online access to their
health information
ii. More than 5% of all
unique patients
discharged from the
inpatient or
emergency
departments of the
eligible hospital or CAH
(POS 21 or 23) during
the EHR reporting
period (or their
authorized
representatives) view,
download, or transmit
to a third party their
health information
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Provide patients
with an electronic
copy of their
discharge
instructions at time
of discharge, upon
request

Capability to
exchange key
clinical information
(for example,
problem list,
medication list,
medication
allergies, diagnostic
test results), among
providers of care
and patient
authorized entities
electronically
Protect electronic
health information
created or
maintained by the
certified EHR
technology through
the implementation
of appropriate
technical
capabilities

More than 50% of all
patients who are
discharged from an
eligible hospital or
CAH’s inpatient
department or
emergency
department (POS 21 or
23) and who request
an electronic copy of
their discharge
instructions are
provided it
Performed at least one
test of certified EHR
technology's capacity
to electronically
exchange key clinical
information

This objective is
eliminated from Stage 1
in 2014 and is no longer a
separate objective for
Stage 2

This measure has been
incorporated into the
View, Download, and
Transmit objective for
Stage 2

This objective is
eliminated from Stage 1
in 2013 and is no longer
an objective for Stage 2

This measure is
eliminated from Stage 1
in 2013 and is no longer a
measure for Stage 2

Conduct or review a
security risk analysis
per 45 CFR 164.308
(a)(1) and implement
security updates as
necessary and correct
identified security
deficiencies as part of
its risk management
process

Protect electronic health
information created or
maintained by the
Certified EHR Technology
through the
implementation of
appropriate technical
capabilities

Conduct or review a
security risk analysis in
accordance with the
requirements under 45
CFR 164.308 (a)(1),
including addressing the
encryption/security of
data at rest and
implement security
updates as necessary and
correct identified security
deficiencies as part of its
risk management process
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Implement drugformulary checks

Incorporate clinical
lab-test results into
certified EHR
technology as
structured data

Generate lists of
patients by specific
conditions to use
for quality
improvement,
reduction of
disparities, research
or outreach

The eligible
hospital/CAH has
enabled this
functionality and has
access to at least one
internal or external
drug formulary for the
entire EHR reporting
period
More than 40% of all
clinical lab tests results
ordered by an
authorized provider of
the eligible hospital or
CAH for patients
admitted to its
inpatient or
emergency
department (POS 21 or
23) during the EHR
reporting period
whose results are
either in a
positive/negative or
numerical format are
incorporated in
certified EHR
technology as
structured data
Generate at least one
report listing patients
of the eligible hospital
or CAH with a specific
condition

No longer a separate
objective for Stage 2

This measure is
incorporated into the ePrescribing measure for
Stage 2

Incorporate clinical labtest results into Certified
EHR Technology as
structured data

More than 55% of all
clinical lab tests results
ordered by authorized
providers of the eligible
hospital or CAH for
patients admitted to its
inpatient or emergency
department (POS 21 or 23
during the EHR reporting
period whose results are
either in a
positive/negative or
numerical format are
incorporated in Certified
EHR Technology as
structured data

Generate lists of patients
by specific conditions to
use for quality
improvement, reduction
of disparities, research, or
outreach

Generate at least one
report listing patients of
the eligible hospital or
CAH with a specific
condition
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Use certified EHR
technology to
identify patientspecific education
resources and
provide those
resources to the
patient if
appropriate
The eligible hospital
or CAH that
receives a patient
from another
setting of care or
provider of care or
believes an
encounter is
relevant should
perform medication
reconciliation
The eligible hospital
or CAH that
transitions their
patient to another
setting of care or
provider of care or
refers their patient
to another provider
of care should
provide summary
of care record for
each transition of
care or referral

More than 10% of all
unique patients
admitted to the
eligible hospital’s or
CAH’s inpatient or
emergency
department (POS 21 or
23) are provided
patient-specific
education resources
The eligible hospital or
CAH performs
medication
reconciliation for more
than 50% of transitions
of care in which the
patient is admitted to
the eligible hospital’s
or CAH’s inpatient or
emergency
department (POS 21 or
23)
The eligible hospital or
CAH that transitions or
refers their patient to
another setting of care
or provider of care
provides a summary of
care record for more
than 50% of transitions
of care and referrals

Use certified EHR
technology to identify
patient-specific education
resources and provide
those resources to the
patient if appropriate

The eligible hospital or
CAH that receives a
patient from another
setting of care or provider
of care or believes an
encounter is relevant
should perform
medication reconciliation

The eligible hospital or
CAH that transitions their
patient to another setting
of care or provider of care
or refers their patient to
another provider of care
should provide summary
of care record for each
transition of care or
referral
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More than 10% of all
unique patients admitted to
the eligible hospital's or
CAH's inpatient and
emergency departments
(POS 21 and 23) are
provided patient- specific
education resources
identified by Certified EHR
Technology
The eligible hospital or CAH
performs medication
reconciliation for more than
50% of transitions of care in
which the patient is
admitted to the eligible
hospital’s or CAH’s inpatient
or emergency department
(POS 21 or 23)

1. The eligible hospital, or
CAH that transitions or
refers their patient to
another setting of care
or provider of care
provides a summary of
care record for more
than 50% of transitions
of care and referrals
2. The eligible hospital or
CAH that transitions or
refers their patient to
another setting of care
or provider of care
provides a summary of
care record either a)
electronically
transmitted to a
recipient using CEHRT or
b) where the

recipient receives the
summary of care
record via exchange
facilitated by an
organization that is a
NwHIN Exchange
participant or is
validated through an
ONC‑established
governance
mechanism to
facilitate exchange for
10% of transitions and
referrals
3. The eligible hospital or
CAH that transitions or
refers their patient to
another setting of care
or provider of care
must either a) conduct
one or more
successful electronic
exchanges of a
summary of care
record with a recipient
using technology that
was designed by a
different EHR
developer than the
sender’s, or b)
conduct one or more
successful tests with
the CMS-designed test
EHR during the EHR
reporting period
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Capability to submit
electronic data to
immunization
registries or
Immunization
Information
Systems and actual
submission except
where prohibited
and in accordance
with applicable law
and practice

Capability to submit
electronic data on
reportable (as
required by state or
local law) lab
results to public
health agencies and
actual submission
except where
prohibited and in
accordance with
applicable law and
practice

Performed at least one
test of certified EHR
technology's capacity
to submit electronic
data to immunization
registries and follow
up submission if the
test is successful
(unless none of the
immunization
registries to which the
eligible hospital or CAH
submits such
information have the
capacity to receive the
information
electronically)
Performed at least one
test of certified EHR
technology’s capacity
to provide electronic
submission of
reportable lab results
to public health
agencies and follow-up
submission if the test
is successful (unless
none of the public
health agencies to
which eligible hospital
or CAH submits such
information have the
capacity to receive the
information
electronically)

Capability to submit
electronic data to
immunization registries or
Immunization Information
Systems and actual
submission except where
prohibited and in
accordance with
applicable law and
practice

Successful ongoing
submission of electronic
immunization data from
Certified EHR Technology
to an immunization
registry or immunization
information system for the
entire EHR reporting
period

Capability to submit
electronic data on
reportable (as required by
state or local law) lab
results to public health
agencies and actual
submission except where
prohibited and in
accordance with
applicable law and
practice

Successful ongoing
submission of electronic
reportable laboratory
results from Certified EHR
Technology to public
health agencies for the
entire EHR reporting
period as authorized, and
in accordance with
applicable State law and
practice
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Capability to submit
electronic
syndromic
surveillance data to
public health
agencies and actual
submission except
where prohibited
and in accordance
with applicable law
and practice

NEW

Performed at least one
test of certified EHR
technology's capacity
to provide electronic
syndromic surveillance
data to public health
agencies and follow-up
submission if the test
is successful (unless
none of the public
health agencies to
which an eligible
hospital or CAH
submits such
information have the
capacity to receive the
information
electronically)
NEW

Capability to submit
electronic syndromic
surveillance data to public
health agencies and actual
submission except where
prohibited and in
accordance with
applicable law and
practice

Successful ongoing
submission of electronic
syndromic surveillance
data from Certified EHR
Technology to a public
health agency for the
entire EHR reporting
period

Automatically track
medications from order to
administration using
assistive technologies in
conjunction with an
electronic medication
administration record
(eMAR)

More than 10% of
medication orders created
by authorized providers of
the eligible hospital's or
CAH's inpatient or
emergency department
(POS 21 or 23) during the
EHR reporting period for
which all doses are
tracked are tracked using
eMAR
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Stage 1
Objective
Record advance
directives for
patients 65 years
old or older

NEW

NEW

Stage 1 Measure
More than 50% of
all unique patients
65 years old or
olderadmitted to
the eligible
hospital’s or CAH’s
inpatient
department (POS
21) have an
indication of an
advance directive
status recorded
NEW

NEW

Stage 2 Objective

Stage 2 Measure

Record whether a
patient 65 years old
or older has an
advance directive

More than 50% of all unique
patients 65 years old or older
admitted to the eligible
hospital's or CAH's inpatient
department (POS 21) during the
EHR reporting period have an
indication of an advance
directive status recorded as
structured data

Record electronic
notes in patient
records

Enter at least one electronic
progress note created, edited
and signed by an EP for more
than 30% of unique patients
admitted to the eligible hospital
or CAH’s inpatient or emergency
department during the EHR
reporting period

Imaging results
consisting of the image
itself and any
explanation or other
accompanying
information are
accessible through
CEHRT.

More than 10% of all scans and
tests whose result is an image
ordered by an authorized
provider of the eligible hospital
or CAH for patients admitted to
its inpatient or emergency
department (POS 21 and
23) during the EHR reporting
period are incorporated into or
accessible through Certified
EHR Technology
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NEW

NEW

Record patient family
health history as
structured data

NEW

NEW

Generate and transmit
permissible discharge
prescriptions electronically
(eRx)

NEW

NEW

Provide structured
electronic lab results to
ambulatory providers
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More than 20% of all
unique patients admitted
to the eligible hospital or
CAH's inpatient or
emergency department
(POS 21 or 23) during the
EHR reporting period have
a structured data entry for
one or more first-degree
relatives or an indication
that family health history
has been reviewed
More than 10% of hospital
discharge medication
orders for permissible
prescriptions (for new or
changed prescriptions) are
compared to at least one
drug formulary and
transmitted electronically
using Certified EHR
Technology
Hospital labs send
structured electronic
clinical lab results to the
ordering provider for
more than 20% of
electronic lab orders
received
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Payment Adjustments & Hardship
Exceptions Tipsheet for Eligible
Hospitals and CAHs
Overview
As part of the American Recovery and Reinvestment Act of 2009 (ARRA), Congress mandated payment
adjustments to be applied to Medicare eligible hospitals, and critical access hospitals (CAHs) that are not
meaningful users of Certified Electronic Health Record (EHR) Technology under the Medicare EHR
Incentive Programs. These payment adjustments will be applied beginning on October 1, 2014, for
Medicare eligible hospitals. Payment adjustments for CAHs will be applied beginning with the fiscal year
2015 cost reporting period. Medicaid eligible hospitals that can only participate in the Medicaid EHR
Incentive Program and do not bill Medicare are not subject to these payment adjustments.
Eligible hospitals and CAHs that can participate in either the Medicare or Medicaid EHR Incentive
Programs will be subject to the payment adjustments unless they are meaningful users under one of the
EHR Incentive Programs in the time periods specified below.
Payment Adjustment for Medicare Subsection (d) Eligible Hospitals
Medicare Subsection (d) eligible hospitals that are not meaningful users will be subject to a payment
adjustment beginning on October 1, 2014. This payment adjustment is applicable to the percentage
increase to the Inpatient Prospective Payment System (IPPS) payment rate for those eligible hospitals
that are not meaningful EHR users. These hospitals will receive a reduced update to the IPPS
standardized amount. The payment adjustment is cumulative for each year that a Medicare Subsection
(d) eligible hospital is not a meaningful EHR user. The table below illustrates the application of the
reduced update to the IPPS standardized amount.

% Decrease

2015

2016

2017

2018

2019

2020+

25%

50%

75%

75%

75%

75%

For example if the increase to IPPS for 2015 was 2%, then an Medicare subsection (d) eligible hospital
that is not a meaningful user would only receive a 1.5% increase in 2015.
Medicare Subsection (d) eligible hospitals that first demonstrated meaningful use in fiscal year 2011 or
2012 must demonstrate meaningful use for a full year in fiscal year 2013 to avoid payment adjustments
in 2015. They must continue to demonstrate meaningful use every year to avoid payment adjustments
in subsequent years. The table below illustrates the timeline to avoid payment adjustments for
Medicare Subsection (d) eligible hospitals that must demonstrate meaningful use for a full year in 2013.
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Payment Adjustment Year

2015

2016

2017

2018

2019

2020

Full Year EHR Reporting Period

2013

2014

2015

2016

2017

2019

Medicare Subsection (d) eligible hospitals that first demonstrate meaningful use in fiscal year 2013 must
demonstrate meaningful use for a 90-day reporting period in 2013 to avoid payment adjustments in
2015. They must continue to demonstrate meaningful use every year to avoid payment adjustments in
subsequent years. The table below illustrates the timeline to avoid payment adjustments for EPs who
demonstrate meaningful use for a 90-day reporting period in 2013.

Payment Adjustment Year

2015

90 day EHR Reporting Period

2013

Full Year EHR Reporting Period

2016

2017

2018

2019

2020

2013

2013

2013

2013

2013

Medicare Subsection (d) eligible hospitals that first demonstrate meaningful use in fiscal year 2014 must
demonstrate meaningful use for a 90-day reporting period in 2014 to avoid payment adjustments in
2015. This reporting period must occur in the first 9 months of fiscal year 2014, and Medicare
Subsection (d) eligible hospitals must attest to meaningful use no later than July 1, 2014, in order to
avoid the payment adjustments. Medicare Subsection (d) eligible hospitals must continue to
demonstrate meaningful use every year to avoid payment adjustments in subsequent years. The table
below illustrates the timeline to avoid payment adjustments for Medicare Subsection (d) eligible
hospitals that first demonstrate meaningful use in 2014.

Payment Adjustment Year

2015

2016

90 day EHR Reporting Period

2014*

2014

Full Year EHR Reporting Period

2017

2018

2019

2020

2015

2016

2017

2019

* Medicare Subsection (d) eligible hospitals must attest to meaningful use no later than April 1, 2014.
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Payment Adjustment for Critical Access Hospitals
Critical Access Hospitals (CAHs) that are not meaningful users will be subject to a payment adjustment
for fiscal year 2015. This payment adjustment is applicable to a CAH's Medicare reimbursement for
inpatient services during the cost reporting period in which they failed to demonstrate meaningful use.
If a CAH has not demonstrated meaningful use for an applicable reporting period, then for a cost
reporting period that begins in FY 2015, its reimbursement would be reduced from 101 percent of its
reasonable costs to 100.66 percent. For a cost reporting period beginning in FY 2016, its reimbursement
would be reduced to 100.33 percent of its reasonable costs. For a cost reporting period beginning in FY
2017 and each subsequent FY, its reimbursement would be reduced to 100 percent of reasonable costs.
The table below illustrates the application of the payment adjustments to CAHs that fail to demonstrate
meaningful use.

% of reasonable costs

2015

2016

2017

2018

2019

2020+

100.66%

100.33%

100%

100%

100%

100%

In order to avoid the payment adjustments, CAHs must demonstrate meaningful use within the full
Federal fiscal year that is the same as the payment adjustment year. The adjustment would then apply
based upon the cost reporting period that begins in the payment adjustment year (that is, fiscal year
2015 and thereafter). Thus, if a CAH is not a meaningful user for fiscal year 2015, and thereafter, then
the adjustment would be applied to the CAH's reasonable costs incurred in a cost reporting period that
begins in that affected fiscal year. The table below illustrates the timeline to avoid payment adjustments
for CAHs that demonstrate meaningful use for the first time prior to fiscal year 2015.

Payment Adjustment Year

2015

2016

2017

2018

2019

2020

Full Year EHR Reporting Period

2015

2016

2017

2018

2019

2020

The table below illustrates the timeline to avoid payment adjustments for CAHs that demonstrate
meaningful use for the first time in fiscal year 2015.

Payment Adjustment Year

2015

90 day EHR Reporting Period

2015

Full Year EHR Reporting Period

171

2016

2017

2018

2019

2020

2016

2017

2018

2019

2020

Note: CAHs are required to submit their attestations for meaningful use by November 30th of the
following fiscal year. For example, if a CAH is attesting that it was a meaningful EHR user for fiscal year
2015, the attestation must be submitted no later than November 30, 2015 in order to avoid payment
adjustments.
Hardship Exceptions for Medicare Eligible Hospitals and CAHs
Eligible hospitals and CAHs may apply for hardship exceptions to avoid the payment adjustments
described above. Hardship exceptions will be granted only under specific circumstances and only if CMS
determines that providers have demonstrated that those circumstances pose a significant barrier to
their achieving meaningful use. Information on how to apply for a hardship exception will be posted on
the CMS EHR Incentive Programs website (www.cms.gov/EHRIncentivePrograms) in the future.
Medicare Subsection (d) eligible hospitals can apply for hardship exceptions in the following categories:
 Infrastructure — Eligible hospitals must demonstrate that they are in an area without sufficient
internet access or face insurmountable barriers to obtaining infrastructure (e.g., lack of
broadband).
 New eligible hospitals — Eligible hospitals with new CMS Certification Numbers (CCNs) that
would not have had time to become meaningful users can apply for a limited exception to
payment adjustments. The hardship exception is limited to one full-year cost reporting period.
 Unforeseen Circumstances — Examples may include a natural disaster or other unforeseeable
barrier.
Critical Access Hospitals (CAHs) can apply for hardship exceptions in the following categories:
 Infrastructure — CAHs must demonstrate that they are in an area without sufficient internet
access or face insurmountable barriers to obtaining infrastructure (e.g., lack of broadband).
 New CAHs — CAHs with new CMS Certification Numbers (CCNs) that would not have had time
to become meaningful users can apply for a limited exception to payment adjustments. The
hardship exception is limited to one full year after the CAH accepts its first patient.
 Unforeseen Circumstances — Examples may include a natural disaster or other unforeseeable
barrier.
Frequently Asked Questions
Does a hospital have to achieve meaningful use each year to avoid the payment adjustments or can it
avoid the payment adjustments by achieving meaningful use only once?
Hospitals must demonstrate meaningful use every year according to the timelines detailed above in
order to avoid Medicare payment adjustments. For example, eligible hospital that demonstrates
meaningful use for the first time in 2013 will avoid the payment adjustment in 2015, but will need to
demonstrate meaningful use again in 2014 in order to avoid the payment adjustment in 2016. Similarly,
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An eligible hospital or CAH demonstrates meaningful use by successfully attesting through either the
CMS Medicare EHR Incentive Programs Attestation System (https://ehrincentives.cms.gov/) or through
its state’s attestation system.
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CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS
BEGINNING WITH FY 2014

CMS
eMeasure
ID

NQF
#

55

0495

111

0497

Measure Title

Denominator
Statement

Measure
Steward

Measure Description

Numerator Statement

Emergency
Department (ED)-1
Emergency
Department
Throughput – Median
time from ED arrival
to ED departure for
admitted ED patients

Median time from
emergency department
arrival to time of
departure from the
emergency room for
patients admitted to the
facility from the
emergency department.

For Meaningful Use
Stage 2 reporting:
Median time (in minutes)
from ED arrival to ED
departure for patients
admitted to the facility
from the emergency
department.

For Meaningful Use
Stage 2 reporting: All ED
patients admitted to the
facility from the ED and
stratified according to
Inpatient Admission or
Diagnosis of
Psychiatric/Mental
Health condition

CMS

ED-2 Emergency
Department
Throughput –
admitted patients –
Admit decision time
to ED departure time
for admitted patients

Median time (in minutes)
from admit decision time
to time of departure from
the emergency
department for
emergency department
patients admitted to
inpatient status.

For Meaningful Use
Stage 2 reporting:
Median time (in minutes)
from Decision to Admit
to ED departure for
patients admitted to the
facility from the
emergency department.

For Meaningful Use
Stage 2 reporting: All
ED patients admitted to
the facility from the ED
and stratified according
to Inpatient Admission or
Diagnosis of
Psychiatric/Mental
Health condition.

CMS

OFMQ is the
developer

OFMQ is the
developer

Link to NQF
website
http://www.qualityfor
um.org/QPS/Measur
eDetails.aspx?stand
ardID=470&print=0&
entityTypeID=1

http://www.qualityfor
um.org/QPS/Measur
eDetails.aspx?stand
ardID=472&print=0&
entityTypeID=1

104

0435

Stroke-2 Ischemic
stroke – Discharged
on anti-thrombotic
therapy.

Ischemic stroke patients
prescribed antithrombotic
therapy at hospital
discharge.

Ischemic stroke patients
prescribed
antithrombotic therapy at
hospital discharge.

Ischemic stroke patients.

The Joint
Commission

http://www.qualityfor
um.org/QPS/Measur
eDetails.aspx?stand
ardID=672&print=0&
entityTypeID=1

71

0436

Stroke-3 Ischemic
stroke –
Anticoagulation
Therapy for Atrial
Fibrillation/Flutter

Ischemic stroke patients
with atrial fibrillation/flutter
who are prescribed
anticoagulation therapy at
hospital discharge.

Ischemic stroke patients
prescribed
anticoagulation therapy
at hospital discharge.

Ischemic stroke patients
with documented atrial
fibrillation/flutter.

The Joint
Commission

http://www.qualityfor
um.org/QPS/Measur
eDetails.aspx?stand
ardID=673&print=0&
entityTypeID=1

175

CMS
eMeasure
ID

NQF
#

91

Denominator
Statement

Measure
Steward

Link to NQF
website

Measure Title

Measure Description

Numerator Statement

0437

Stroke-4 Ischemic
stroke – Thrombolytic
Therapy

Acute ischemic stroke
patients who arrive at this
hospital within 2 hours
(120 minutes) of time last
known well and for whom
IV t-PA was initiated at
this hospital within 3
hours (180 minutes) of
time last known well.

Acute ischemic stroke
patients for whom IV
thrombolytic therapy was
initiated at this hospital
within 3 hours (less than
or equal to 180 minutes)
of time last known well.

Acute ischemic stroke
patients whose time of
arrival is within 2 hours
(less than or equal to
120 minutes) of time last
known well.

The Joint
Commission

http://www.qualityfor
um.org/QPS/Measur
eDetails.aspx?stand
ardID=674&print=0&
entityTypeID=1

72

0438

Stroke-5 Ischemic
stroke –
Antithrombotic
therapy by end of
hospital day two

Ischemic stroke patients
administered
antithrombotic therapy by
the end of hospital day
two.

Ischemic stroke patients
who had antithrombotic
therapy administered by
end of hospital day two.

Ischemic stroke patients.

The Joint
Commission

http://www.qualityfor
um.org/QPS/Measur
eDetails.aspx?stand
ardID=675&print=0&
entityTypeID=1

105

0439

Stroke-6 Ischemic
stroke – Discharged
on Statin Medication

Ischemic stroke patients
with LDL greater than or
equal to 100 mg/dL, or
LDL not measured, or,
who were on a lipidlowering medication prior
to hospital arrival are
prescribed statin
medication at hospital
discharge.

Ischemic stroke patients
prescribed statin
medication at hospital
discharge.

Ischemic stroke patients
with an LDL greater than
or equal to 100 mg/dL,
OR LDL not measured,
OR who were on a lipidlowering medication prior
to hospital arrival.

The Joint
Commission

http://www.qualityfor
um.org/QPS/Measur
eDetails.aspx?stand
ardID=676&print=0&
entityTypeID=1
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CMS
eMeasure
ID

NQF
#

107

102

Denominator
Statement

Measure
Steward

Link to NQF
website

Measure Title

Measure Description

Numerator Statement

0440

Stroke-8 Ischemic or
hemorrhagic stroke –
Stroke education

Ischemic or hemorrhagic
stroke patients or their
caregivers who were
given educational
materials during the
hospital stay addressing
all of the following:
activation of emergency
medical system, need for
follow-up after discharge,
medications prescribed at
discharge, risk factors for
stroke, and warning signs
and symptoms of stroke.

Ischemic or hemorrhagic
stroke patients with
documentation that they
or their caregivers were
given educational
material addressing all
of the following:
1. Activation of
emergency medical
system
2. Need for follow-up
after discharge
3. Medications
prescribed at
discharge
4. Risk factors for stroke
5. Warning signs and
symptoms of stroke.

Ischemic stroke or
hemorrhagic stroke
patients discharged to
home.

The Joint
Commission

http://www.qualityfor
um.org/QPS/Measur
eDetails.aspx?stand
ardID=678&print=0&
entityTypeID=1

0441

Stroke-10 Ischemic
or hemorrhagic
stroke – Assessed for
Rehabilitation

Ischemic or hemorrhagic
stroke patients who were
assessed for
rehabilitation services.

Ischemic or hemorrhagic
stroke patients assessed
for or who received
rehabilitation services.

Patients admitted to the
hospital for inpatient
acute care with a
principal diagnosis code
for ischemic or
hemorrhagic stroke with
hospital stays <= 120
days during the
measurement period for
patients age 18 and
older at the time of
hospital admission.

The Joint
Commission

http://www.qualityfor
um.org/QPS/Measur
eDetails.aspx?stand
ardID=680&print=0&
entityTypeID=1
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CMS
eMeasure
ID

NQF
#

108

0371

190

0372

Measure Title

Denominator
Statement

Measure
Steward

Link to NQF
website

Measure Description

Numerator Statement

Venous
Thromboembolis
m (VTE)-1 VTE
prophylaxis

This measure assesses
the number of patients
who received VTE
prophylaxis or have
documentation why no
VTE prophylaxis was
given the day of or the
day after hospital
admission or surgery end
date for surgeries that
start the day of or the day
after hospital admission.

Patients who received
VTE prophylaxis or have
documentation why no
VTE prophylaxis was
given:
 the day of or the day
after hospital
admission
 the day of or the day
after surgery end date
for surgeries that start
the day of or the day
after hospital
admission

All patients in the initial
patient population.

The Joint
Commissio
n

http://www.qualityfor
um.org/QPS/Measur
eDetails.aspx?stand
ardID=270&print=0&
entityTypeID=1

VTE-2 Intensive Care
Unit (ICU) VTE
prophylaxis

This measure assesses
the number of patients
who received VTE
prophylaxis or have
documentation why no
VTE prophylaxis was
given the day of or the
day after the initial
admission (or transfer) to
the ICU or surgery end
date for surgeries that
start the day of or the day
after ICU admission (or
transfer).

Patients who received
VTE prophylaxis or have
documentation why no
VTE prophylaxis was
given:
 the day of or the day
after ICU admission
(or transfer)
 the day of or the day
after surgery end date
for surgeries that start
the day of or the day
after ICU admission
(or transfer)

Patients directly admitted
or transferred to ICU.

The Joint
Commission

http://www.qualityfor
um.org/QPS/Measur
eDetails.aspx?stand
ardID=267&print=0&
entityTypeID=1
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CMS
eMeasure
ID

NQF
#

73

0373

Measure Title
VTE-3 VTE Patients
with Anticoagulation
Overlap Therapy

Measure Description

Numerator Statement

This measure assesses
the number of patients
diagnosed with confirmed
VTE who received an
overlap of parenteral
(intravenous [IV] or
subcutaneous [subcu])
anticoagulation and
warfarin therapy. For
patients who received
less than five days of
overlap therapy, they
must be discharged on
both medications or have
a reason for
discontinuation of overlap
therapy. Overlap therapy
must be administered for
at least five days with an
international normalized
ratio (INR) greater than or
equal to 2 prior to
discontinuation of the
parenteral anticoagulation
therapy, discharged on
both medications or have
a reason for
discontinuation of overlap
therapy.

Patients who received
overlap therapy
(warfarin and parenteral
anticoagulation):
 Five or more days,
with an INR greater
than or equal to 2 prior
to discontinuation of
parenteral therapy, OR
 Five or more days,
with an INR less than
2 and discharged on
overlap therapy, OR
 Less than five days
and discharged on
overlap therapy, OR
 With documentation of
reason for
discontinuation of
overlap therapy, OR
 With documentation of
a reason for no
overlap therapy
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Denominator
Statement
Patients with confirmed
VTE who received
warfarin.

Measure
Steward

Link to NQF
website

The Joint
Commission

http://www.qualityfor
um.org/QPS/Measur
eDetails.aspx?stand
ardID=271&print=0&
entityTypeID=1

CMS
eMeasure
ID

NQF
#

109

0374

110

0375

Measure Title

Denominator
Statement

Measure
Steward

Link to NQF
website

Measure Description

Numerator Statement

VTE-4 VTE Patients
Receiving
Unfractionated
Heparin (UFH) with
Dosages/Platelet
Count Monitoring by
Protocol (or
Nomogram)

This measure assesses
the number of patients
diagnosed with confirmed
VTE who received
intravenous (IV) UFH
therapy dosages AND
had their platelet counts
monitored using defined
parameters such as a
nomogram or protocol.

Patients who have their
IV UFH therapy dosages
AND platelet counts
monitored according to
defined parameters such
as a nomogram or
protocol.

Patients with confirmed
VTE receiving IV UFH
therapy.

The Joint
Commission

http://www.qualityfor
um.org/QPS/Measur
eDetails.aspx?stand
ardID=268&print=0&
entityTypeID=1

VTE-5 VTE discharge
instructions

This measure assesses
the number of patients
diagnosed with confirmed
VTE that are discharged
to home, home care,
court/law enforcement or
home on hospice care on
warfarin with written
discharge instructions
that address all four
criteria: compliance
issues, dietary advice,
follow-up monitoring, and
information about the
potential for adverse drug
reactions/interactions.

Patients with
documentation that they
or their caregivers were
given written discharge
instructions or other
educational material
about warfarin that
addressed all of the
following:
1. compliance issues
2. dietary advice
3. follow-up monitoring
4. potential for adverse
drug reactions and
interactions

Patients with confirmed
VTE discharged to home
or court/law enforcement
on warfarin therapy.

The Joint
Commission

http://www.qualityfor
um.org/QPS/Measur
eDetails.aspx?stand
ardID=269&print=0&
entityTypeID=1
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CMS
eMeasure
ID

NQF
#

114

0376

100

0142

113

0469

Measure Title

Denominator
Statement

Measure
Steward

Link to NQF
website

Measure Description

Numerator Statement

VTE-6 Incidence of
potentially
preventable VTE

This measure assesses
the number of patients
diagnosed with confirmed
VTE during
hospitalization (not
present at admission)
who did not receive VTE
prophylaxis between
hospital admission and
the day before the VTE
diagnostic testing order
date.

Patients who received
no VTE prophylaxis prior
to the VTE diagnostic
test order date.

Patients who developed
confirmed VTE during
hospitalization.

The Joint
Commission

http://www.qualityfor
um.org/QPS/Measur
eDetails.aspx?stand
ardID=272&print=0&
entityTypeID=1

AMI-2-Aspirin
Prescribed at
Discharge for AMI

AMI patients who are
prescribed aspirin at
hospital discharge.

Acute Myocardial
Infarction patients who
are prescribed aspirin at
hospital discharge.

All AMI patients age 18
and older with an ICD-9CM Principal Diagnosis
Code for Acute
Myocardial Infarction.

CMS

http://www.qualityfor
um.org/QPS/Measur
eDetails.aspx?stand
ardID=1145&print=0
&entityTypeID=1

PC-01 Elective
Delivery Prior to 39
Completed Weeks
Gestation

Patients with elective
vaginal deliveries or
elective cesarean
sections at >= 37 and <
39 weeks of gestation
completed.

Patients with elective
deliveries.

Patients delivering
newborns with >= 37 and
< 39 weeks of gestation
completed.

The Joint
Commission

181

OFMQ is the
developer

http://www.qualityfor
um.org/QPS/Measur
eDetails.aspx?stand
ardID=296&print=0&
entityTypeID=1

CMS
eMeasure
ID

NQF
#

60

0164

Measure Title
AMI-7a Fibrinolytic
Therapy Received
Within 30 minutes of
Hospital Arrival

Measure Description

Numerator Statement

Acute myocardial
infarction (AMI) patients
with ST-segment
elevation or LBBB on the
ECG closest to arrival
time receiving fibrinolytic
therapy during the
hospital stay and having
a time from hospital
arrival to fibrinolysis of 30
minutes or less.

AMI patients whose time
from hospital arrival to
fibrinolysis is 30 minutes
or less.

182

Denominator
Statement
AMI patients age 18 and
older with ST-elevation
or LBBB on ECG who
received fibrinolytic
therapy with an ICD-9CM Principal Diagnosis
Code for AMI AND STsegment elevation or
LBBB on the ECG
performed closest to
hospital arrival AND
Fibrinolytic therapy
within 6 hours after
hospital arrival AND
Fibrinolytic therapy is
primary reperfusion
therapy.

Measure
Steward
CMS
OFMQ is the
developer

Link to NQF
website
http://www.qualityfor
um.org/QPS/Measur
eDetails.aspx?stand
ardID=1152&print=0
&entityTypeID=1

CMS
eMeasure
ID

NQF
#

53

0163

Measure Title
AMI-8a Primary PCI
Received Within 90
Minutes of Hospital
Arrival

Measure Description

Numerator Statement

Acute myocardial
infarction (AMI) patients
with ST-segment
elevation or LBBB on the
ECG closest to arrival
time receiving primary
PCI during the hospital
stay with a time from
hospital arrival to PCI of
90 minutes or less.

AMI patients whose time
from hospital arrival to
primary PCI is 90
minutes or less.

183

Denominator
Statement
Principal diagnosis of
AMI (International
Classification of
Diseases, 9th revision,
Clinical Modification
[ICD-9-CM] principal
diagnosis code: 410.00,
410.01, 410.10, 410.11,
410.20, 410.21, 410.30,
410.31, 410.40, 410.41,
410.50, 410.51, 410.60,
410.61, 410.70, 410.71,
410.80, 410.81, 410.90,
410.91); and PCI
procedure ICD-9-CM
principal or other
procedure code for PCI:
00.66); and AMI patients
age 18 and older with
ST-elevation or LBBB on
ECG who received
primary PCI with an ICD9-CM Principal
Diagnosis Code for AMI
AND PCI (ICD-9-CM
Principal and Other
Procedure Codes for
PCI) AND ST-segment
elevation or LBBB on the
ECG performed closest
to hospital arrival; and
PCI performed within 24
hours after hospital
arrival.

Measure
Steward
CMS
OFMQ is the
developer

Link to NQF
website
http://www.qualityfor
um.org/QPS/Measur
eDetails.aspx?stand
ardID=1151&print=0
&entityTypeID=1

CMS
eMeasure
ID

NQF
#

30

0639

188

0147

Measure Title

Measure Description

Numerator Statement

Denominator
Statement

AMI-10 Statin
Prescribed at
Discharge

Acute Myocardial
Infarction (AMI) patients
who are prescribed a
statin at hospital
discharge.

AMI patients who are
prescribed a statin
medication at hospital
discharge.

AMI patients.

PN-6 Initial Antibiotic
Selection for
CommunityAcquired Pneumonia
(CAP) in
Immunocompetent
Patients

Immunocompetent
patients with CAP who
receive an initial antibiotic
regimen during the first
24 hours that is
consistent with current
guidelines.

Pneumonia patients who
received an initial
antibiotic regimen
consistent with current
guidelines during the
first 24 hours of
hospitalization.
Numerator 1 (in
population 1) defines
appropriate antibiotics
for ICU patients.
Numerator 2 (in
population 2) defines
appropriate antibiotics
for non-ICU patients.

Pneumonia patients 18
years of age and older
with an ICD-9-CM
Hospital MeasuresPrincipal Diagnosis Code
of pneumonia, OR ICD9-CM Hospital
Measures-Principal
Diagnosis Code of
septicemia or respiratory
failure (acute or chronic)
and also a secondary
ICD-9-CM Other
Diagnosis Code of
pneumonia, and
abnormal findings on
chest x-ray or CT scan of
the chest within 24 hours
prior to hospital arrival or
during the
hospitalization.

184

Measure
Steward
CMS
OFMQ is the
developer

CMS
OFMQ is the
developer

Link to NQF
website
http://www.qualityfor
um.org/QPS/Measur
eDetails.aspx?stand
ardID=102&print=0&
entityTypeID=1
http://www.qualityfor
um.org/QPS/Measur
eDetails.aspx?stand
ardID=1134&print=0
&entityTypeID=1

CMS
eMeasure
ID

NQF
#

171

0527

Measure Title

Measure Description

Numerator Statement

SCIP-INF-1
Prophylactic
Antibiotic Received
within 1 Hour Prior to
Surgical Incision

Surgical patients with
prophylactic antibiotics
initiated within one hour
prior to surgical incision.
Patients who received
Vancomycin or a
Fluoroquinolone for
prophylactic antibiotics
should have the
antibiotics initiated within
2 hours prior to surgical
incision. Due to the
longer infusion time
required for Vancomycin
or a Fluoroquinolone, it is
acceptable to start these
antibiotics within 2 hours
prior to incision time.

Number of surgical
patients with
prophylactic antibiotics
initiated within one hour
prior to surgical incision
(two hours if receiving
vancomycin, in Appendix
C, Table 3.8, or a
fluoroquinolone, in
Appendix C, Table 3.10).

Denominator
Statement
All selected surgical
patients 18 years of age
and older with no
evidence of prior
infection with an ICD-9CM Principal Procedure
Code of selected
surgeries.
Denominator for
population 1 – Coronary
artery bypass graft
(CABG) procedures
Denominator for
population 2 – Other
cardiac surgery
Denominator for
population 3 – Hip
arthroplasty
Denominator for
population 4 – Knee
arthroplasty
Denominator for
population 5 – Colon
surgery
Denominator for
population 6 –
Abdominal hysterectomy
Denominator for
population 7 – Vaginal
hysterectomy
Denominator for
population 8 – Vascular
surgery

185

Measure
Steward
CMS
OFMQ is the
developer

Link to NQF
website
http://www.qualityfor
um.org/QPS/Measur
eDetails.aspx?stand
ardID=1154&print=0
&entityTypeID=1

CMS
eMeasure
ID

NQF
#

172

0528

Measure Title
SCIP-INF-2
Prophylactic
Antibiotic Selection
for Surgical Patients

Measure Description Numerator Statement
Surgical patients who
received prophylactic
antibiotics consistent
with current guidelines
(specific to each type
of surgical procedure).

Number of surgical
patients who received
recommended
prophylactic antibiotics
for their specific surgical
procedures.

Denominator
Statement
All selected surgical patients
18 years of age and older
with no evidence of prior
infection with an ICD-9- CM
Hospital Measures- Principal
Procedure Code of selected
surgeries.
Denominator for population
1 – Coronary artery bypass
graft (CABG) procedures
Denominator for
population 2 – Other
cardiac surgery
Denominator for
population 3 – Hip
arthroplasty
Denominator for
population 4 – Knee
arthroplasty
Denominator for
population 5 – Colon
surgery
Denominator for population
6–- Abdominal hysterectomy
Denominator for
population 7 – Vaginal
hysterectomy
Denominator for population
8 – Vascular surgery

186

Measur
e
Stewar
CMS
d
OFMQ is
the
developer

Link to
NQF
website
http://www.qualityf
or
um.org/QPS/Meas
ur
eDetails.aspx?sta
nd
ardID=1155&print
=0
&entityTypeID=1

CMS
eMeasure
ID

NQF
#

178

0453

32

0496

Denominator
Statement

Measure
Steward

Measure Title

Measure Description

Numerator Statement

SCIP-INF-9 Urinary
catheter removed on
Postoperative Day 1
(POD1) or
Postoperative Day 2
(POD2) with day of
surgery being day
zero

Surgical patients with
urinary catheter removed
on Postoperative Day 1
or Postoperative Day 2
with day of surgery being
day zero.

Number of surgical
patients whose urinary
catheter is removed on
POD 1 or POD 2 with
day of surgery being day
zero.

All selected surgical
patients 18 years of age
and older with a
catheter in place
postoperatively with an
ICD-9-CM Principal
Procedure Code of
selected surgeries.

CMS

ED-3 Median time
from ED arrival to ED
departure for
discharged ED
patients

Median time from
emergency department
arrival to time of
departure from the
emergency room for
patients discharged from
the emergency
department.

For Meaningful Use
Stage 2 reporting:
Median time (in minutes)
from ED arrival to ED
departure for patients
discharged from the
emergency department.

For Meaningful Use
Stage 2 reporting: All
ED patients discharged
from the ED and
stratified according to
Discharge Home,
Diagnosis of
Psychiatric/Mental
Health condition,
Observation status,
Transferred to Another
Acute Care Hospital, or
other patients not
discharged from the ED.
Do Not Include in any of
the Strata: Patients who
are not an ED Patient;
Patients who expire in
the ED; Patients
admitted to the hospital
from the ED.

CMS

187

OFMQ is the
developer

OFMQ is the
developer

Link to NQF
website
http://www.qualityfor
um.org/QPS/Measur
eDetails.aspx?stand
ardID=648&print=0&
entityTypeID=1

http://www.qualityfor
um.org/QPS/Measur
eDetails.aspx?stand
ardID=471&print=0&
entityTypeID=1

CMS
eMeasure
ID

NQF
#

26

0338

Measure Title

Measure Description

Numerator Statement

Home Management
Plan of Care (HMPC)
Document Given to
Patient/Caregiver

An assessment that there
is documentation in the
medical record that a
Home Management Plan
of Care document was
given to the pediatric
asthma patient/caregiver.

Pediatric asthma
inpatients with
documentation that they
or their caregivers were
given a written HMPC
document that
addresses all of the
following:
1. Arrangements for
follow-up care
2. Environmental control
and control of other
triggers
3. Method and timing of
rescue actions
4. Use of controllers
5. Use of relievers

188

Denominator
Statement
Pediatric asthma
inpatients with an age of
2 through 17 years,
length of stay less than
or equal to 120 days,
and discharged to home
or police custody.

Measure
Steward
The Joint
Commissio
n

Link to NQF
website
http://www.qualityfor
um.org/QPS/Measur
eDetails.aspx?stand
ardID=348&print=0&
entityTypeID=1

CMS
eMeasure
ID

NQF
#

9

0480

Measure Title
Exclusive Breast Milk
Feeding

Measure Description
Exclusive breast milk
feeding during the
newborn's entire
hospitalization.

Numerator Statement
Newborns that were fed
breast milk only since
birth.

189

Denominator
Statement

Measure
Steward

Link to NQF
website

Single term newborns
discharged from the
hospital who have no
diagnosis of
galactosemia, no
procedure of parenteral
infusion, no diagnosis of
premature newborn, and
length of stay less than
or equal to 120 days.

The Joint
Commission

http://www.qualityfor
um.org/QPS/Measur
eDetails.aspx?stand
ardID=307&print=0&
entityTypeID=1

CMS
eMeasure
ID

NQF
#

185

0716

31

1354

Measure Title

Denominator
Statement

Measure
Steward

Link to NQF
website

Measure Description

Numerator Statement

Healthy Term
Newborn

Percent of term singleton
live births (excluding
those with diagnoses
originating in the fetal
period) who DO NOT
have significant
complications during birth
or in nursery care.

The absence of
conditions or procedures
reflecting morbidity that
happened during birth
and nursery care to an
otherwise normal infant.

The denominator is
composed of singleton,
term (>=37 weeks),
inborn, livebirths in their
birth admission. The
denominator further has
eliminated fetal
conditions likely to be
present before labor.
Maternal and obstetrical
conditions (e.g.,
hypertension, prior
cesarean,
malpresentation) are not
excluded unless
evidence of fetal effect
prior to labor (e.g.,
IUGR/SGA).

California
Maternal
Quality Care
Collaborativ
e

http://www.qualityfor
um.org/QPS/Measur
eDetails.aspx?stand
ardID=171&print=0&
entityTypeID=1

EHDI-1a Hearing
screening before
hospital discharge

This measure assesses
the proportion of births
that have been screened
for hearing loss before
hospital discharge.

All live births during the
measurement time
period born at a facility
and screened for
hearing loss prior to
discharge, or screened
but still not discharged;
or not screened due to
medical reasons or
medical exclusions.

All live births during the
measurement time
period born at a facility
and, discharged without
being screened, or
screened prior to
discharge, or screened
but still not discharged.

Centers for
Disease
Control and
Prevention

http://www.qualityfor
um.org/QPS/Measur
eDetails.aspx?stand
ardID=1354&print=0
&entityTypeID=1
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CLINICAL QUALITY MEASURES FOR CMS’S 2014 EHR INCENTIVE PROGRAM
FOR ELIGIBLE HOSPITALS
RELEASE NOTES

In August 2012, the Centers for Medicare & Medicaid Services (CMS) finalized the clinical
quality measures (CQMs) for the 2014 Medicare and Medicaid Electronic Health Record (EHR)
Incentive Program for Eligible Hospitals, also known as Meaningful Use Stage 2 (MU2) for Eligible
Hospitals.1 This list of CQMs for MU2 includes measures retained from Meaningful Use Stage 1 (MU1)
for use in MU2. All retained MU1 measures have been updated based on advances in technology and
tools for eMeasure development, comments from stakeholders, changes initiated by measure developers,
and CMS’s standards as defined in the agency’s Measures Management System Blueprint, Version 8
(Blueprint).2 2
CMS recognizes the importance of providing support, training, and information to MU
stakeholders, particularly as the EHR Incentive Programs transition to MU2. The purpose of this
document is to inform eligible hospitals and the vendor community about updated program requirements
related to the CQMs. This update includes information about global changes incorporated across all
measures as well as specific changes to the measures retained in MU2. Global changes are listed first and
include structural modifications; updates to value sets; and data elements and standards revised in
accordance with the Blueprint. Specific changes to measures include changes to measure components,
such as initial patient populations, denominators, numerators, exclusions, and exceptions, as well as logic
changes that affect how data elements interrelate during the measurement period.

This document is intended for readers who are familiar with eMeasure components and the
current standards for construction an eMeasure. For more information on eMeasures, please visit the
CMS website (http://www.cms.gov/Regulations-andGuidance/Legislation/EHRIncentivePrograms/ClinicalQualityMeasures.html)

1

CMS. “Medicare and Medicaid Programs; Electronic Health Record Incentive Program—Stage 2.” 2012.

Available at [ http://www.ofr.gov/(X(1)S(uzclbwrx5fwqm2w2mipkysrh))/OFRUpload/OFRData/2012-21050_PI.pdf ]. Accessed August
28, 2012.
2

CMS. “CMS Measure Management System Blueprint, .” Available at [ http://www.cms.gov/Medicare/Quality-Initiatives-Patient-

Assessment-Instruments/MMS/MeasuresManagementSystemBlueprint.html ]. Accessed August 28, 2012. Since the completion of MU2
CQM’s the latest Blueprint version is 9.0.
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Global Edits


Introduced a new measure-identification scheme that combines the eMeasure identifier, National Quality
Forum (NQF) number (if applicable), and eMeasure version number.



Updated the rationale, clinical recommendation statements, and references to include the latest clinical
guidance related to the measures.



Provided additional guidance to help implementers interpret the calculation requirements for the measures
as well as instructional and clarifying notes.



Updated the eMeasure header to reflect Blueprint requirements (such as using the initial patient population
to define the denominator and including stratification variables in the header) and modified other fields,
such as population criteria, to reflect these changes.



Changed the standardization of the measurement period from “year” to “period.”



Updated the measure logic to reflect the changes to the Quality Data Model (QDM), to reflect consistent
use of relative timing across measures (including age calculation), occurrencing, and denominator
exclusions.



Assigned data elements based on version 2.1.1.1 of the QDM 3 to each clinical concept, adding attributes as
needed to precisely define QDM elements.



For measures using the QDM of “Medication, Active,” added the AND / AND NOT construct to
compensate for varying interpretations of the relative timing “during.” The “Medication, Active” period
can start at any time but cannot end before “Occurrence A of Encounter, Performed.”



Incorporated supplemental data elements (race, ethnicity, sex, and payer) as required by the Blueprint.



Reorganized and retitled the encounter value sets to standardize them across developers. Also incorporated
encounter value sets using SNOMED-CT to align with the Health Information Technology Standards
Committee (HITSC) vocabulary recommendation for the QDM data type “Encounter.”



Updated existing value sets and added new value sets to align with the transitional and final vocabularies,
based on the HITSC recommendations and required by the Blueprint.



Value sets include fully-specified ICD-9-CM and ICD-10-CM codes.



Provided grouping object identifiers for each data element.



Added copyright information for vocabularies.

3

For more on the Quality Data Model, visit the NQF website at http://www.qualityforum.org/QualityDataModel.aspx
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NQF 0495 Median time from ED arrival to ED departure for admitted ED patients




Added length of stay check for initial patient population of <=120 days
Observation services no longer used for stratification
ED visit must end within one hour of the inpatient encounter to associate the ED encounter with the
inpatient encounter.

NQF 0497 Median admit decision time to ED departure time for admitted patients




Added length of stay check for initial patient population of <=120 days
Observation services no longer use for stratification
ED visit must end within one hour of the inpatient encounter to associate the ED encounter with the
inpatient encounter.

NQF 0435 Ischemic stroke – Discharged on anti-thrombotic therapy



Added logic to denominator exclusion to accept documentation of palliative care (comfort measures
only) order during ED encounter for ED encounters within one hour of the inpatient encounter.
Specified that a medication order for antithrombotic therapy could be present within one day prior to
discharge.

NQF 0436 Ischemic stroke – Anticoagulation Therapy for Atrial Fibrillation/Flutter



Added logic to denominator exclusion to accept documentation of palliative care (comfort measures
only) order during ED encounter for ED encounters within one hour of the inpatient encounter.
Created the Atrial Ablation procedure value set to only include procedures specifically done for atrial
fibrillation/flutter.

NQF 0437 Ischemic stroke – Thrombolytic Therapy





Revised “Last Known Well” data element to create value sets for neurologic symptoms of stroke or
baseline state symptom documented within 120 minutes of ED arrival.
ED visit must end within one hour of the inpatient encounter to associate the ED encounter with the
inpatient encounter.
Added denominator exclusion if Thrombolytic Therapy (t-PA) was administered within two days prior
to inpatient encounter.
Added denominator exclusion for risk category of National Institute of Health Stroke Scale = 0.

NQF 0438 Ischemic stroke – Antithrombotic therapy by end of hospital day two



Added logic to denominator exclusion to accept documentation of palliative care (comfort measures
only) order during ED encounter for ED encounters within one hour of the inpatient encounter.
Added logic to denominator exclusion to identify patients with Thrombolytic Therapy (t-PA)
administered during their ED encounter for ED encounters within one hour of the inpatient encounter.
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NQF 0439 Ischemic stroke – Discharged on Statin Medication






Added logic to denominator to evaluate timing of LDL-c laboratory results or Lipid-Lowering
medication in relation to the ED encounter for ED encounters within one hour of the inpatient
encounter.
Added logic to denominator exclusion to accept documentation of palliative care (comfort measures
only) order during ED encounter for ED encounters within one hour of the inpatient encounter.
Specified that a medication order for statin could be present within one day prior to discharge.
Removed denominator exclusion for patients without evidence of atherosclerosis.

NQF 0440 Ischemic or hemorrhagic stroke – Stroke education


Added logic to denominator exclusion to accept documentation of palliative care (comfort measures
only) order during ED encounter for ED encounters within one hour of the inpatient encounter.

NQF 0441 Ischemic or hemorrhagic stroke – Assessed for Rehabilitation



Added logic to denominator exclusion to accept documentation of palliative care (comfort measures
only) order during ED encounter for ED encounters within one hour of the inpatient encounter.
Added numerator statement to include patients transferred to a rehabilitation facility.

NQF 0371 Venous Thromboembolism Prophylaxis






Added logic to denominator exclusion to accept documentation of palliative care (comfort measures
only) order during ED encounter for ED encounters within one hour of the inpatient encounter.
Added denominator exclusion for patients with palliative care (comfort measures only) orders within
one day of a procedure using general or neuraxial anesthesia occurring the day of or the day after the
inpatient encounter.
VTE prophylaxis medication and VTE prophylaxis mechanical device value sets separated into
individual value sets based on type of medication and device.
Added numerator statement for patient assessment of low risk for VTE.

NQF 0372 Intensive Care Unit (ICU) Venous Thromboembolism Prophylaxis






Added logic to denominator exclusion to accept documentation of palliative care (comfort measures
only) order during ED encounter for ED encounters within one hour of the inpatient encounter.
Added denominator exclusion for patients with palliative care (comfort measures only) orders within
one day of a procedure using general or neuraxial anesthesia occurring the day of or the day after the
ICU admission or transfer.
VTE prophylaxis medication and VTE prophylaxis mechanical device value sets separated into
individual value sets based on type of medication and device.
Added numerator statement for patient assessment of low risk for VTE.
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NQF 0373 Venous Thromboembolism Patients with Anticoagulation Overlap Therapy









Added logic to denominator exclusion to accept documentation of palliative care (comfort measures
only) order during ED encounter for ED encounters within one hour of the inpatient encounter.
Removed denominator exclusion for patients not discharged on warfarin.
Added denominator exclusions for the following discharge status values:
o Discharge to Another Hospital
o Discharge to Home for Hospice Care
o Discharge to Health Care Facility for Hospice Care
o Patient expired
o Left against advice
Added denominator statement to include patients with warfarin administration starting within one day
prior to inpatient encounter.
Clarified calculation method for determining patients who were on 5 or more days of overlap therapy.
Added numerator statements to include patients with documented reason for no overlap or
discontinuation of overlap therapy.
Added numerator statements to check for the administration of parenteral anticoagulant during the ED
encounter for ED encounters within one hour of the inpatient encounter.

NQF 0374 Venous Thromboembolism Patients Receiving Unfractionated Heparin (UFH) with
Dosages/Platelet Count Monitoring by Protocol (or Nomogram)






Added logic to denominator exclusion to accept documentation of palliative care (comfort measures
only) order during ED encounter for ED encounters within one hour of the inpatient encounter.
Added denominator exclusions for the following discharge status values:
o Discharge to Another Hospital
o Discharge to Home for Hospice Care
o Discharge to Health Care Facility for Hospice Care
o Patient expired
o Left against advice
Added denominator statement to use confirmed VTE from diagnostic study performed up to two days
prior to inpatient encounter.
Added denominator statement to use confirmed VTE from diagnostic study performed up to two days
prior to ED encounter for ED encounters within one hour of the inpatient encounter.

NQF 0375 Venous Thromboembolism Discharge Instructions






Added denominator statement to use confirmed VTE from diagnostic study performed up to two days
prior to inpatient encounter.
Added denominator statement to use confirmed VTE from diagnostic study performed up to two days
prior to ED encounter for ED encounters within one hour of the inpatient encounter.
Revised description and updated denominator statement to include patients discharged to court/law
enforcement.
Added denominator statement to include patients with warfarin administration starting within one day
prior to inpatient encounter
Added numerator statement to include patients who refused discharge instructions.
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NQF 0376 Incidence of potentially preventable Venous Thromboembolism





Added denominator statement to use confirmed VTE from diagnostic study performed up to two days
prior to inpatient encounter.
Added denominator statement to use confirmed VTE from diagnostic study performed up to two days
prior to ED encounter for ED encounters within one hour of the inpatient encounter.
Added logic to denominator exclusion to accept documentation of palliative care (comfort measures
only) order during ED encounter for ED encounters within one hour of the inpatient encounter.
VTE prophylaxis medication and VTE prophylaxis mechanical device value sets separated into
individual value sets based on type of medication and device.
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